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ABSTRACT 
Members of the genus Vibrio are Gram-negative, halophilic bacteria that inhabit warm 
coastal and estuarine waters worldwide. Among pathogenic vibrios, Vibrio parahaemolyticus is 
the leading cause of seafood-related illnesses and Vibrio vulnificus causes the highest number of 
seafood-related deaths in the United States. Moreover, according to the U.S. Centers for Disease 
Control and Prevention, the incidence of infections of the two vibrios due to the consumption of 
oysters has shown a sustained increase since 2001, indicating further measures are needed to 
prevent human Vibrio illness.  
In this dissertation research, a total of 622 Vibrio isolates, consisting of 252 V. 
parahaemolyticus and 370 V. vulnificus, were recovered from 82 Louisiana Gulf and retail raw 
oysters between 2005 and 2006. A selected subset of the isolates (168 V. parahaemolyticus and 
151 V. vulnificus) was determined for antimicrobial susceptibility profiles. In addition, V. 
vulnificus isolates (n = 349) were characterized by the presence/absence of a viuB-associated 
fragment and genotypes of three biomarkers: the virulence-correlated gene (vcg), 16S rRNA, and 
the capsular polysaccharide operon (CPS). Then multiplex PCR assays using three biomarkers: 
vcg, 16S rRNA and CPS, as well as species-specific vvhA were developed to simultaneously 
detect and characterize V. vulnificus. Finally, loop-mediated isothermal amplification (LAMP) 
assays were developed and evaluated to detect total or virulent-type V. vulnificus in raw oysters. 
Compared to PCR, LAMP assay developed were highly specific, sensitive and quantitative.  
The dissertation research provided comprehensive information on the genotypes, 
population dynamics, and antimicrobial resistance profiles of the two important vibrios. The 
rapid, specific, sensitive, and cost-effective molecular detection assays developed provided 
invaluable tools for the regulatory agencies and seafood industry to facilitate better control of 
 x
Vibrio in seafood, therefore reducing the incidence of foodborne illnesses and deaths resulted 
from the consumption of raw oysters. 
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CHAPTER 1: INTRODUCTION 
  
 2
Members of the genus Vibrio are Gram-negative, halophilic, and curved-rod shape 
bacteria that inhabit warm coastal and estuarine waters worldwide, which are especially 
abundant in the gut of filter-feeding shellfish such as oysters, clams, and mussels. Among 
pathogenic vibrios, Vibrio parahaemolyticus causes the most seafood-associated bacterial 
gastroenteritis in the United States and Asian countries, while Vibrio vulnificus is responsible for 
more than 95% of seafood-related deaths in the U.S. Therefore, multi-faceted strategies are 
needed to reduce the number of human infections caused by the two important vibrios. 
In this dissertation research, detection methods, genotypes, and antimicrobial 
susceptibility profiles of these two vibrios were investigated. Firstly, we isolated V. 
parahaemolyticus and V. vulnificus from Louisiana Gulf and retail oysters between 2005 and 
2006. Secondly, we characterized their antimicrobial susceptibility profiles and genotypic 
patterns. Finally, we developed sensitive and specific molecular detection assays for the 
detection and quantification of total and pathogenic V. vulnificus, in order to facilitate the 
regulatory agencies and the seafood industry to better control the potential Vibrio risks in raw 
oyster and reduce the incidence of oyster-related foodborne illnesses and deaths.  
 This dissertation is organized as following:  
 Chapter 1-Introduction. 
 Chapter 2-Literature review on general information of V. parahaemolyticus and V. 
vulnificus, antimicrobial resistance profiles, and molecular detection. 
 Chapter 3-Prevalence and antimicrobial susceptibilities of V. parahaemolyticus and V. 
vulnificus isolates from Louisiana Gulf and retail raw oysters from 2005 to 2006.  
 Chapter 4-Genotypic characterization of V. vulnificus isolates from Louisiana Gulf and 
retail raw oysters. Part I shows the genotypic characterization of V. vulnificus from Louisiana 
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oyster isolates, focusing on the differentiation of clinical-type from environmental-type strains. 
Part II describes a multiplex PCR assay for the simultaneous detection and characterization of V. 
vulnificus strains. 
 Chapter 5-Development of loop-mediated isothermal amplification (LAMP) assays to 
detect total and virulent-type V. vulnificus strains. The LAMP assays developed include one 
conventional LAMP for total V. vulnificus, a real-time LAMP on two real-time platforms for the 
quantification of total V. vunificus, and a real-time LAMP for the detection and quantification of 
virulent-type V. vulnificus strains in raw oysters. 
 Chapter 6-Conclusions.  
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CHAPTER 2: LITERATURE REVIEW
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Epidemiology 
Human infections with Vibrio occur all over the world (Bauer et al., 2006; Dalsgaard et 
al., 1996; Hoi et al., 1998; Wong et al., 1999). In the United States, it is estimated that Vibrio 
cause 8,000 cases, 200 hospitalizations, and 50 deaths each year (Mead et al., 1999a). According 
to the Centers for Disease Control and Prevention (CDC)’s report, Vibrio infections due to the 
consumption of raw or undercooked oysters have shown an increase since year 2001, indicating 
the need to control human Vibrio infections  (Figure 2-1) (Centers for Disease Control and 
Prevention, 2010).  Among pathogenic vibrios, V. parahaemolyticus causes the highest number 
of seafood-associated bacterial gastroenteritis in the United States and Asian countries (Mead et 
al., 1999b) while V. vulnificus is responsible for more than 95% of seafood-related deaths in the 
U.S. (Oliver, 2006). 
 
Figure 2 - 1 Relative rates of laboratory-confirmed infections with Campylobacter, STEC 
O157, Listeria, Salmonella, and Vibrio compared with 1996--1998 rates, by year --- Foodborne 
Diseases Active Surveillance Network (FoodNet), United States, 1996—2009 (Centers for 
Disease Control and Prevention, 2010) 
 
Initiated by CDC, U.S. Food and Drug Administration (FDA), and the Gulf Coast states 
(Alabama, Florida, Louisiana, Mississippi, and Texas) in 1988, the Cholera and Other Vibrio 
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Illness Surveillance System (COVIS) has been collecting the information on Vibrio human 
infections in order to obtain reliable information on illnesses associated with Vibrio species. 
Figure 2-2 list the infection caused by V. parahaemolyticus and V. vulnificus reported to COVIS 
from 1997 to 2007. 
 
Figure 2 - 2 Vibrio parahaemolyticus and Vibrio vulnificus cases (excluding toxigenic Vibrio 
cholerae) reported to COVIS, 1997-2007 
 
 
In 2007, a total of 549 Vibrio cases (excluding toxigenic Vibrio cholerae) were reported 
to COVIS, with 39% of patients hospitalized and 7% dies (Cholera and Other Vibrio Illness 
Surveillance, 2009). Among all of these cases, V. parahaemolyticus was the most frequently 
reported Vibrio species, isolated from 42% (232 of 549) of the patients; while V. vulnificus was 
isolated from 17% (95 of 549) of the patients, with a 36% mortality rate. Most V. 
parahaemolyticus and V. vulnificus infections had a clear seasonal peak during summer, with 
most cases (70%) occurring during May to September, and the greatest frequency happening 
during August (Figure 2-3).  
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Figure 2 - 3 Numbers of cases of Vibrio illnesses (excluding toxigenic V. cholerae), by month of 
illness onset or specimen isolation, 2007 (N = 549) (Cholera and Other Vibrio Illness 
Surveillance, 2009) 
 
Louisiana, as one of the five Gulf Coast states, reported a total of 1,007 Vibrio infections 
to the Infectious Disease Epidemiology Department of the Louisiana Office of Public Health 
between 1980 and 2005, with 249 (25%) V. parahaemolyticus and 257 (25%) V. vulnificus cases 
(Thomas et al., 2007). The fatality rate for V. parahaemolyticus and V. vulnificus was 6% and 
31%, respectively.  
Given the number of illnesses and deaths caused by these two vibrios, research is needed 
to provide data and strategies to better control the potential Vibrio risks in seafood, particularly 
oysters. 
Microbiology 
V. parahaemolyticus and V. vulnificus are Gram-negative, motile bacteria that inhabit 
warm coastal and estuarine waters worldwide, especially in the gut of filter-feeding shellfish 
such as oysters, clams and mussels (Barbieri et al., 1999; Hervio-Heath et al., 2002; Hoi et al., 
1998). Both V. parahaemolyticus and V. vulnificus are halophilic, requiring a minimum of 0.5% 
NaCl for growth (Kaysner & DePaola, 2001). They are mesophilic and proliferate in warm water 
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(Cook et al., 2002b). A seasonal preference has been demonstrated on all coasts in the U.S., with 
the most abundant presence during warm weather (> 20oC) and moderate salinity (5 to 25 ppt) 
(Bryan et al., 1999; DePaola et al., 2003a; Kaspar & Tamplin, 1993). In winter when the 
temperature is below 10oC, they would enter a status termed viable but nonculturable (VBNC), 
during which they will lose the ability to be cultured on routine media but retain their viability 
(Bates & Oliver, 2004; Oliver et al., 1995)  
Both of these two vibrios are sucrose-negative, thus forming green colonies on thiosulfate 
citrate bile salts sucrose agar (TCBS) (Kobayashi et al., 1963). However, V. vulnificus is 
cellobiose positive while most other vibrios including V. parahaemolyticus are cellobiose 
negative. Therefore, modified cellobiose polymyxin B colistin (mCPC) agar, which takes 
advantage of the resistance of V. vulnificus to colistin and polymyxin B and the fermentation of 
cellobiose, has been reported to be effective for the isolation of V. vulnificus from environmental 
sources (Massad & Oliver, 1987; Tamplin et al., 1991). 
Clinical Symptoms  
The clinical symptoms of V. parahaemolyticus infection include watery diarrhea, 
abdominal cramps, nausea, vomiting, headache, fever, and chills, which may last for 2 to 10 days 
and are normally self-limiting (Iida et al., 2006). 
V. vulnificus, on the other hand, causes gastroenteritis, wound infections, and primary 
septicemia.  Gastroenteritis is the mildest human syndrome among the three, usually occurring 
within 16 hours of ingesting the organism and mostly needing no hospitalization. In contrast, 
primary septicemia, the most significant form of V. vulnificus infection, had > 50% motility rate, 
especially for at-risk groups, which include people with immunocompromising conditions, 
diabetes, and elevated serum iron concentrations due to chronic liver disease or alcohol abuse 
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(Wright et al., 1981). Furthermore, most cases (> 88.5% of the U.S. cases between 2000 and 
2003) of septicemia related to V. vulnificus infection are males over the age of 50, suggesting the 
protective effect of women’s estrogen (Oliver, 2006). Symptoms of wound infection are pain, 
erythema, and edema, with 20% to 25% fatality rate. 
Prevalence in Seafood  
The prevalence of V. parahaemolyticus and V. vulnificus in seafood varies greatly 
depending on the variety of seafood, geographic area and temperature. It has been reported that 
V. vulnificus abundance was 32-2,511 cells/ml in Mobile Bay, Alabama (DePaola et al., 1994), 
0-200 cells/ml in Chesapeake Bay, Delaware (Wright et al., 1996), and 0-7,000 cells/ml in 
Apalachicola Bay, Florida (Tamplin et al., 1982). In oyster sample, it was reported that 0-12,000 
colony forming units per gram (CFU/g) of V. parahaemolyticus was found in Alabama oysters 
from March 1999 to September 2000 (DePaola et al., 2003a). A national survey from June 1998 
to July 1999 on V. parahaemolyticus and V. vulnificus in 370 oysters was conducted in coastal 
and markets throughout the U.S. and the highest densities of both organisms were found in 
oysters harvested from the Gulf Coast, which normally exceeded 10,000 MPN/g (Cook et al., 
2002b). One following study carried from 1999 to 2000 in Atlantic and Gulf Coast molluscan 
shellfish found 5% of the samples contained more than 1,000 CFU/g V. parahaemolyticus, also 
Gulf Coast had higher densities of V. parahaemolyticus in shellfish than that from the Atlantic 
(Cook et al., 2002a). A recent study by FDA showed approximately 44% and 38% of samples 
harvested from Louisiana in 2007 sampled from different lots exceeded 10,000 MPN/g for V. 
vulnificus and V. parahaemolyticus, respectively, and Gulf oysters had significantly higher V. 
vulnificus levels than either the North Atlantic and Pacific regions during each season (DePaola 
et al., 2010). 
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The occurrence of V. parahaemolyticus and V. vulnificus in Norwegian blue mussels was 
10.3% and 0.1%, respectively after examining 885 blue mussel samples (Bauer et al., 2006). In 
Japan, 2-13% V. parahaemolyticus and 1-4% V. vulnificus was dominant in shrimp samples from 
multiple shrimp farm environment (Gopal et al., 2005). In China, a study showed 73.3% (165 of 
225) of seafood samples were positive for V. parahaemolyticus, with a range of 0-719 CFU/g 
(Luan et al., 2008).  
Since multiple studies have showed Gulf Coast oysters normal contained significantly 
high level of V. parahaemolyticus and V. vulnificus, and most current studies sampled oysters 
from Coast regions, lacking the information from restaurant site, it is important to monitor both 
of the two species from oysters sampled in Gulf Coast and retail sites. However, the last 
comprehensive study could only trace to FDA’s studies in 2000s, so the prevalence of V. 
parahaemolyticus and V. vulnificus in Gulf Coast oysters need to be studied to provide more 
information for the risk assessment of the two species.  
Antimicrobial Susceptibility Profiles 
Since the introduction of penicillin in the 1920s, hundreds of antimicrobial agents have 
been discovered, synthesized, and applied for either clinical use or food animals for therapy, 
prophylaxis, and growth promotion (Aarestrup & Wegener, 1999).  However, as a result, the 
occurrence of antimicrobial resistance of bacteria in food animals has been reported to be 
associated with the consumption of antimicrobial agents in animal husbandry, which could cause 
the failure of clinical therapy (Aarestrup, 1999).  
Traditionally, Vibrio is considered to be susceptible to all antibiotics, except that 
ampicillin-resistance was observed in V. parahaemolyticus and V. vulnificus (Joseph et al., 1978; 
Zanetti et al., 2001). However, some studies indicated that antimicrobial resistance has been 
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surfaced into V. parahaemolyticus and V. vulnificus in Austria (Akinbowale et al., 2006), the 
Philippines and Thailand (Maluping et al., 2005) by characterizing the antimicrobial 
susceptibility profile of these two vibrios. One study in the past found very high ampicillin 
resistance rate (> 90% for V. parahaemolyticus), indicating the exhibition of -lactamase activity 
(Joseph et al., 1978). Another study in Italy tested antibiotics against eight V. parahaemolyticus, 
six V. vulnificus and some other Vibrio strains isolated in the coastal waters of Italy. They found 
that more than 80% of Vibrio isolates were resistant to ampicillin (Zanetti et al., 2001). A similar 
susceptibility profile was found in V. parahaemolyticus from patients in Indonesia with 98% 
resistance rate to ampicillin while all isolates (100%) were sensitive to chloramphenicol, 
tetracycline, trimethoprim-sulfamethoxazole, gentamicin, and ciprofloxacin (Lesmana et al., 
2001). In 2008, a study screened 151 coastal isolated V. vulnificus and 10 primary septicemia 
isolates against 26 antimicrobial agents. Surprisingly, 45% (68 of 151) of the environmental 
sourced V. vulnificus strains were resistant to three or more classes of antibiotics (Baker-Austin 
et al., 2009). However, weather V. parahaemolyticus and V. vulnificus has become more resistant 
is unknown. 
In clinical therapy, tetracycline has been recommended as the antimicrobial of choice to 
treat severe V. parahaemolyticus and V. vulnificus infections (Morris & Tenney, 1985), and 
alternative treatments are a combination of a third-generation cephalosporin (e.g., ceftazidime) 
and doxycycline, or a fluoroquinolone alone (Tang et al., 2002). Trimethoprim-sulfamethoxazole 
plus an aminoglycoside are used to treat children in whom doxycycline and fluoroquinolones are 
contraindicated (Centers for Disease Control and Prevention, 2005).  
Considering few recent studies have investigated the antimicrobial susceptibility testing 
on these two species, especially information is lacking in the U.S. since the 1990s, research is 
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needed to test first-line drugs if they remain highly effective against both V. parahaemolyticus 
and V. vulnificus. 
Virulence Properties  
About 400-500 cases of Vibrio infections were reported to CDC annually; however, 
considering millions pounds of oyster meats consumed in the U.S. each year, it is hypothesized 
that not all environmental V. parahaemolyticus and V. vulnificus are virulent (Chatzidaki-Livanis 
et al., 2006a). 
For V. parahaemolyticus, the thermostable direct hemolysin (TDH) and TDH-related 
hemolysin (TRH) have been considered the major virulent factors by multiple studies, and most 
clinical strains carry one or both of the two hemolysins (DePaola et al., 2000; Takahashi et al., 
2000), while less than 1% of food or environmental strains have the tdh gene coding for TDH 
(DePaola et al., 2003a). One study showed that most clinical isolates from the Pacific Northwest 
of the U.S. are likely to have both tdh and trh genes (DePaola et al., 2003b). The prevalence of 
pathogenic V. parahaemolyticus varies from 6% in Atlantic and Gulf coast mollusk shellfish 
(Cook et al., 2002a) to 21.8% in Alabama oyster (DePaola et al., 2003a) depending on the 
environmental parameters such as area, water temperature, and salinity.  
For V. vulnificus, several potential virulent factors have been examined which included 
the lipopolysacchride (LPS), flagella, and capsular polysaccharide (CPS) (Lee et al., 2004; 
Linkous & Oliver, 1999; Strom & Paranjpye, 2000). LPS, endotoxin, was the factor reported to 
cause shock and death by V. vulnificus infection (Oliver, 2006). A study tested intravenous 
injections of V. vulnificus LPS into rats and the results showed decreased heart rate and blood 
pressure within 10 min and further decline lead to death in 30 to 60 min (McPherson et al., 
1991). A follow up study found the lethal effect was reversed after using a LPS-induced enzyme 
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(nitric oxide synthase) (Elmore et al., 1992). The presence and amount of CPS on any given 
virulent isolate has been positively correlated with measures of virulence of V. vulnificus in 
mouse model (Wright et al., 1990; Yoshida et al., 1985), which were demonstrated that the 
presence of CPS protected the bacteria by conferring resistance to the bactericidal effects of 
serum and phagocytosis by macrophages (Johnson et al., 1984; Yoshida et al., 1985). However, 
whether one or more of those factors play an important role in the virulence of V. vulnificus 
remains to be determined. 
Given that unique virulence markers have not been identified, alternative strategies are 
sought. Recently, several biomarkers have been explored to differentiate virulent- (i.e., clinical-) 
from non-virulent- (i.e., environmental-) type V. vulnificus strains with varied degree of success. 
A 200- to 178- bp segment was observed always present in the clinical strains while the segment 
was occasionally present in the environmental isolates (Warner & Oliver, 1999).  A follow up 
study using the virulence-correlated gene (vcg) to screen 55 strains found that 90% of vcgC-type 
(correlates with clinical origin) strains were clinical isolates, while 93% of environmental 
isolates were vcgE-type (correlates with environmental origin) (Rosche et al., 2005). The same 
group analyzed the RAPD genotype of V. vulnificus isolates from oysters and seawater and a 
total of 880 isolates from oysters confirmed the previous study by showing 84.4% of the isolates 
revealed the vcgE type, while 292 isolates from the seawater showed almost equal distribution 
among the two genotypes of vcgE and vcgC (Warner & Oliver, 2008). Meanwhile, the 
polymorphisms discrimination of the 16S rRNA has been reported as a virulence indicator 
between the clinical and the environmental V. vulnificus isolates (Nilsson et al., 2003). One study 
in 2003 examined 33 nonclinical isolates and 34 clinical isolates by terminal restriction fragment 
length polymorphism (T-RFLP) of the 16S rRNA gene, and they found the majority (31 of 33) of 
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the nonclinical strains belonged to 16S rRNA A type, while 26 of 34 clinical ones were 16S 
rRNA B type (Nilsson et al., 2003). The same group did a following study by combining the T-
RFLP with real-time to be a new assay to analyze a total of 86 V. vulnificus isolates including 67 
from the previous study strain collection (Vickery et al., 2007). Surprisingly, they found 15 
strains, which were previously found as 16S rRNA A type showed as both A and B. A recent 
study characterized the polysaccharide operon by identifying two CPS allele 1 and 2 
(Chatzidaki-Livanis et al., 2006b), and a following study indicated significant relationship 
between the clinical and capsular 1, while environmental isolates were predominantly capsular 2 
(Chatzidaki-Livanis et al., 2006a). Beside the three biomarkers, a vulnibactin-encoding viuB 
gene was reported to closely correlate with clinical-type V. vulnificus isolates in shellfish 
(Panicker et al., 2004c), one of the siderophore genes involved in iron acquisition (Litwin et al., 
1996). However, none of those could serve as a unique virulence marker that to be used to screen 
for virulent V. vulnificus isolates from oysters. 
Given the lack information of the virulent factors, research is needed to apply single or a 
combination of biomarkers for the identification of virulent-type V. parahaemolyticus and V. 
vulnificus in seafood, especially oysters. 
Isolation and Identification Methods 
Traditional isolation and detection methods for V. parahaemolyticus and V. vulnificus, 
approved by FDA as standard methods, are mainly based on microbiological culturing methods; 
however, they are labor-intensive and time-consuming (Kaysner & DePaola, 2001). DNA probe 
hybridization, also approved by FDA, is more rapid and specific, but it still takes 2-3 days 
(Morris et al., 1987; Nordstrom et al., 2006). The detection limit by DNA hybridization was 
between 102 to 104 CFU/g of oyster (Raghunath et al., 2007; Wright et al., 1993).  
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 Immunological-based assays, such as enzyme-linked immunosorbent assay (ELISA) used 
the monoclonal antibody and achieved a detection limit of 2.0 × 103 cells (Tamplin et al., 1991). 
A recent study on the use of anti-flagella protein monoclonal antibody to detect V. 
parahaemolyticus exhibited about 35% to 45% binding of 102 to 103 cells in phosphate-buffered 
saline (Datta et al., 2008). One problem of conventional ELISA is that the antibody for antigen 
capture is nonspecifically and physically adsorbed onto ELISA plates, thus the antigen captured 
by the antibody may easily detach from the ELISA plates during subsequent processing, so 
chemically immobilizing antibody on nylon was developed to ensure the stable immobilization 
of sufficient amounts of antibodies on nylon (Honda et al., 1995). 
ELISA to detect V. vulnificus hemolysin has been reported, however, cross-reaction with 
other Vibrio (Vibrio campbelli, Vibrio harveyi, Vibrio pelagius, and Vibrio splendidus) 
(Nishibuchi & Seidler, 1985), or non-Vibrio species (Acinetobacter calcoaceticus, 
Achromobacter icthyodermis, Aeromonas hydrophila, and Pseudomonas aeruginosa) (Parker & 
Lewis, 1995) were found, indicating specificity problem.  
Compared to conventional method, immunological-based assays greatly eliminate the 
lengthy and labor-intensive cultural assays for Vibrio identification, but the cross-reactions were 
distinguished owing to the nature of the test method, which limits the application of such assays. 
Molecular-based DNA detection assays, mainly PCR and real-time PCR (Campbell & 
Wright, 2003; Gordon et al., 2008; Nordstrom et al., 2007; Panicker et al., 2004b; Panicker et 
al., 2004c; Panicker & Bej, 2005), have been widely employed for the rapid and specific 
detection of V. parahaemolyticus and V. vulnificus worldwide. A multiplex PCR detecting the 
total and virulent strains of V. parahaemolyticus was developed by targeting tlh, tdh, and trh, and 
the detection limit was found 10-100 CFU per 10 g of alkaline peptone water enriched seeded 
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oyster tissue homogenate after 6 h enrichment (Bej et al., 1999). Compared to conventional PCR, 
real-time PCR is more sensitive and rapid, and also quantitative. It is reported the real-time PCR 
could detect 1 CFU V. parahaemolyticus in oyster tissue homogenate after overnight enrichment 
(Ward & Bej, 2006). Another group developed a real-time multiplex PCR assay for the 
simultaneous detection of tlh, tdh, and trh of V. parahaemolyticus, and the multiplex assay 
detected <10 CFU/reaction of pathogenic V. parahaemolyticus in the presence of >104 
CFU/reaction of total V. parahaemolyticus bacteria (Nordstrom et al., 2007). When applied to 
oyster samples, compared to MPN, the multiplex real-time PCR assay detected more tubes 
positive for total and pathogenic V. parahaemolyticus bacteria (Nordstrom et al., 2007).  
Similar results were found by using PCR and real-time PCR for the detection of V. 
vulnificus. Back to 1991, two studies have been reported by PCR for detecting general (Hill et 
al., 1991) and nonculturable V. vulnificus cells (Brauns et al., 1991), all targeting vvhA. Later, 
Multiplex PCR analysis for simultaneous identification of V. vulnificus and other vibrios, have 
been reported (Dalmasso et al., 2009; Panicker et al., 2004a; Teh et al., 2009). When applied in 
real-time, SYBR Green-based real-time PCR (Panicker et al., 2004b) and Taqman real-time PCR 
(Campbell & Wright, 2003) both targeting vvhA have been reported to quantify V. vulnificus 
from oysters, both of the assays are highly specific. SYBR Green-based real-time PCR was able 
to detect the equivalent of 102 cells in pure culture and 102/ml in seawater without enrichment, 
however, after 5h enrichment, the detection limit was found to one cell (Panicker et al., 2004b). 
Taqman real-time PCR could detect the equivalent of six cells in pure culture, 102 CFU/g from 
oyster homogenates using purified DNA templates (Campbell & Wright, 2003). 
Compared to PCR, real-time offers quantitative analysis while reducing the need for post-
processing, thus providing more rapid analysis. However, for both PCR and real-time PCR, a 
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dedicated thermal cycler is needed, which is rather expensive especially for real-time PCR, and 
hinders the wide application of such assays.  
 A newer molecular method, loop-mediated isothermal amplification (LAMP), developed 
by Tsugunori Notomi in Japan in 2000, applied four to six primers to specifically recognize six 
to eight distinct sequences on the target DNA under isothermal conditions in less than one hour 
(Notomi et al., 2000). Also this novel nucleic acid amplification method could be observed by 
naked eye or real-time turbidity meter due to the formation of magnesium pyrophosphate as a 
by-product (Mori et al., 2001). Since its invention, LAMP has been applied to detect multiple 
bacterial and viral agents, including those of major food safety concerns, such as Salmonella 
(Hara-Kudo et al., 2005; Ohtsuka et al., 2005), Campylobacter (Yamazaki et al., 2008c), 
Flavobacterium (Yeh et al., 2006), E. coli (Hara-Kudo et al., 2007; Yano et al., 2007), 
Staphylococcus aureus (Goto et al., 2007; Misawa et al., 2007), Vibrio (Chen & Ge, 2010; 
Yamazaki et al., 2008a; Yamazaki et al., 2008b), and virus (Fukuda et al., 2007; Mekata et al., 
2006; Yamada et al., 2006). Meanwhile, real-time LAMP has been developed by using a 
fluorescent DNA-intercalating dye in a real-time PCR format (Aoi et al., 2006) or measuring the 
turbidity change during LAMP amplification in a turbidimeter (Chen & Ge, 2010; Mori et al., 
2001). Figure 2-3 shows the LAMP procedure (Eiken Genome Site, 2000). 
Advantages of LAMP detection include: 1) isothermal (60-65oC), no special thermal 
cycling instrument is required; 2) rapid, the assay can be completed in 15-60 min (Nagamine et 
al., 2002); 3) specific, the assay targets 6-8 regions of the target gene sequence; 4) sensitive, 
extremely large amount of DNA can be amplified from a few target cells; 5) detection by the 
naked eye due to the formation of large quantities of a by-product, magnesium pyrophosphate, 
which turns positive reaction tubes turbid (Mori et al., 2001); 6) direct amplification, there is no 
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need to denature DNA templates before amplification (Nagamine et al., 2001); 7) robust, LAMP 
is less subjective to inhibition by biological substances (Kaneko et al., 2007); and 8) quantitative, 
real-time LAMP is used to quantify DNA in the reaction (Chen & Ge, 2010). 
 
Figure 2 - 4 Loop-mediated isothermal amplification (LAMP) procedure 
 
Given the lack of information on both the epidemiology and sensitive and cost-effective 
method for the rapid detection of general and virulent-type of Vibrio, this dissertation research 
was carried out to fulfill three objectives: 1) To isolate V. parahaemolyticus and V. vulnificus 
from Louisiana Gulf and Retail oysters; 2) To characterize the V. parahaemolyticus and V. 
vulnificus isolates, including antimicrobial susceptibility profile and genotypic patterns; and 3) 
To develop and evaluate LAMP assays for real-time detection of general and virulent-type V. 
vulnificus. The successful complete of this dissertation generated baseline data on the prevalence, 
genotypes, and antimicrobial susceptibility profiles of the two vibrios from Louisiana oysters, 
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and rapid, specific, sensitive, and yet cost-effective molecular detection assays for both general 
and virulent V. vulnificus were developed, which could contribute to developing effective control 
strategies to reduce the incidences of human Vibrio infections due to the consumption of oysters 
in the long run. 
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Introduction 
Members of the genus Vibrio are Gram-negative, motile bacteria that inhabit warm 
coastal and estuarine waters worldwide (Barbieri et al., 1999; Hervio-Heath et al., 2002; Hoi et 
al., 1998). However, the consumption of raw or undercooked seafood, particularly oysters, may 
lead to their transmission to humans with clinical manifestations ranging from mild diarrhea to 
death (Blake et al., 1980). Among pathogenic vibrios, Vibrio parahaemolyticus is the leading 
cause of seafood-associated bacterial gastroenteritis in the United States (Mead et al., 1999) and 
the most common foodborne pathogen in Asian countries (Joseph et al., 1982); whereas Vibrio 
vulnificus inflicts the highest mortality rate (> 50% in primary septicemia patients and 25% for 
those with wound infections) among all foodborne pathogens, responsible for more than 95% of 
seafood-related deaths in the U.S. (Oliver, 2006). Fortunately, the vast majority of environmental 
V. parahaemolyticus strains tested are not pathogenic (being both tdh and trh negative) (DePaola 
et al., 2003), and for fatal V. vulnificus infections, predisposed risk factors have been identified, 
which include compromised immune systems, diabetes, and elevated serum iron concentrations 
due to liver disease or alcohol abuse (Strom & Paranjpye, 2000). Nonetheless, according to a 
recent FoodNet report from the Centers for Disease Control and Prevention (CDC), amidst the 
decrease of infections caused by all major foodborne pathogens, the incidence of V. 
parahaemolyticus and V. vulnificus infections due to eating raw or undercooked oysters has 
shown a sustained increase since 2001, indicating further measures are needed to prevent human 
illness caused by these pathogens in oysters (Centers for Disease Control and Prevention, 2010).  
Although most V. parahaemolyticus infections are self-limiting, antimicrobial therapy 
may be necessary in patients with severe or prolonged diarrhea (Centers for Disease Control and 
Prevention, 2005b). In the case of V. vulnificus primary septicemia and wound infection, prompt 
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antimicrobial treatment can be lifesaving because of the extreme rapidity of disease progress and 
severity of patient outcomes (Strom & Paranjpye, 2000). Tetracycline has been recommended as 
the antimicrobial of choice to treat severe Vibrio infections (Morris & Tenney, 1985), and 
alternative treatments are a combination of a third-generation cephalosporin (e.g., ceftazidime) 
and doxycycline, or a fluoroquinolone alone (Tang et al., 2002). Trimethoprim-sulfamethoxazole 
plus an aminoglycoside are used to treat children in whom doxycycline and fluoroquinolones are 
contraindicated (Centers for Disease Control and Prevention, 2005a).  
Traditionally, Vibrio is considered highly susceptible to virtually all antimicrobials, 
although ampicillin resistance has been observed in both V. parahaemolyticus and V. vulnificus 
(Joseph et al., 1978; Zanetti et al., 2001). During the past decade, however, antimicrobial 
resistance has emerged and evolved in many species of microorganisms due to the excessive use 
of antimicrobials in humans, agriculture, and aquaculture (Cabello, 2006; Mazel & Davies, 
1999). Campylobacter and Salmonella, two major foodborne bacterial pathogens of terrestrial 
sources, are part of the National Antimicrobial Resistance Monitoring System (NARMS) in the 
U.S. (Centers for Disease Control and Prevention, 2006), and have been studied extensively for 
the development and dissemination of antimicrobial resistance (Chen et al., 2004; D'Lima C et 
al., 2007; Ge et al., 2005; Skov et al., 2007). In contrast, the awareness of antimicrobial-resistant 
bacteria in the aquatic environment is not as well documented (Cabello, 2006). For both clinical 
and environmental isolates of Vibrio cholera, antimicrobial resistance has been investigated 
extensively (Dalsgaard et al., 2000; Hochhut et al., 2001; Iwanaga et al., 2004), and there are 
some very recent reports examining the antimicrobial susceptibilities in other aquatic species 
such as Aeromonas (Gordon et al., 2007; Jacobs & Chenia, 2007). But only a few recent studies 
have investigated the antimicrobial resistance in non-cholera vibrios. These studies were 
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conducted in Australia, India, the Philippines, and Thailand, and included small numbers of 
either V. parahaemolyticus or V. vulnificus (Akinbowale et al., 2006; Maluping et al., 2005; 
Vaseeharan et al., 2005). Antimicrobial resistance in these two bacterial species has not been 
reported in the U.S. since the 1990s.   
The objectives of this study were to determine the prevalence of V. parahaemolyticus and 
V. vulnificus in oysters obtained from the Louisiana Gulf Coast and four retail outlets in Baton 
Rouge, Louisiana, and more importantly, to determine the antimicrobial susceptibility profiles of 
these Vibrio isolates by a broth microdilution method.  
Materials and Methods 
 Sample Collection and Preparation. From June 2005 to September 2006, a total of 20 
oyster samples were harvested, at quarterly intervals, from two sites near the Louisiana Gulf 
Coast. Due to Hurricanes Katrina and Rita, no sampling trips were made in September 2005. 
Both sites were in shellfish-growing areas approved by the National Shellfish Sanitation Program 
and available for commercial harvesting. Another 74 oyster samples were obtained through retail 
sampling conducted weekly in Baton Rouge, Louisiana from February to August 2006. One 
grocery store that offered shellstock oysters for sale (February-April) and three seafood 
restaurants with “oyster bars” where shellstock oysters were opened onsite for raw consumption 
(April-August) were included in the sampling. On each sampling day, two paired oyster samples 
(12 oysters/sample) were obtained from each site, transported on ice to the laboratory, and 
analyzed within 4 h of collection. The oysters collected from both the Gulf and retail outlets 
were Eastern oysters, Crassostrea virginica. 
 Oysters in the shell were scrubbed, and those belonging to one sample were shucked into 
a sterile stomacher bag to make 200-250 g per sample. After adding equal volume of alkaline 
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peptone water (APW; BD Diagnostic Systems, Sparks, MD), samples were homogenized in a 
food stomacher (Model 400; Tekmar Company, Cincinnati, OH) for 90 seconds to produce 1:1 
oyster-APW homogenate.  
 Bacterial Isolation. Dehydrated media and reagents were purchased from BD Diagnostic 
Systems. Media formulations and procedures described in the Food and Drug Administration 
Bacteriological Analytical Manual (BAM) (Kaysner & DePaola, 2001) and a previous study 
(DePaola et al., 2003) were used to isolate V. parahaemolyticus and V. vulnificus with a few 
modifications. Two isolation methods, direct plating and enrichment, were proceeded 
simultaneously.  
For direct plating, 200 µl of the 1:1 oyster-APW homogenate (i.e., 0.1 g homogenized 
oyster tissue) and 100 µl of a 1:10 dilution of the oyster-APW homogenate in APW (i.e., 0.01 g 
homogenized oyster tissue) were spread-plated in duplicate onto thiosulfate-citrate-bile salts-
sucrose (TCBS) agar and modified cellobiose-polymyxin B-colistin (mCPC) agar for isolating V. 
parahaemolyticus and V. vulnificus, respectively. After 24 h of incubation at 35oC and 40oC for 
TCBS and mCPC, respectively, five to ten presumptive V. parahaemolyticus colonies on TCBS 
(green or bluish green, round, 2-4 mm in diameter) and V. vulnificus on mCPC (flat yellow, fried 
egg shape, 1-2 mm in diameter) were subcultured on trypticase soy agar with 2% NaCl (TSAS) 
and confirmed by PCR as described below. Following isolation and identification, the isolates 
were stored at -80oC in brain heart infusion with 50% glycerol.  
For enrichment, 50 g of the 1:1 oyster-APW homogenate was added into a sterile flask 
containing 200 ml of APW and incubated at 35oC with shaking at 100 rpm for 24 h. The 
enrichment broth was serially diluted in phosphate buffered saline (PBS) and appropriate 
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dilutions (10-2, 10-3, or 10-4) were plated in duplicate onto either TCBS or mCPC agar. The 
remaining isolation procedures were the same as those described above for direct plating. 
PCR Assays. Presumptive V. parahaemolyticus and V. vulnificus isolates were confirmed 
by performing a multiplex PCR assay that targeted both V. parahaemolyticus thermolabile 
hemolysin (encoded by tl) and V. vulnificus cytolysin (vvhA). For confirmed V. 
parahaemolyticus by this PCR, another multiplex PCR targeting the thermostable direct 
hemolysin (Tdh) encoded by tdh and the Tdh-related trh gene was conducted. Primer sequences 
for all four genes were the same as those described in BAM (Kaysner & DePaola, 2001). 
Bacterial DNA templates were prepared by heating cell suspensions in TE (10 mM Tris, 
1 mM EDTA; pH 8.0) at 95oC for 10 min. Each multiplex PCR mixture contained 1 x PCR 
buffer, 0.2 mM of deoxynucleotide triphosphate, 2.5 mM of MgCl2, 0.5 unit of Taq DNA 
polymerase (Applied Biosystems, Foster City, CA), 0.5 µM of each primer, and 5 µl of DNA 
template in a total volume of 25 µl. PCR was conducted using 30 cycles of denaturation at 94°C 
for 1 min, primer annealing at 58°C for 1 min, extension at 72°C for 1 min, and a final extension 
of 72°C for 7 min in a GeneAmp PCR System 2400 (Applied Biosystems). PCR products were 
analyzed by electrophoresis on 2% agarose gel containing ethidium bromide, and visualized 
under UV light. Gel images were documented by a Stratagene Eagle Eye II system (La Jolla, 
CA). 
Antimicrobial Susceptibility Testing. Minimal inhibitory concentrations (MICs) for a 
randomly selected subset of 319 V. parahaemolyticus and V. vulnificus (Table 3-1, last three 
columns, numbers in parenthesis) were determined using a broth microdilution testing method as 
described in a document recently published by the Clinical and Laboratory Standards Institute 
(CLSI; formerly the NCCLS) (Clinical and Laboratory Standards Institute, 2006b). Additionally, 
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ten reference strains, including six V. parahaemolyticus (ATCC33847, ATCC49529, TX-2103, 
CT-6636, NY-477, and 8332924) and four V. vulnificus (VV1007, ATCC29306, VV-WR1, and 
515-4C2), provided by Dr. Angelo DePaola from the Gulf Coast Seafood Laboratory, Food and 
Drug Administration, were tested. Eight antimicrobial agents of clinical relevance to treating 
vibriosis were tested: ampicillin, cefotaxime, ceftazidime, chloramphenicol, ciprofloxacin, 
gentamicin, imipenem, and tetracycline. All antimicrobials were purchased from Sigma-Aldrich 
(St. Louis, MO) except for imipenem (United States Pharmacopeia, Rockville, MD). For 
preparing stock solutions, antimicrobials were dissolved in distilled water or buffer as 
recommended by CLSI (Clinical and Laboratory Standards Institute, 2006a). A custom designed 
panel plate incorporating these antimicrobials at a concentration range of 0.03-64 μg/ml (for 
chloramphenicol and gentamicin, the test ranges of 1-1024 μg/ml and 0.06-64 μg/ml were used, 
respectively) was made with cation-adjusted Mueller-Hinton broth, sealed with perforated plate 
seal (Trek Diagnostic Systems Inc., Cleveland, OH), and stored at -80oC. 
Before testing, the susceptibility panels were warmed at room temperature for at least 30 
min. Escherichia coli ATCC 25922 was used as the quality control organism (Clinical and 
Laboratory Standards Institute, 2006b). Briefly, suspensions of Vibrio were prepared from fresh 
cultures grown on TSAS plates into 3-4 ml of 0.85% NaCl (physiological saline) and adjusted to 
a turbidity of 0.5 McFarland. Further dilutions were made in 10 ml of saline. A multichannel 
pipette was used to inoculate the panels, leaving only the negative control well uninoculated. 
Colony counts were performed regularly to validate the inoculum density to be around 5 x 105 
CFU/ml in the wells. The panels were sealed and incubated at 35oC in ambient air for 16-20 h. 
MICs were recorded as the lowest concentrations of antimicrobial agents that completely 
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inhibited bacterial growth in the wells. The interpretive criteria followed CLSI document M45-A 
(Clinical and Laboratory Standards Institute, 2006b).  
Data Analysis. Prevalence data sorted by Vibrio species, sampling location, and 
sampling season were analyzed by using the analysis of variance (ANOVA) (SAS for Windows, 
Version 9; SAS Institute Inc., Cary, NC). Antimicrobial susceptibility data were organized by 
each species for MIC50, MIC90, MIC range, and percentages of isolates that were susceptible, 
intermediate, or resistant to each antimicrobial tested. The MIC values (expressed in log2 scale) 
between the two species were also compared using ANOVA. Additionally, resistance plus 
intermediate rates to ampicillin between species and among different sampling locations were 
analyzed by Chi-square and Fisher’s exact two-tailed tests, and ANOVA. Differences between 
mean values were considered significant when P < 0.05. 
Results 
 Five sampling trips were made to the Louisiana Gulf Coast from June 2005 to September 
2006. Four retail outlets, including one grocery store and three seafood restaurants, were visited 
a total of 38 times between February and August 2006. Ninety-four oyster samples, 20 from the 
Gulf and 74 at retail, were collected and analyzed for the prevalence of V. parahaemolyticus and 
V. vulnificus, followed by susceptibility testing of some of the isolates.  
Prevalence of V. parahaemolyticus and V. vulnificus. The prevalence rates of V. 
parahaemolyticus and V. vulnificus in 94 Gulf and retail oyster samples are shown in Table 3-1. 
A total of 622 Vibrio isolates, including 252 V. parahaemolyticus and 370 V. vulnificus, were 
recovered from 82 (87.2%) of the oyster samples. Among 53 samples (56.4%) that contained V. 
parahaemolyticus, the grocery store had the highest prevalence rate (85.7%), followed by 
restaurant A (66.7%), the Gulf (50%), restaurant B (50%), and restaurant C (25%). In contrast, 
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restaurant B (87.5%) had a significantly higher V. vulnificus prevalence rate (P < 0.05) in its 
oyster samples than those of the Gulf (55%) and restaurant C (50%), but not significantly 
different from that of restaurant A (66.7%) (Table 3-1). Interestingly, not a single V. vulnificus 
was isolated from the grocery store during the period sampled (Table 3-1). Among twenty-five 
(26.6%) oyster samples from which both V. parahaemolyticus and V. vulnificus were recovered, 
nine, nine, five, and two originated from restaurants A, B, the Gulf, and restaurant C, 
respectively. Overall the prevalence of one or both Vibrio species fell between 58.3% (restaurant 
C) and 100% (restaurant B), with restaurant C having a significantly lower rate than other 
sampling locations (P < 0.05) (Table 3-1). The average prevalence rate among the four retail 
outlets was calculated to be 89.2%. About half of the 622 Vibrio isolates were recovered using 
the direct plating method, and the other half through enrichment. For paired oyster samples 
collected from the same collection site, there were nine out of 38 occasions from retail outlets 
where the presence of Vibrio species differed (data not shown).  
Seasonality of V. parahaemolyticus and V. vulnificus Presence in Oysters. The 
prevalence of V. parahaemolyticus and V. vulnificus varied greatly during the sampling period 
(Table 3-2). For example, there was an increase in the prevalence of V. vulnificus and 
simultaneous decrease of V. parahaemolyticus as the survey proceeded in 2006. The Gulf and 
retail samples in February and March were 75-100% culture positive for V. parahaemolyticus, 
but decreased to 0-33% in or between April and September (Table 3-2). In contrast, the 
prevalence rate of V. vulnificus in oysters was low in February/March (0 in the grocery store and 
50% in the Gulf), and reached 100% in June and September for the retail and Gulf samples, 
respectively. At the end of retail sampling in August, the culture positive rate for V. vulnificus 
remained above 75%; whereas V. parahaemolyticus rates ranged between 0 to 67%. For the Gulf 
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Coast sampling in September and December, prevalence rates for V. vulnificus were 100% and 
25%, respectively; whereas the positive rates for V. parahaemolyticus were 0 in September and 
25% in December (Table 3-2). Overall a prevalence rate of 100% was observed for oysters from 
certain collecting sites between February and June for V. parahaemolyticus and June to 
September for V. vulnificus. 
Due to unavailable or few data points in certain months (Table 3-2), we grouped the 
months arbitrarily into seasons, with December, February, and March as winter, April to June as 
spring, and July to September as summer. When pooling the samples from all locations, the 
prevalence of V. parahaemolyticus was significantly higher in winter (80%) and spring (77.8%) 
than summer (23.7%), where V. vulnificus had a higher significantly higher prevalence rate in 
summer (84.2%) than either spring (52.8%) or winter (15%), with the rates of spring and winter 
being significantly different from each other as well (P < 0.05). However, when examining the 
prevalence of either V. parahaemolyticus or V. vulnificus in oysters sampled during the seasons, 
no significant difference was observed, and the prevalence rates were 91.7%, 86.8%, and 80% 
for spring, summer, and winter, respectively. 
Multiplex PCR Results. The first multiplex PCR confirmed the identity of presumptive 
V. parahaemolyticus and V. vulnificus in approximately 60% and 70% of the isolates picked, 
respectively (data not shown). However, there were a few cases (53 out of 252 V. 
parahaemolyticus) where colonies from mCPC were tested by this PCR to be V. 
parahaemolyticus, and even less frequently, 19 out of 370 V. vulnificus were isolated from the 
TCBS plates and confirmed by this PCR. Based on the second multiplex PCR assay specific for 
the tdh and trh genes in V. parahaemolyticus, none of the 252 V. parahaemolyticus recovered in 
this study possessed these two virulence-related genes. 
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Table 3 - 1 Prevalence of Vibrio parahaemolyticus and Vibrio vulnificus in 94 Louisiana Gulf and Retail Oysters 
Oyster collecting 
site 
Samples 
collected 
No. (%) of samples positive fora Isolates 
recoveredb
No. of isolates belonging tob 
V.  
parahaemolyticus 
V.  
vulnificus 
Either 
 species 
V.  
parahaemolyticus 
V.  
vulnificus 
Gulf 20 10 (50) BC 11 (55) B 16 (80) A 114 (70) 57 (40) 57 (30) 
Grocery Store 14 12 (85.7) A 0 (0) C 12 (85.7) A 49 (46) 49 (46) 0 (0) 
Restaurant A 24 16 (66.7) AB 16 (66.7) AB 23 (95.8) A 180 (86) 78 (44) 102 (42) 
Restaurant B 24 12 (50) BC 21 (87.5) A 24 (100) A 227 (96) 54 (30) 173 (66) 
Restaurant C 12 3 (25) C 6 (50) B 7 (58.3) B 52 (21) 14 (8) 38 (13) 
Total 94 53 (56.4) 54 (57.4) 82 (87.2) 622 (319) 252 (168) 370 (151) 
a Prevalence rates under the same column followed by different letters are significantly different (P < 0.05). The letters A to C were 
used to indicate a descending order of the mean values of each group. 
b The numbers in parenthesis are the number of isolates included for susceptibility testing. 
 
Table 3 - 2 Prevalence of Vibrio parahaemolyticus and Vibrio vulnificus by month of isolation, in oyster samples obtained from the 
Louisiana Gulf Coast and retail outlets in 2005-2006 
Site Vibrio  Species 
Ratio of positive samples vs. samples purchased at that sitea 
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Gulf parahaemolyticus   3/4    6/6   0/6    1/4 
vulnificus   2/4    2/6    6/6    1/4  
Grocery store parahaemolyticus  2/2  10/10 0/2         
vulnificus  0/2 0/10 0/2         
Restaurant A parahaemolyticus    4/4  6/6  4/4  2/8  0/2     
vulnificus    0/4 4/6  4/4  6/8  2/2      
Restaurant B parahaemolyticus     4/4 3/6 1/8 4/6     
vulnificus     1/4 6/6 8/8 6/6     
Restaurant C parahaemolyticus     1/2 0/2 1/4 1/4     
vulnificus     0/2 2/2 1/4 3/4     
a When multiple sampling visits were made at one site during a particular month, the average prevalence rates were used. Blank data 
point means no sampling visits were made to that site in that month.  
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Antimicrobial Susceptibility Profiles. The MIC distributions of the 319 V. 
parahaemolyticus and V. vulnificus isolates sorted by species are presented in Table 3-3. The 
MIC50, MIC90, and MIC range for V. parahaemolyticus tended to be one or more dilutions higher 
than those for V. vulnificus, except in the case of imipenem where both V. vulnificus MIC50 and 
MIC90 were about four-fold higher. For ampicillin, the differences in MIC distributions between 
the two species were much greater (32-64 fold in MIC50 and MIC90), with V. parahaemolyticus 
MIC50 falling in the resistance end of the MIC ranges, whereas V. vulnificus in the susceptible 
end. 
Based on the statistical comparison of log2MIC values among V. parahaemolyticus and 
V. vulnificus included in the susceptibility testing, significant differences were observed in MICs 
to ampicillin, cefotaxime, ciprofloxacin, imipenem, and tetracycline (P < 0.0001), among which 
impenem was the only one that V. vulnificus had higher mean log2MIC value (Table 3-3).  
According to breakpoints recommended by the CLSI M45-A document (Clinical and 
Laboratory Standards Institute, 2006b), the only non-susceptible isolates among the 319 Vibrio 
tested were 95 (29.8%) and 41 (12.9%) isolates, possessing ampicillin MICs in the resistant and 
intermediate categories, respectively. These isolates were all V. parahaemolyticus, resulting in 
the overall ampicillin resistance and intermediate rates among the 168 V. parahaemolyticus 
isolates tested to be 56.5% and 24.4%, respectively (Table 3-4), i.e., 81% of the V. 
parahaemolyticus tested had an MIC ≥ 16 µg/ml. The 151 V. vulnificus isolates included in the 
susceptibility testing, on the other hand, were all susceptible to ampicillin. The distribution of 
ampicillin-resistant V. parahaemolyticus in the oyster collecting sites indicated that restaurant A 
had the highest ampicillin resistance and intermediate combined rate (90.9%), followed closely 
by restaurant B (90%), the Gulf (77.5%), the grocery store (74%), and restaurant C (50%).  
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Table 3 - 3 Antimicrobial susceptibility testing ranges, breakpoints, and MIC distribution for 319 Vibrio parahaemolyticus and Vibrio 
vulnificus isolates for eight antimicrobials tested 
Antimicrobial 
agent 
Test range 
(g/ml) 
Breakpoint (g/ml)a MIC (g/ml) distribution forb 
S I R V. parahaemolyticus (n =168) V. vulnificus (n =151) 
MIC50 MIC90 Range Meanb MIC50 MIC90 Range Meanb 
Ampicillin 0.03-64 ≤8 16 ≥32 32 32 0.5-64 4.25c 1 1 0.06-8 -0.20 c 
Cefotaxime 0.03-64 ≤8 16-32 ≥64 0.25 0.5 ≤0.03-4 -1.85 c 0.25 0.25 ≤0.03-2 -2.27 c 
Ceftazidime 0.03-64 ≤8 16 ≥32 0.25 0.5 ≤0.03-4 -2.13 0.25 0.5 ≤0.03-1 -2.17 
Chloramphenicol 1-1024 ≤8 16 ≥32 1 1 0.06-8 -0.75 1 1 0.06-8 -0.50 
Ciprofloxacin 0.03-64 ≤1 2 ≥4 0.125 0.5 ≤0.03-1 -3.28 c ≤0.03 0.06 ≤0.03-0.25 -5.39 c 
Gentamicin 0.06-64 ≤4 8 ≥16 0.5 2 0.125-2 -0.49 0.5 1 ≤0.03-2 -0.57 
Imipenem 0.03-64 ≤4 8 ≥16 ≤0.03 0.06 ≤0.03-2 -5.29 c 0.125 0.25 ≤0.03-0.5 -3.28 c 
Tetracycline 0.03-64 ≤4 8 ≥16 0.5 1 0.06-2 -1.14 c 0.25 0.5 0.06-2 -2.21 c 
a Breakpoints recommended by the Clinical and Laboratory Standards Institute in M45-A (Clinical and Laboratory Standards Institute, 
2006b). S, I, and R stand for susceptible, intermediate, and resistant, respectively. 
b Mean MIC values were expressed in log2 scale. When MIC was ≤0.03 g/ml, a -6 value was used as the value for mean calculation. 
c Indicates significantly different mean MIC values (in log2 scale) between V. parahaemolyticus and V. vulnificus (P < 0.05). 
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However, except for that of restaurant C, all other ampicillin resistance and intermediate 
combined rates were not statistically significant (Table 3-4). 
For the ten reference strains included in the susceptibility testing, similar to our oyster 
isolates, these strains were susceptible to the majority of antimicrobials tested except that 
ampicillin resistance was observed in 3 out of 6 V. parahaemolyticus strains and one additional 
V. parahaemolyticus was intermediate to ampicillin. 
Table 3 - 4 The presence of ampicillin-resistant and intermediate Vibrio parahaemolyticus 
isolates from Louisiana Gulf and retail oysters among 168 Vibrio parahaemolyticus isolates 
included in the susceptibility testing 
Site 
No. (%a) of V. parahaemolyticusb 
R I R+Ic 
Gulf 18 (45) 13 (32.5) 31 (77.5)A 
Grocery Store 25 (54.3) 9 (19.6) 34 (73.9)A 
Restaurant A 29 (65.9) 11 (25) 40 (90.9)A 
Restaurant B 21 (70) 6 (20) 27 (90)A 
Restaurant C 2 (25) 2 (25) 4 (50)B 
Total 95 (56.5) 41 (24.4) 136 (81) 
a Denominators indicate numbers of V. parahaemolyticus recovered from oyster samples 
collected in that particular sampling site and were included for susceptibility testing  
b R and I stand for resistant and intermediate to ampicillin, respectively. 
C Percentages in the same column followed by different letters are significantly different (P < 
0.05). 
 
Discussion 
This study represents the first report on both prevalence and antimicrobial susceptibility 
of V. parahaemolyticus and V. vulnificus in Louisiana oysters, from the Gulf harvesting sites and 
consumer ready, since 1998. The study demonstrated that these two Vibrio spp. may be 
frequently isolated from oysters harvested from the Louisiana Gulf Coast (80%) and from retail 
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outlets (89.2%), particularly during spring to summer (February to June) for V. parahaemolyticus 
and summer months (June to September) for V. vulnificus, when a 100% detection rate was 
recorded at some sampling sites. This observation is supported by previous survey studies 
indicating generally high prevalence and density of these Vibrio spp. in the Gulf Coast oysters 
and waters (Cook et al., 2002a; Cook et al., 2002b; DePaola et al., 1990; DePaola et al., 2003), 
and correlates well with human Vibrio infections reported to CDC through the Cholera and other 
Vibrio Illness Surveillance (COVIS) System that began in Gulf Coast states (Alabama, Florida, 
Louisiana, Mississippi, and Texas) in 1988 (Centers for Disease Control and Prevention, 2005c) 
and through FoodNet.  
The prevalence rates (50%-60%) of individual Vibrio spp. observed in this study for 
either Gulf Coast or retail oyster samples combined, however, were lower than those reported by 
other investigators. In a comprehensive national survey of these two Vibrio spp. in U.S. retail 
shell oysters from June 1998 to July 1999, Cook et al. reported that oysters from the Gulf Coast 
consistently had the highest numbers of both V. parahaemolyticus and V. vulnificus year-round, 
and prevalence rates of 97.4% and 96.2% were observed for V. parahaemolyticus and V. 
vulnificus, respectively, among 80 retail oyster samples harvested from Louisiana (Cook et al., 
2002b). Another study conducted in 1999 and 2000 by the same group, examining V. 
parahaemolyticus in Atlantic and Gulf Coast oysters at harvest, reported the highest detection 
rate (82%) for the Gulf Coast samples and the lowest (34.6%) for the North Atlantic coast 
samples (Cook et al., 2002a). A third study testing 156 Alabama oysters during the same period 
of time for V. parahaemolyticus reported the detection of this organism in all samples with the 
25 g enrichments (DePaola et al., 2003). Several reasons may account for differences in 
prevalence rates between the present study and others. First, since the main aim of our study was 
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to examine the antimicrobial susceptibility of the two vibrios instead of quantifying the levels of 
their presence in the oysters, our methodology was focused on isolation rather than enumeration. 
Therefore, we picked 5 to 10 presumptive Vibrio colonies from the direct plating or enrichment 
plates, instead of up to 48 colonies as recommended for quantitative direct-plating (DePaola et 
al., 2003). Second, oysters sold at retail outlets, although harvested in the same region as the 
Gulf, may have gone through post-harvest treatments, resulting in significant reduction of the 
prevalence of Vibrio spp., but that information was not made available for the present study. 
Last, all the studies mentioned above were conducted in or before 2000, and the Louisiana Gulf 
Coast environment may have since changed, particularly in light of the two hurricanes, Katrina 
and Rita, which made landfalls in August and September 2005, respectively. These storms may 
have had an effect on the ecology of Vibrio spp. in oysters harvested from the Louisiana Gulf 
Coast.  
The seasonal distribution of V. parahaemolyticus and V. vulnificus in the coastal waters and 
oysters, characterized by maximum population abundance during the summer months and 
subsequent decline to undetectable levels during the cold winter months, has been well 
documented by microbiological analysis and supported by epidemiological data of human Vibrio 
infections (Centers for Disease Control and Prevention, 2005c; Cook et al., 2002b; DePaola et 
al., 2003). Much of this seasonal distribution is attributable to the positive correlation between 
Vibrio density and water temperature (DePaola et al., 2003; Pfeffer et al., 2003; Randa et al., 
2004). In the present study, a similar seasonal trend in the prevalence rates of both Vibrio spp. 
was observed. Interestingly, our data indicated a marked difference in the seasonal distribution of 
individual Vibrio populations, with the highest prevalence rates for V. parahaemolyticus falling 
between February and June, whereas V. vulnificus from June to September, possibly suggesting 
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that V. parahaemolyticus strains are more cold tolerant than V. vulnificus strains. However, 
further characterizations of these Vibrio populations are needed to explain this observation. 
Among 252 V. parahaemolyticus isolated and identified in this study, none possessed Tdh 
or Trh, thus were not considered to be pathogenic. Previous studies reported that the prevalence 
of pathogenic V. parahaemolyticus in the U.S. is low, ranging from 0-6% (Cook et al., 2002a; 
Cook et al., 2002b; DePaola et al., 1990); however, a recent study found a much greater rate of 
detection (21.8%) of pathogenic V. parahaemolyticus isolates when many more colonies were 
tested for pathogenicity, particularly during cold months (DePaola et al., 2003). Similar to 
previous studies, the present study did not conduct extensive examination of pathogenic V. 
parahaemolyticus, so the zero prevalence of pathogenic V. parahaemolyticus in the Louisiana 
oyster samples reported in this study should be interpreted with caution. 
In 2005, according to CDC, COVIS received reports of 578 Vibrio isolates from 546 
patients (Centers for Disease Control and Prevention, 2005c). Among 218 patients (40%) 
infected with V. parahaemolyticus, 23% were hospitalized and 1% died. On the other hand, V. 
vulnificus was isolated from 121 (22%) patients; 90% were hospitalized and 26% died (Centers 
for Disease Control and Prevention, 2005c). Despite their public health significance, strains of V. 
parahaemolyticus and V. vulnificus were not extensively monitored for antimicrobial resistance, 
in contrast to enteric pathogens such as Salmonella or Campylobacter. Aquatic bacteria 
including V. parahaemolyticus and V. vulnificus live in the coastal and estuarine waters, an open 
area particularly subject to environmental contaminations by agricultural runoff or waste water 
treatment plants, which may contain various levels of antimicrobials and heavy metals, and act as 
selective pressure for antimicrobial-resistant aquatic bacteria (Gordon et al., 2007; Stepanauskas 
et al., 2006).  
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Prior to May 2006, no standardized susceptibility testing method was available for non-
cholera Vibrio spp. Because of this, it was difficult to compare data from different laboratories 
due to variables involved in the testing. CLSI recently published the M45-A document which 
presented the most current information for drug selection, interpretation, and quality control for 
MIC testing of infrequently isolated or fastidious bacteria, including non-Cholera Vibrio spp. 
(Clinical and Laboratory Standards Institute, 2006b; Jorgensen & Hindler, 2007). The present 
study closely followed these guidelines for MIC testing using broth microdilution. All eight 
antimicrobials tested in the present study were in accordance with the guidelines of the M45-A 
document and represent antimicrobials agents that may be used in the treatment of non-Cholera 
Vibrio spp. infections, particularly tetracycline, cefotaxime, ceftazidime, and fluoroquinolones. 
Our findings indicated that these first-line drugs remained highly effective against both V. 
parahaemolyticus and V. vulnificus; however, the high prevalence of ampicillin-resistant V. 
parahaemolyticus suggested that ampicillin should not be used empirically to treat V. 
parahaemolyticus infection. This is in contrast to recommendations posted by CDC (Centers for 
Disease Control and Prevention, 2005d). Interestingly, ampicillin resistance in V. 
parahaemolyticus is not a new phenomenon. A study in 1978 in the U.S. reported that over 90% 
of 160 V. parahaemolyticus was resistant to ampicillin, and exhibited β-lactamase activity 
(Joseph et al., 1978). Another study conducted in Italy in 2001 also reported unexpectedly high 
frequency (80%) of ampicillin resistance in eight V. parahaemolyticus and six V. vulnificus, 
mostly attributable to the production of β-lactamase (Zanetti et al., 2001). A recent report in the 
Philippines and Thailand found twelve out of fourteen V. parahaemolyticus were resistant to 
ampicillin (Maluping et al., 2005). Similarly, a study in India reported 100% ampicillin 
resistance among seven V. vulnificus and five V. parahaemolyticus tested by the disk diffusion 
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method (Vaseeharan et al., 2005). More recently, a study in Australia reported an ampicillin 
resistance rate of 40% for Vibrio spp., however, only one V. parahaemolyticus and no V. 
vulnificus were included in that study (Akinbowale et al., 2006). The findings in the present 
study are in agreement with results from these earlier studies, which found high prevalence of 
ampicillin resistance in V. parahaemolyticus. Interestingly, none of the V. vulnificus isolates 
tested for antimicrobial susceptibility in this study showed ampicillin resistance.   
Our examination of the prevalence and antimicrobial susceptibility of V. parahaemolyticus 
and V. vulnificus also revealed discernable differences between these two species, e.g. the higher 
prevalence of V. parahaemolyticus in colder months, the generally reduced susceptibility of V. 
parahaemolyticus to antimicrobials, and the compromised ability of V. vulnificus to grow 
directly on TCBS agar, suggesting different microbial physiology may play a role. Further 
studies are needed to better explain these phenomena. Those physiological differences may 
provide a basis to develop better selective and differential media for isolating V. 
parahaemolyticus and V. vulnificus, which can dramatically reduce the number of colonies 
needed to be tested by molecular confirmation methods such as probe hybridization or PCR.  
Conclusion 
Our findings demonstrated the prevalence of V. parahaemolyticus and V. vulnificus in 
oysters from the Louisiana Gulf and at retail outlets, a point of contact closest to human 
consumption. These results illustrated the need for appropriate food safety practices when 
consuming these products. Part of the food safety program could be a national oyster 
surveillance program at the retail level as no such program currently exists. Moreover, the 
observed high percentage of ampicillin-resistant V. parahaemolyticus isolates suggests a 
potential for low efficiency of ampicillin in empirical treatment of infections caused by this 
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organism. Continued monitoring of both the prevalence and antimicrobial susceptibility profile is 
needed to better ensure oyster safety; particularly the retail survey could be expanded to the 
national level. 
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Introduction 
Vibrio vulnificus is a Gram-negative halophilic bacterium that inhabits warm coastal and 
estuarine waters worldwide, and the numbers are especially high in filter-feeding bivalve 
mollusks such as oysters (Oliver, 2006; Strom & Paranjpye, 2000). Three types of human 
illnesses can result from contact with V. vulnificus. Ingestion of the organism in raw or 
undercooked oysters can rapidly lead to primary septicemia, a severe and life-threatening illness 
characterized by fever, nausea, hypotension, and secondary blistering skin lesions (Blake et al., 
1979; Morris, 1988). When persons with preexisting wounds come into direct contact with 
seawaters containing V. vulnificus, potentially fatal wound infections may occur (Tacket et al., 
1984). Much less frequently, V. vulnificus causes gastroenteritis following raw oyster 
consumption (Strom & Paranjpye, 2000). While no fatality has been reported from V. vulnificus 
gastroenteritis, the reported case-fatality rate for primary septicemia and wound infection 
combined is around 30%, responsible for approximately 30 deaths annually in the United States 
(Cholera and Other Vibrio Illness Surveillance, 2009). 
As an opportunistic human pathogen, V. vulnificus causes fatal illness predominantly in 
at-risk groups, which include people with immunocompromising conditions, diabetes, and 
elevated serum iron concentrations due to chronic liver disease or alcohol abuse (Strom & 
Paranjpye, 2000). Besides host susceptibility, epidemiological data also suggest that only a small 
percentage of V. vulnificus strains in oysters are virulent (Cholera and Other Vibrio Illness 
Surveillance, 2009; Jackson et al., 1997; Jones & Oliver, 2009; Warner & Oliver, 2008a) 
Several virulence factors have been identified in V. vulnificus as reviewed previously 
(Gulig et al., 2005; Jones & Oliver, 2009). The expression of a capsular polysaccharide (CPS) is 
considered a major virulence factor for V. vulnificus (Chatzidaki-Livanis et al., 2006b; Simpson 
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et al., 1987). However, both clinical and environmental isolates are generally encapsulated 
(Wright et al., 1996). The frequencies of occurrence of other putative virulence factors, including 
lipopolysaccharide (McPherson et al., 1991), flagella (Kim & Rhee, 2003), cytolysin (Gray & 
Kreger, 1985), and metalloprotease (Kothary & Kreger, 1987) did not differ between 
environmental and clinical V. vulnificus isolates as examined by multiple studies (DePaola et al., 
2003; Gulig et al., 2005; Stelma et al., 1992). Using animal models, studies found that both 
clinical and environmental V. vulnificus isolates were virulent to mice (DePaola et al., 2003; 
Starks et al., 2000; Stelma et al., 1992; Tison & Kelly, 1986); although one study found that 
higher bacterial inoculum was required for environmental isolates to generate identical frequency 
and magnitude of infection as clinical ones (Starks et al., 2000). Therefore, there lacks a unique 
virulence marker that can be used to screen for virulent V. vulnificus isolates from oysters. One 
exception was the siderophores production which was found to differ between a virulent and 
weakly virulent V. vulnificus strain (Simpson & Oliver, 1983). Another study also reported a 
good correlation between clinical-type V. vulnificus isolates in shellfish and the detection of a 
vulnibactin-encoding viuB gene (Panicker et al., 2004b), one of the siderophore genes involved 
in iron acquisition (Litwin et al., 1996). However, because the reverse primer used in that study 
extended to the viuB downstream intergenic region, technically, the target detected was a viuB-
associated fragment, not viuB per se.  
Given the lack of unique virulence markers, bacterial genotyping methods have been 
used recently to associate certain V. vulnificus genotypes with clinical or environmental type 
strains (Chatzidaki-Livanis et al., 2006a; Gordon et al., 2008; Nilsson et al., 2003; Rosche et al., 
2005; Vickery et al., 2007; Warner & Oliver, 2008a; Warner & Oliver, 1999). Firstly, using 
random amplified polymorphic DNA (RAPD), a virulence-correlated gene (vcg) was identified 
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in V. vulnificus (Warner & Oliver, 1999). Among 55 randomly selected V. vulnificus, 90% of 
clinical isolates possessed the vcgC sequence variant and 93% of environmental isolates had the 
vcgE sequence variant (Rosche et al., 2005). Secondly, the polymorphic regions (17 bp) of the V. 
vulnificus 16S rRNA gene have been explored to differentiate between clinical and 
environmental strains (Nilsson et al., 2003; Vickery et al., 2007). Using restriction fragment 
length polymorphism (RFLP), a study found that the majority (31 out of 33) of nonclinical V. 
vulnificus isolates had 16S rRNA type A, whereas a significant percentage (24 out of 34) of 
clinical isolates belonged to 16S rRNA type B (Nilsson et al., 2003). Real-time PCR assays have 
since been designed to differentiate the two16S rRNA genotypes (Gordon et al., 2008; Vickery 
et al., 2007). Lastly, genetic variations in the V. vulnificus CPS operon have been characterized 
and two distinct genotypes termed CPS allele 1 and 2 were identified (Chatzidaki-Livanis et al., 
2006b). A follow-up study analyzing 68 clinical and environmental V. vulnificus isolates 
indicated a significant association between clinical isolates and CPS allele 1 whereas 
environmental isolates and CPS allele 2 (Chatzidaki-Livanis et al., 2006a). Additionally, that 
study also independently evaluated the use of vcg and 16S RNA to differentiate clinical and 
environmental types of V. vulnificus isolates. Although significant associations of distinct 
genotypes with clinical isolates were confirmed, greater diversity (i.e., lower percentages of 
association) than those previously reported was also observed (Chatzidaki-Livanis et al., 2006a). 
Therefore, more independent studies are needed to evaluate the usefulness of these biomarkers to 
predict clinically important V. vulnificus isolates from environmental sources such as oysters. 
We previously recovered 349 V. vulnificus isolates from Louisiana oysters (Han et al., 
2007). The objectives of this study were to determine the distribution of different genotypes 
among these V. vulnificus isolates by analyzing the genetic variations in vcg, 16S rRNA, and 
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CPS, and the presence/absence of the viuB-associated fragment, and to identify environmental 
factors associated with an increased prevalence of clinical-type V. vulnificus isolates in oysters. 
Materials and Methods 
Bacterial Strains and Culture Conditions. V. vulnificus strains (n = 356) used in this 
study included 7 reference strains (Table 4-1) and 349 isolates previously recovered from 
Louisiana Gulf and retail oysters (Han et al., 2007). The V. vulnificus isolates from oysters were 
recovered using methods described in the Food and Drug Administration Bacteriological 
Analytical Manual and PCR was used for confirmation and speciation (Han et al., 2007). The 
cultures were stored in Luria-Bertani broth (BD Diagnostic Systems, Sparks, MD) containing 
30% glycerol at -80oC. V. vulnificus strains were routinely cultured on trypticase soy agar (BD 
Diagnostic Systems) supplemented with 2% NaCl and incubated at 35oC for 24 h. 
 
Table 4 - 1 Vibrio vulnificus reference strains used in this study, their source of isolation, and 
genotypic characteristics based on the virulence-correlated gene (vcg), 16S rRNA, capsular 
polysaccharide operon (CPS), and the vulnibactin gene (viuB)-associated fragment 
V. vulnificus straina Source of isolation Characteristicsb 
vcg 16S rRNA CPS viuB 
C E A B 1 2 
Clinical strains (n = 5)        
    ATCC 27562  Blood, Florida  - + + - - + + 
    ATCC 29306 Corneal ulcer, Virginia - + + - - + + 
    ATCC 33815 Leg ulcer, Wisconsin + - - + + - + 
    ATCC 33816 Blood, Alaska + - - + + - + 
    1007 Blood, Louisiana + - - + + - + 
Environmental strains (n = 2)        
515-4C2 Oyster, California - + + - - + - 
WR1 Sea water, Washington - + + - - - - 
a ATCC, American Type Culture Collection, Manassas, VA. 
b The following genotypes denote clinical-type V. vulnificus: vcgC, 16S rRNA type B, CPS allele 
1, and the presence of viuB. 
“+” stands for amplificaition of the gene, “-” stands for no amplification of the gene. 
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 Multilocus PCR Assays. Primer sets used for each locus are listed in Table 4-2. For vcg, 
two pairs of primers (a common reverse primer) previously published were utilized, one 
targeting the clinical-type V. vulnificus strains and the other one amplifying environmental-type 
strains (Rosche et al., 2005). For 16S rRNA, a Taqman real-time PCR assay designed previously 
was adopted (Vickery et al., 2007). For CPS, two pairs of primers were designed using the 
Primer3 software (http://frodo.wi.mit.edu/), one targeting the hypothetical protein 1 (HP1) in V. 
vulnificus MO6-24/O (CPS allele 1) and the other one amplifying the hypothetical protein 2 
(HP2) in V. vulnificus YJ106/O (CPS allele 2) (Chatzidaki-Livanis et al., 2006b). For viuB-
associated fragment, one pair of primers was used which targeted the viuB gene and downstream 
intergenic region, and the amplification of this fragment indicated clinically important V. 
vulnificus strains (Panicker et al., 2004a; Panicker et al., 2004b).  
Chromosomal DNAs of the V. vulnificus strains were prepared by using a UltraClean 
DNA isolation kit (MO BIO Laboratories, Carlsbad, CA). PCR or real-time PCR conditions for 
vcg, 16S rRNA, and the viuB fragment followed previously described protocols (Panicker et al., 
2004b; Rosche et al., 2005; Vickery et al., 2007). For CPS, each PCR mix in a total volume of 
25 µl consisted of the following: 1 × PCR buffer, 0.2 mM of each deoxynucleotide triphosphate, 
1.5 mM of MgCl2, 0.5 unit of Go Taq Hot Start Polymerase (Promega, Madison, WI), 0.2 µM of 
each primer (Invitrogen, Carlsbad, CA), and 1 µl of chromosomal DNA template. The PCR 
reaction was conducted using 95°C for 5 min followed by 30 cycles of denaturation at 94°C for 1 
min, primer annealing at 50°C for 1 min, extension at 72°C for 1 min, and a final extension at 
72°C for 7 min in a Bio-Rad C1000 Thermal Cycler (Hercules, CA). PCR products were 
analyzed by electrophoresis on 1.5% agarose gel containing ethidium bromide, and visualized 
under UV light, and documented by a Gel Doc XR system (Bio-Rad).  
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Table 4 - 2 PCR primers used to characterize Vibrio vulnificus genotypes 
Target 
locus 
Genotypea Primer name Sequence (5-3)b GenBank 
accession no. 
Position Amplicon 
size (bp)c 
Reference
vcg C P1 AGCTGCCGATAGCGATCT  AY626575 156-173 278 (Rosche 
et al., 
2005) 
  P3 CGCTTAGGATGATCGGTG  416-433  
 E P2 CTCAATTGACAATGATCT AY626579 156-173 278 
  P3 CGCTTAGGATGATCGGTG  416-433  
16S rRNA Common Vvu16S51-F CAAGTCGAGCGGCAGCA X76333 and 
X76334 
51-67 171 (Vickery 
et al., 
2007) 
 Vvu16S221-R TCCTGACGCGAGAGGCC 205-221  
 A Vvu16SA-P 6FAM-TGATAGCTTCGGCTCAA-
MGBNFQ 
X76333 173-189  
 B Vvu16SB-P TET-CCCGTAGGCATCATGC-
MGBNFQ 
X76334 185-170  
CPS 1 HP1F TTTGGGATTTGAAAGGCTTG DQ360502 2156-2175 342 This 
study 
 
  HP1R GTGCCTTTGCGAATTTTGAT  2478-2497  
 2 HP2F TTCCATCAAACATCGCAGAA NC_005139 
(VV0338) 
125-144 152 
  HP2R CTTTTGTCCGGCTTCTATCG 257-276  
viuB 
fragment 
clinical F-viuB GGTTGGGCACTAAAGGCAGATATA U32676 1729-1752 505 (Panicker 
et al., 
2004a)   R-viuB CGGCAGTGGACTAATACGCAGC  2212-2233  
a The following genotypes denote clinical-type V. vulnificus: vcgC, 16S rRNA type B, CPS allele 1, and the presence of viuB-
associated fragment. 
b MGBNFQ is minor groove binding non-fluorescent quencher. 
c Differences in amplicon sizes were noted from those originally published after reanalysis of the sequences and primer locations.
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Statistical Analysis. The distributions of different genotypes among V. vulnificus oyster 
isolates were sorted by the target locus and the month of isolation and analyzed by using one-
way analysis of variance (ANOVA) followed by post-hoc multiple comparisons using the Least 
Significant Difference (LSD) test (SAS for Windows, version 9; SAS Institute Inc., Cary, NC). 
Additionally, differences in the presence of the viuB-associated fragment among clinical-type 
(harboring vcgC, 16S rRNA B, CPS allele 1, and the viuB fragment) and environmental-type 
(being vcgE, 16S rRNA A, CPS allele 2, and lack the viuB fragment) V. vulnificus isolates as 
characterized by different markers (vcg, 16S rRNA, and CPS) were compared by using the Chi-
square test. Differences between the mean values were considered significant when P < 0.05. 
Results 
Distribution of V. vulnificus Genotypic Profiles. Genotypic profiles of the seven V. 
vulnificus reference strains are shown in Table 4-1. V. vulnificus genotypes were designated 
using a combination of the strains’ vcg type, 16S rRNA type, and CPS allele type following that 
order. Among the five V. vulnificus clinical strains, two (ATCC 27562 and ATCC 29306) had 
genotype EA2, and the rest (ATCC 33815, ATCC 33816, and 1007) CB1. For the two 
environmental strains, 515-4C2 possessed genotype EA2 whereas WR1 had genotype EANone 
since no amplification was obtained using either CPS allele 1 or 2 primer sets (Table 4-1). 
Table 4-3 shows the distribution of genotypic profiles among 349 V. vulnificus oyster 
isolates. Based on the vcg genotypic analysis, the majority (59%) of V. vulnificus oyster isolates 
belonged to environmental-type strains (genotype vcgE), and the remainders (41%) were vcgC 
genotype which was associated with clinical-type strains. Similarly, there was also a higher 
percentage of V. vulnificus oyster isolates possessing environmental-type genotypes than that of 
clinical-type ones based on the analysis of the 16S rRNA and CPS loci (Table 4-3). For 16S 
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rRNA, there was a small proportion (8%) of the oyster isolates harbored both A and B 
genotypes, making it difficult to designate them as clinical- or environmental-type strains (Table 
4-3). For CPS, the absence of both allele 1 and 2 indicated that the strain was not encapsulated, 
i.e., an environmental-type strain. Therefore, environmental-type strains were 72.5% based on 
the CPS analysis, much higher than clinical-type strains (27.5%). 
 
Table 4 - 3 Distributions of genotypic profiles among 349 Vibrio vulnificus oyster isolates based 
on genotypic characteristics of three loci (vcg, 16S rRNA, and CPS) 
Target locus Clinical-type Environmental-type Atypicala 
 Genotype No. (%) Genotype No. (%) Genotype No. (%) 
vcg C 143 (41) E 206 (59) ND  
16S rRNA B 141 (40.4) A  180 (51.6) AB 28 (8) 
CPS 1 96 (27.5) 2 180 (51.6) ND  
   None 73 (20.9)   
   Subtotal 253 (72.5)   
All three loci CB1 74 (21.2) EA2 130 (37.2) CA1 1 (0.3) 
  EANone 31 (8.9) CA2 3 (0.9) 
  Subtotal  161 (46.1) CAB2 1 (0.3) 
    CABNone 1 (0.3) 
    CB2 25 (7.2) 
    CBNone 38 (10.9) 
    EA1 15 (4.3) 
    EAB1 6 (1.7) 
    EAB2 18 (5.2) 
    EABNone 2 (0.6) 
    EB2 3 (0.9) 
     EBNone 1 (0.3) 
     Subtotal 114 (32.7) 
a ND means not detected. 
 
When combining the three loci, the prevalence of environmental-type V. vulnificus strains 
among the 349 oyster isolates was 46.1% compared to 21.2% for clinical-type strains (Table 4-
3). A notable percentage (32.7%) of isolates was atypical with various genotypic combinations 
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of the three loci (Table 4-3). Major atypical genotypes include CBNone (38; 10.9%), CB2 (25; 
7.2%), EAB2 (18; 5.2%), and EA1 (15; 4.3%).  
Prevalence of the viuB-associated Fragment. The presence of the viuB fragment among 
the seven V. vulnificus reference strains is also shown in Table 4-1. All five clinical strains 
possessed the viuB-associated fragment, whereas neither of the two environmental V. vulnificus 
strains was positive for this gene, indicating a good correlation between the presence of the viuB 
fragment and the clinical source of the strains as well as the absence of this gene and the 
environmental source of the strains. 
 Among 349 V. vulnificus oyster isolates, the majority (59%) showed no amplification of 
the viuB fragment. The association between environmental and clinical genotypes based on 
analysis of each of the three loci (vcg, 16S rRNA, and CPS) and the presence/absence of the viuB 
fragment is presented in Table 4-4. Based on either vcg or 16S rRNA analysis, over 75% of 
isolates assigned to the clinical-type V. vulnificus strains had the viuB fragment, whereas 
between 83-85% of the environmental-type strains lacked this fragment. For isolates assigned to 
be clinical-type strains based on the CPS analysis, 63.5% of them were viuB-associated fragment 
positive, while only 32.4% of environmental-type isolates based on CPS were viuB-associated 
fragment positive (Table 4-4). Statistical analysis indicated significantly higher percentages of 
clinical-type strains than environmental ones possessed the viuB fragment regardless of which 
genotyping analysis was used to assign the clinical- or environmental-type strains (P < 0.0001).  
Prediction of Clinically Important V. vulnificus. Predictions were made using various 
combinations of the four biomarkers: vcg type, 16S rRNA type, CPS allele type, and the 
presence/absence of the viuB-associated fragment. When all four biomarkers were used, three out 
of five V. vulnificus reference strains from clinical sources were shown to be clinically important 
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because of having CA1 genotype and possessing viuB-associated fragment, whereas none of the 
two environmental strains was presumed to be clinically important due to possessing EA2 or 
EAnone genotype and lacking the viuB fragment. 
 
Table 4 - 4 Associations between environmental and clinical Vibrio vulnificus genotypes based 
on analysis of each of the three loci (vcg, 16S rRNA, and CPS) and the presence/absence of the 
viuB-associated fragment among 349 V. vulnificus oyster isolates 
Target 
locusa  
Number (percentage) of V. vulnificus isolates with the presence or absence of the viuB-
associated fragment among all isolates of 
 Clinical-type Environmental-type 
 Genotype No. Present Absent Genotype No. Present Absent 
vcg C 143 108 (75.5) 35 (24.5) E 206 35 (17) 171 (83) 
16S rRNA B 141 107 (75.9) 34 (24.1) A 180 27 (15) 153 (85) 
CPS 1 96 61 (63.5) 35 (36.5) 2 180 49 (27.2) 131 (72.8) 
     None 73 33 (45.2) 40 (54.8) 
     Subtotal 253 82 (32.4) 171 (67.6) 
a Due to the presence of atypical isolates based on the 16S rRNA gene analysis, the total number 
of isolates did not add up to 349 for the 16S rRNA row. 
 
Table 4-5 shows predictions of clinically important V. vulnificus isolates from the oyster 
samples based on various combinations of the biomarkers used. When using all four biomarkers, 
16.3% (57/349) of isolates were predicted to be clinically important due to harboring vcgC, 16S 
rRNA B, CPS allele 1, and the viuB fragment. When three biomarkers were used, the predicted 
percentages of clinical-type V. vulnificus strains ranged between 16.3% and 30.7%. When only 
two biomarkers were used, the range became 17.5-39.3% for clinically important V. vulnificus 
strains. Regardless of two or three biomarkers were used, combinations including vcg and 16S 
rRNA gave higher percentages of clinically important V. vulnificus isolates whereas 
combinations including CPS gave lower percentages. Furthermore, agreements in assigning 
clinical or environmental type V. vulnificus strains based on all the biomarkers used in each 
combination are presented in Table 4-5. Not surprisingly, the agreement was the lowest when all 
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four biomarkers were used (55.3%), and among combinations involving two biomarkers, the 
highest agreement was found in the vcg/16S rRNA combination (89.7%) whereas the lowest one 
CPS/viuB (66.5%). When three markers were used, the highest agreement was found for vcg/16S 
rRNA/viuB (73.6%) and the lowest for 16S rRNA/CPS/viuB (56.2%). 
 
Table 4 - 5 Predictions of clinically important Vibrio vulnificus isolates from Louisiana oysters 
based on various combinations of the four biomarkers used in this study 
Biomarker combinationa Clinical-type Environmental-type Agreement
b (%)  Genotype No. (%) Genotype No. (%) 
vcg/16S rRNA/CPS/viuB CB1Yes 57 (16.3) EA2No or EANoneNo 136 (39) 193 (55.3) 
vcg/16S rRNA/CPS CB1 74 (21.2) EA2 or EANone 161 (46.1) 235 (67.3) 
vcg/16S rRNA/viuB CBYes 107 (30.7) EANo  150 (43) 257 (73.6) 
vcg/CPS/viuB C1Yes 58 (16.6) E2No or ENoneNo 153 (43.8) 211 (60.5) 
16S rRNA/CPS/viuB B1Yes 57 (16.3) A2No or ANoneNo 139 (39.8) 196 (56.2) 
vcg/16S rRNA CB 137 (39.3) EA  176 (50.4) 313 (89.7) 
vcg/CPS C1 75 (21.5) E2 or ENone 185 (53) 260 (74.5) 
vcg/viuB CYes 108 (30.9) ENo 171 (49) 279 (80) 
16S rRNA/CPS B1 74 (21.2) A2 or ANone 164 (47) 238 (68.2) 
16S rRNA/viuB BYes 107 (30.7) ANo 153 (43.8) 260 (74.5) 
CPS/viuB 1Yes 61 
(17.5) 
2No or NoneNo 171 (49) 232 (66.5) 
a Due to the presence of atypical genotypes, the total number of isolates did not add up to be 349. 
b Percent agreement was calculated by using the total number of isolates assigned to either 
clinical or environmental-type V. vulnificus strains by all the biomarkers used in each 
combination divided by 349. 
 
Seasonal Distribution of Clinical-type V. vulnificus. Figure 4-1 presents the ratios of 
clinical-type and environmental-type Vibrio vulnificus oyster isolates by the month of isolation. 
An apparent seasonal pattern where warmer months were associated with more clinical-type V. 
vulnificus oyster isolates was observed when analyzing using vcg, 16S rRNA, CPS, and the viuB-
associated fragment individually (Fig. A-D). A combination of the four markers analysis also 
indicated a similar seasonal distribution (Fig. E), and clinical-type strains had the highest 
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percentage in September followed by August, July, and June, whereas absent from May and 
April isolates (P < 0.05).  
 
       
  
 
Figure 4 - 1 Ratios of clinical-type and environmental-type of Vibrio vulnificus oyster isolates by 
the month of isolation when analyzed by vcg (A), 16S rRNA (B), CPS (C), viuB-associated 
fragment (D), and a combination of all four markers (E). 
 The solid bars at the bottom indicate percentages of clinical-type strains (vcgC, 16S rRNA type 
B, CPS allele 1, and the presence of viuB fragment) and the croass-hatch bars indicate 
percentages of environmental-type strains. Due to the presence of strains with atypical genotypes 
by 16S rRNA and combinations of all four biomarkers, the total percentages for some months 
did not add up to be 100% in B and E. 
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Discussion 
The apparent discrepancy between human exposure to V. vulnificus through oyster 
consumption and the annual number of illness/deaths resulted have prompted many investigators 
to examine the virulence potential of V. vulnificus isolates from oysters and to investigate tools 
that could be used to differentiate clinical-type V. vulnificus strains from environmental-type 
ones (Aznar et al., 1994; DePaola et al., 2003; Gordon et al., 2008; Jones & Oliver, 2009; 
Nilsson et al., 2003; Panicker et al., 2004b; Rosche et al., 2005; Sanjuan et al., 2009; Vickery et 
al., 2007; Warner & Oliver, 2008b; Warner & Oliver, 1999). In the present study, we evaluated 
356 V. vulnificus strains including 7 reference strains and 349 oyster isolates using four 
biomarkers, vcg, 16S rRNA, CPS, and viuB. This is the first study that combinations of these 
four biomarkers were used to independently evaluate their usefulness in predicting clinically 
important V. vulnificus isolates from oysters. 
Genotypic analysis of three biomarkers (vcg, 16S rRNA, and CPS) indicated that the 
majority of 349 V. vulnificus oyster isolates belonged to environmental-type strains, i.e., vcgE, 
16S rRNA type A, and capsule allele 2 or absent, although the actual percentages of 
environmental-type strains differed dependent upon the biomarkers examined, ranging from 
51.6% for 16S rRNA (type A) and 72.5% for the capsular polysaccharide operon (allele 2 or 
absent). Very few studies have examined V. vulnificus populations from natural oyster or 
seawater by using these markers. One study characterized vcg genotypes among V. vulnificus 
oyster and seawater isolates recovered from the eastern coast of North Carolina and found that 
84.4% of the 880 oyster isolates had the vcgE type, whereas an almost equal distribution of the 
two vcg genotypes (46.9% vcgE versus 53.1% vcgC) was found among 292 seawater isolates 
(Warner & Oliver, 2008a). Another study using SYBR-based real-time PCR to detect and 
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differentiate 16S rRNA A and B types showed that the ratio of A: B was 5:8 (A type 38.5%; n = 
26) from oysters in poor water quality while for oysters in good water quality, the ratio was 10:1 
(A type 90.9%; n = 22) (Gordon et al., 2008). In our study, the percentages of oyster isolates 
possessing vcgE and 16S rRNA A genotypes were 59% and 51.6%, respectively, which may be 
partly explained by the different geographical regions and seasons involved in sampling. On the 
other hand, when using the three biomarkers to analyze seven reference strains with known 
source of isolation in this study, two out of five clinical strains showed environmental-type 
characteristics (vcgE, 16S rRNA type A, and CPS allele 2) by all three markers (Table 4-1). This 
finding is not surprising as indicated by multiple previous studies using larger collections of V. 
vulnificus strains, although significant associations between clinical strains and vcgC, 16S rRNA 
type B, or CPS allele 1 were observed, small percentages of clinical isolates did fall into the 
opposite genotypes, i.e., EA2 (Chatzidaki-Livanis et al., 2006a; Nilsson et al., 2003; Rosche et 
al., 2005). Such findings highlight the drawbacks associated with assigning clinical or 
environmental-type V. vulnificus strains based on genotyping studies, rather than based on the 
presence or absence of a unique virulence marker.  
Interestingly, analyzing the 349 oyster isolates by 16S rRNA real-time PCR indicated 
approximately 8% of the isolates had both A and B types, which confirmed findings from 
previous studies that the two 16S rRNA sequence variants could be present simultaneously 
within a single V. vulnificus strain (Chatzidaki-Livanis et al., 2006b; Vickery et al., 2007). Type 
AB strains have been sequenced previously and data suggested that in the genome of most 
strains, there were more copies of the type A gene present than that of type B (Vickery et al., 
2007). Nonetheless, the presence of 16S rRNA AB type made it difficult to designate those 
strains as either clinical- or environmental-type strains, which was not a desirable feature when 
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genotyping was conducted primarily to differentiate clinical-type V. vulnificus strains from 
environmental-type ones. 
In contrast to the above mentioned three biomarkers, especially vcg and 16S rRNA, viuB 
has not been used widely to differentiate clinical and environmental-type V. vulnificus strains. 
Among the seven reference strains used in the study, a 100% correlation between the presence or 
absence of the viuB-associated fragment with strains from clinical or environmental sources, 
respectively was found, similar to those reported previously (Panicker et al., 2004b). Such 
findings suggested that the viuB fragment could be used as a promising biomarker to identify V. 
vulnificus environmental or food isolates with clinical potentials, although further studies 
examining a large collection of V. vulnificus strains with known clinical or environmental 
sources coupled with mouse bioassays would be necessary to confirm this possibility. 
Among the 349 V. vulnificus oyster isolates examined in this study, approximately 41% 
showed amplification of the viuB fragment. A previous study examining the prevalence of viuB 
among natural oyster samples reported 5 out of 33 (15%) V. vulnificus-positive oyster samples 
contained viuB (Panicker et al., 2004b). Again, different regions and seasons of oyster sample 
collection may explain the difference in the prevalence of viuB fragment observed. It is 
noteworthy that when combining viuB analysis with three marker genotyping data, our data 
showed that over 75% of clinical-type strains assigned by vcg and 16S rRNA possessed the viuB-
associated fragment whereas approximately 83% of environmental-type strains lacked this 
fragment (Table 4-4). Such significant association (P < 0.0001) further suggested the potential 
usefulness of the viuB-associated fragment as a biomarker for identifying clinical-type V. 
vulnificus strains. 
Based on the agreement analysis, among the four biomarkers used in this study, the best 
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agreement was found between vcg and 16S rRNA (Table 4-5). Additionally, our data indicated 
that CPS tended to give lower estimate of potentially clinical important V. vulnificus strains 
compared to vcg, 16S rRNA, or viuB. However, findings based on a single study are not 
conclusive and future studies involving a large collection of V. vulnificus strains would be 
needed to better assess the usefulness of these biomarkers in predicting clinically important V. 
vulnificus strains from oysters or the environment. Nonetheless, the fact that there were many 
atypical strains when combinations of biomarkers were used suggest that fundamentally it is 
difficult to appropriately assign clinical or environmental types to these V. vulnificus strains. 
Interestingly, a seasonal presence of clinical-type V. vulnificus among oyster isolates was 
observed, corroborating findings from previous studies (Panicker et al., 2004b; Warner & Oliver, 
2008a). Such finding is alarming, as it is well established that V. vulnificus resides in high 
numbers (103 to 104 per gram) in oysters during summer months and temperature is a major 
parameter that strongly correlates with V. vulnificus density (Randa et al., 2004; Wright et al., 
1996). Therefore, future control measures need to target more specifically on seasons that tend to 
accumulate high-density clinical-type V. vulnificus. 
Finally, besides markers examined in this study, other markers such as vvhA (encodes V. 
vunificus hemolysin) has been used for the similar purpose. In a very recent study evaluating 
multiple genotypic (ribotyping, DNA polymorphism at vcg, 16S rRNA, and vvhA) and 
phenotypic (API 20E, API 20 NE, and BIOLOG) methods to distinguish clinical from 
environmental V. vulnificus strains, the authors concluded that profile 1 strains were vcgC, 16S 
rRNA B, and vvhA type 1, and included most (75%) of the biotype 1 human septicemic isolates 
from blood (Sanjuan et al., 2009). In contrast to our findings, 75% of oyster isolates also 
belonged to profile 1, suggesting of clinical-type strains. It is noteworthy that the isolates used in 
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that study were collected from multiple continents over extended time periods, and may not 
represent isolates typical in the United States Gulf region. Our findings, although supported the 
usefulness of utilizing biomarkers in characterizing V. vulnificus strains, also highlighted the 
drawbacks of using biomarker genotypes to predict V. vulnificus strain virulence and called for 
more virulence mechanism studies to identify unique virulence markers in this organism to be 
used as unequivocal ways to screen for virulent V. vulnificus strains from oysters or the 
environment. 
Conclusion 
In this study, we used multiple biomarkers to characterize 349 V. vulnificus oyster 
isolates previously isolated from Louisiana oysters. The majority of V. vulnificus isolates were of 
environmental type, and there existed a seasonal variation in the V. vulnificus genotypes 
identified, which may have important implications for future control measures. Among the 
biomarkers used, vcg and 16S rRNA had the best agreement, whereas using all four biomarkers 
was the most discriminatory typing method. However, predicting V. vulnificus strain virulence 
using biomarker genotyping had drawbacks and unique virulence markers in this organism 
would be necessary to facilitate future screening of virulent V. vulnificus strains from oysters or 
the environment. 
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Introduction 
Vibrio vulnificus, a Gram-negative halophilic bacterium, is a natural inhabitant of the 
estuarine and coastal waters worldwide (Oliver, 2006). This organism is capable of causing fatal 
illness such as primary septicemia and wound infection, especially among immunocompromised 
persons and those with increased serum iron level due to diabetes or chronic liver disease (Strom 
& Paranjpye, 2000). In the United States, V. vulnificus is responsible for over 95% of seafood-
related deaths (Oliver, 2006). One major source of V. vulnificus infection is the consumption of 
raw or undercooked seafood, particularly oysters (Cholera and Other Vibrio Illness Surveillance, 
2009). To better control V. vulnificus risks in oysters, rapid and specific detection methods are 
imperative, especially if information on the virulence potential of the strain could be obtained 
simultaneously. 
A number of molecular-based detection methods, primarily PCR and real-time PCR 
targeting the V. vulnificus cytolysin/hemolysin gene (vvhA) have been descried (Coleman et al., 
1996; Hill et al., 1991; Panicker & Bej, 2005; Wright et al., 2007). Although widely used and 
highly specific to V. vulnificus, this species-specific gene is not capable of predicating the 
virulence potential of V. vulnificus strains. Given that unique virulence markers, which present 
exclusively in virulent V. vulnificus strains have not been identified (Han et al., 2009), alternative 
strategies are sought. Recently, several biomarkers have been explored to differentiate virulent- 
(i.e., clinical-) from non-virulent- (i.e., environmental-) type V. vulnificus strains with varied 
degree of success. The first biomarker is the virulence-correlated gene (vcg), which was 
identified using randomly amplified polymorphic DNA (Warner & Oliver, 1999). A follow-up 
study showed that 90% of clinical strains had the vcgC sequence variant whereas 93% of 
environmental isolates possessed the vcgE sequence variant (Rosche et al., 2005). Secondly, 
 75
polymorphism in 17 nucleotides of the V. vulnificus 16S rRNA gene was used to differentiate 
clinical- from environmental-type strains using restriction fragment length polymorphism 
(Nilsson et al., 2003). By real-time PCR, the majority of clinical isolates were determined to be 
16S rRNA type B, while most environmental strains belonged to 16S rRNA type A (Gordon et 
al., 2008; Vickery et al., 2007). Thirdly, the capsular polysaccharide (CPS) operon was 
examined and significant associations were identified between clinical isolates and CPS allele 1, 
as well as between environmental isolates and CPS allele 2 (Chatzidaki-Livanis et al., 2006a; 
Chatzidaki-Livanis et al., 2006b). Therefore, it now seems technically feasible to design 
molecular detection assays that specifically target polymorphic regions of these biomarkers to 
differentiate virulent- from non-virulent-type V. vulnificus strains. 
 In most studies using biomarkers to differentiate V. vulnificus strains, single PCR or real-
time PCR assays have been used. Frequently, two PCR reactions were needed for one biomarker 
and a high-fidelity DNA polymerase was required (Chatzidaki-Livanis et al., 2006a; Rosche et 
al., 2005; Sanjuan et al., 2009), rending the process both labor-intensive and costly. In addition, 
species detection and strain characterization were commonly done in sequential steps, rather than 
simultaneously. Recently, a multiplex PCR assay was developed which targeted vcgC, vcgE, and 
vvhA, that allowed for both species-level identification and determination of the vcg genotype 
(Warner & Oliver, 2008b). Nonetheless, only one biomarker was targeted in this multiplex PCR 
and several studies have pointed out the benefit of using multiple biomarkers in characterizing V. 
vulnificus strains (Han et al., 2009; Sanjuan et al., 2009). 
The objective of this study was to develop multiplex PCR assays that targeted vvhA and a 
combination of several potential virulence biomarkers (vcg, 16S rRNA, and CPS) to 
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simultaneously detect and characterize V. vulnificus strains, either virulent type or non-virulent 
type. 
Materials and Methods 
Bacterial Strains and Culture Conditions. V. vulnificus strains (n = 90) used in this 
study included 10 reference strains (Table 4-6) and 80 isolates (Table 4-7) previously recovered 
from Louisiana Gulf and retail oysters (Han et al., 2007). The strains were confirmed using the 
vvhA-PCR (Kaysner & DePaola, 2001) and characterized by single PCR or real-time PCR for the 
three biomarkers, vcg, 16S rRNA, and CPS (Han et al., 2009). The cultures were stored in Luria-
Bertani broth (BD Diagnostic Systems, Sparks, MD) containing 30% glycerol at -80oC. V. 
vulnificus strains were routinely cultured on trypticase soy agar (BD Diagnostic Systems) 
supplemented with 2% NaCl and incubated at 35oC for 24 h. 
 Multiplex PCR Assays. PCR primers used for each biomarker are listed in Table 4-8. 
Two pairs of multiplex PCR assays were developed, with one pair targeted four genes (vcg, 16S 
rRNA, CPS and vvhA) and the other pair three genes (vcg, 16S rRNA, and vvhA). For virulent-
type V. vulnificus assays, a combination of vcgC, 16S rRNA type B, CPS allele 1, and vvhA was 
used, whereas for non-virulent-type assays, a combination of vcgE, 16S rRNA type A, CPS allele 
2, and vvhA was used. Two sets of vcgC primers were used, one in the 4-target virulent-type 
multiplex PCR and the other one in 3-target virulent-type multiplex PCR, amplifying PCR bands 
of 99 bp and 278 bp, respectively (Table 4-8). 
V. vulnificus genomic DNAs were prepared by using an UltraClean Microbial DNA 
Isolation kit (MO BIO Laboratories, Carlsbad, CA). Each prototype PCR mix in a total volume 
of 25 µl consisted of the following: 1 × PCR buffer, 0.2 mM of each deoxynucleotide 
triphosphate (dNTP), 1.5 mM of MgCl2, 0.5 U of GoTaq Hot Start polymerase (Promega, 
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Madison, WI), 0.2 µM of each primer (Invitrogen, Carlsbad, CA), and 1 µl of genomic DNA 
template. The PCR reaction was conducted using 95°C for 5 min followed by 30 cycles of 
denaturation at 94°C for 1 min, primer annealing at 50°C for 1 min, extension at 72°C for 1 min, 
and a final extension at 72°C for 7 min in a Bio-Rad C1000 Thermal Cycler (Hercules, CA).  
PCR products were analyzed by electrophoresis on 1.5% agarose gel containing ethidium 
bromide, visualized under UV light, and documented by a Gel Doc XR system (Bio-Rad). 
Optimization of Multiplex PCR Assays. Annealing temperature (50 to 70oC in 2oC 
increments) and primer concentration (0.1 to 0.8 M in 0.1 M increments and one pair at a time) 
were optimized. Annealing temperature was decreased when the bands intensity was too low, 
and increased when it was too high. In contrast, primer concentration was increased when the 
corresponding band intensity was too low, and decreased it was too high. V. vulnificus ATCC 
33815 was used for optimizing the 4-target or 3-target virulent-type multiplex PCR assays 
whereas V. vulnificus 515-4C2 for non-virulent-type assays. Each optimization experiment was 
repeated twice. 
Specificity of Multiplex PCR Assays. Ten V. vulnificus reference strains and eighty V. 
vulnificus oyster isolates with known strain characteristics for the three biomarker genes (Han et 
al., 2009) were used. False positive and false negative rates, if any, were calculated by using the 
numbers of false positive or false negative strains divided by respective negative or positive 
strains included in the testing. 
Results 
Effect of Annealing Temperature on Multiplex PCR. To allow for high-efficiency 
PCR amplifications of all of the target genes, the annealing temperature was optimized in 2oC 
increments and repeated twice. 
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Table 4 - 6 Ten Vibrio vulnificus reference strains used for multiplex PCR 
V. vulnificus 
strain IDa 
Source and origin Characteristics of 
target geneb 
Multiplex PCR results 
virulent-type non-virulent-type 
vcg 16S CPS vcgC 16S B CPS 1 vvhA vcgE 16S A CPS 2 vvhA 
ATCC 27562  Blood, Florida  E A 2 - - - + + + + + 
ATCC 29306 Corneal ulcer, Virginia E A 2 - - - + + + + + 
ATCC 33815 Leg ulcer, Wisconsin C B 1 + + + + - - - + 
ATCC 33816 Blood, Alaska C B 1 + + + + - - - + 
1003 Wound, Louisiana C B 1 + + + + - - - + 
1004 Stool, Louisiana C B 1 + + + + - - - + 
1006 Blood, Louisiana C B 2 + + - + - - + + 
1007 Blood, Louisiana C B 1 + + + + - - - + 
WR1 Seawater, Washington E A none - - - + + + - + 
515-4C2 Oyster, California E A 2 - - - + + + + + 
a ATCC, American Type Culture Collection, Manassas, VA. 
b Obtained using single PCR methods described in our previous study (Han et al., 2009). The 16S was a short form of 16S rRNA. 
  “+” stands for amplificaition of the gene, “-” stands for no amplification of the gene.
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Table 4 - 7 Vibrio vulnificus oyster isolates used in the specificity test of multiplex PCR 
V. vulnificus strain type and IDa No. Characteristics of target 
genea 
Multiplex PCR results 
 virulent-type non-virulent-type 
 vcg 16S CPS vcgC 16S B CPS 1 vvhA vcgE 16S A CPS 2 vvhA 
Virulent-type 19 C B 1 + + + + - - - + 
V332, V358, V360, V363, V388, 
V419, V443, V444, V469, V499, 
V501, V504, V513, V534, V544, 
V545, V560, V601, V616 
 C B 1 + + + + - - - + 
Non-virulent-type 34 E A 2 or none - - - + + + varies + 
V209, V213, V225, V240, V242,  
V248, V252, V261, V280, V292, 
V324, V327, V333, V350, V372, 
V381, V383, V392, V416, V471, 
V484, V546, V574, V631 
24 E A 2 - - - + + + + + 
V223, V238, V260, V274, V299, 
V304, V308, V354, V364, V477  
10 E A None - - - + + + - + 
Atypical 27 varies varies 
V246  1 C A 1 + - + + - + - + 
V241, V457  2 C A 2 + - - + - + + + 
V214 1 C AB 2 + + - + - + + + 
V414 1 C AB None + + - + - + - + 
V371, V385, V389, V447 4 C B 2 + + - + - - + + 
V377, V465, V552, V576 4 C B None + + - + - - - + 
V239, V297, V387, V438, V490 5 E A 1 - - + + + + - + 
V337, V598 2 E AB 1 - + + + + + - + 
V328, V584 2 E AB 2 - + - + + + + + 
V470, V474 2 E AB None - + - + + + - + 
V432, V433 2 E B 2 - + - + + - + + 
V606  1 E B None - + - + + - - + 
a Obtained using single PCR methods described in our previous study (Han et al., 2009). The 16S was a short form of 16S rRNA. 
“+” stands for amplificaition of the gene, “-” stands for no amplification of the gene. 
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Table 4 - 8 Multiplex PCR primers to simultaneously detect and characterize Vibrio vulnificus strains 
Assay 
type 
Target 
gene 
Primer 
name 
Sequence (5′-3′) GenBank 
accession no. 
Position Amplicon 
size (bp) 
Reference 
Both vvhA Vvh-785F CCGCGGTACAGGTTGGCGCA M34670 785-804 519 (Kaysner & 
DePaola, 2001)Vvh-1303R CGCCACCCACTTTCGGGCC  1285-1303  
Virulent vcgC a vcgC F AGCTGCCGATAGCGATCT AY626575 156-173 99b (Warner & 
Oliver, 2008b) vcgC R TGAGCTAACGCGAGTAGTGAG  234-254  
P1 AGCTGCCGATAGCGATCT  156-173 278 (Rosche et al., 
2005) P3 CGCTTAGGATGATCGGTG  416-433  
16S B B F1 GCCTACGGGCCAAAGAGG X76334 177-194 839 (Warner & 
Oliver, 2008a) B R1 CCTGCGTCTCCGCTGGCT  998-1015  
CPS 1 HP1F TTTGGGATTTGAAAGGCTTG DQ360502 2156-2175 342 (Han et al., 
2009) HP1R GTGCCTTTGCGAATTTTGAT  2478-2497  
Non-
virulent 
vcgE P2 CTCAATTGACAATGATCT AY626579 156-173 278 (Rosche et al., 
2005) P3 CGCTTAGGATGATCGGTG  416-433  
16S A A F2 AGCTTCGGCTCAAAGAGG X76333 177-194 839 This study 
A R2 CCAGCGTCTCCGCTAGAT  998-1015  
CPS 2 HP2F TTCCATCAAACATCGCAGAA NC_005139 
(VV0338) 
125-144 152 (Han et al., 
2009) HP2R CTTTTGTCCGGCTTCTATCG 257-276  
a Two sets of vcgC primers were used in this study, i.e., vcgC F/vcgC R and P1/P3 for the 4-target and 3-target virulent-type multiplex 
PCR, respectively. 
b In the original paper, 97 bp was used. 
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The optimized annealing temperature for 4-target multiplex PCR assays was 56oC for 
virulent-type V. vulnificus and 50oC for non-virulent-type V. vulnificus. After excluding CPS, the 
optimized annealing temperature for 3-target multiplex PCR assays was 60oC for virulent-type V. 
vulnificus and 50oC for non-virulent-type V. vulnificus. 
 
Figure 4 - 2 An agarose gel showing multiplex PCR amplification products using typical 
virulent- and non-virulent-type Vibrio vulnificus strains. 
Lanes 1, 10, 19: molecular weight marker (New England Biolabs, Ipswich, MA); lanes 2-5, 
obtained using 3-target multiplex PCR (60oC annealing temperature) for virulent-type V. 
vulnificus; lanes 6-9, using 3-target multiplex PCR (50oC annealing temperature)  for non-
virulent-type V. vulnificus; lanes 11-14, using 4-target multiplex PCR (56oC annealing 
temperature) for virulent-type V. vulnificus; lanes 15-18, using 4-target multiplex PCR (50oC 
annealing temperature) for non-virulent-type V. vulnificus. DNA templates used for multiplex 
PCR amplifications: V. vulnificus ATCC 33815 (vcgC, 16S rRNA B type, CPS allele 1, and vvhA 
+) in lanes 2, 6, 11, 15; V. vulnificus 515-4C2 (vcgE, 16S rRNA A type, CPS allele 2, and vvhA 
+) in lanes 3, 7, 12, 16; V. vulnificus V223 (vcgE, 16S rRNA A type, CPS none, and vvhA +) in 
lanes 4, 8, 13, 17; negative control in lanes 5, 9, 14, 18. Target gene amplification products as 
shown in the descending order by size in the 3-target multiplex PCR pair are: 16S rRNA B type 
(839 bp), vvhA (519 bp), and vcgC (278 bp) for virulent-type V. vulnificus, and 16S rRNA A type 
(839 bp), vvhA (519 bp), and vcgE (278 bp) for non-virulent-type V. vulnificus. In the 4-target 
multiplex PCR pair, the amplicon sizes are: 16S rRNA B type (839 bp), vvhA (519 bp), CPS 
allele 1 (342 bp), and vcgC (99 bp) for the multiplex PCR assays for virulent-type V. vulnificus, 
and 16S rRNA A type (839 bp), vvhA (519 bp), vcgE (278 bp), and CPS allele 2 (152 bp) for the 
multiplex PCR assays for non-virulent-type V. vulnificus. 
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Effect of Primer Concentration on Multiplex PCR. In order to amplify all of the target 
genes with equal efficiency, i.e., same band intensity, the concentrations of individual primer 
pairs were optimized. The optimized primer concentrations for the 4-target virulent-type 
multiplex PCR were: 0.3 M of vcgC primers (vcgC F/vcgC R), 0.2 M of 16S rRNA type B 
primers (B F1/B R1), 0.7 M of CPS allele 1 primers (HP1F/HP1R), and 0.1 M of vvhA 
primers (Vvh-785F/Vvh-1303R). For the 4-target non-virulent-type assay, the optimized primer 
concentrations were: 0.3 M of vcgE primers (P2/P3), 0.3 M of 16S rRNA type A primers (A 
F2/A R2), 0.2 M of CPS allele 2 primers (HP2F/HP2R), and 0.1 M of vvhA primers (Vvh-
785F/Vvh-1303R) (data not shown). After excluding CPS, the optimum primer concentrations 
remained the same as in the corresponding 4-target multiplex PCR pair. 
Specificity of Multiplex PCR Assays. Among 10 V. vulnificus reference strains and 80 
oyster isolates (Tables 4-6 & 4-7), false-positive or false-negative multiplex PCR results were 
not observed for any of the four target genes, i.e., 100% match with known strain characteristics 
obtained previously using single PCR or real-time PCR assay (Han et al., 2009). Figure 4-2 
shows a representative gel of multiplex PCR amplification products using typical virulent- and 
non-virulent-type V. vulnificus strains.  
Discussion 
In order to simultaneously detect and differentiate V. vulnificus strains, we combined the 
species-specific vvhA gene with three V. vulnificus potential virulence biomarkers (vcg, 16S 
rRNA, and CPS) in two pairs of multiplex PCR assays. The first multiplex PCR pair amplified 
all of the four target genes whereas the second pair amplified three genes except for CPS. For 
each multiplex pair, one assay was designed for virulent-type V. vulnificus strains while the other 
one for non-virulent-type V. vulnificus strains. Although these biomarkers have been used 
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previously in single PCR or real-time PCR format to distinguish between clinical- (i.e., virulent-) 
and environmental- (i.e., non-virulent) type V. vulnificus strains (Chatzidaki-Livanis et al., 2006a; 
Gordon et al., 2008; Rosche et al., 2005; Vickery et al., 2007), this is the first study that 
designed assays targeting multiple V. vulnificus biomarkers and vvhA to detect and characterize 
either virulent-type or non-virulent-type V. vulnificus strains. 
The vvhA gene was included as a species control so that only V. vulnificus strains were 
detected and characterized by these multiplex PCR assays. Additionally, BLAST searches 
(http://www.ncbi.nih.gov/BLAST) indicated both vcg and CPS are highly specific to V. 
vulnificus. Therefore, we did not include non-V. vulnificus strains in the specificity 
testing.Application of these multiplex PCR assays in 10 V. vulnificus reference strains and 80 
V.vulnificus oyster isolates suggested that the assays were highly specific and accurate, with 
results matching exactly with those obtained previously by using single PCR or real-time PCR 
(Han et al., 2009). Therefore, by running one multiplex PCR reaction, e.g., the 4-target virulent-
type assay, information on the strain genus/species and the presence or absence of the vcgC 
sequence variant, 16S rRNA type B, and CPS allele 1 would be obtained simultaneously. 
Similarly, the 4-target non-virulent-type assay would specifically characterize the strain 
genus/species and the presence or absence of the vcgE sequence variant, 16S rRNA type A, and 
CPS allele 2.  
In addition, results for some biomarkers from the paired multiplex PCR assays agreed 
well with each other, e.g., a strain positive for vcgC by using the virulent-type multiplex PCR 
assay would show negative amplification for vcgE by using the non-virulent-type assay, and vice 
versa. This mutual exclusivity of vcgC and vcgE sequence variants in V. vulnificus agreed with 
several previous studies (Chatzidaki-Livanis et al., 2006a; Drake et al., 2010; Han et al., 2009; 
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Rosche et al., 2005; Sanjuan et al., 2009). However, another study (Warner & Oliver, 2008a) 
reported the isolation of V. vulnificus strains from oyster and water that amplified both vcgC and 
vcgE sequences. For 16S rRNA types, the majority of V. vulnificus strains were mutually 
exclusive, reflected by the amplification of either 16S rRNA B type in the virulent-type 
multiplex PCR assay or A type in the non-virulent-type assay. Occasionally, strains amplifying 
both 16S rRNA A and B types occurred as shown in Table 4-7 under atypical strains. This 
phenomenon has been frequently reported in the literature (Chatzidaki-Livanis et al., 2006a; 
Drake et al., 2010; Gordon et al., 2008; Han et al., 2009; Sanjuan et al., 2009; Senoh et al., 
2005; Vickery et al., 2007; Warner & Oliver, 2008a), possibly to meet V. vulnificus survival 
needs under different environmental conditions. For CPS, there has been no reports of V. 
vulnificus strain possessing both allele 1 and 2; however, strains possessing neither allele have 
been reported (Chatzidaki-Livanis et al., 2006a; Han et al., 2009). In that scenario, those strains 
would be negative for CPS allele 1 by the virulent-type multiplex PCR as well as CPS allele 2 
negative by the non-virulent-type assay. Regardless of the strains being virulent-type, non-
virulent-type, or atypical, evaluating 90 V. vulnificus confirmed the accuracy of the multiplex 
PCR results when compared with single PCR or real-time PCR results (Tables 4-6 & 4-7), 
suggesting reliable multiplex PCR assays. 
In the present study, besides a pair of 4-target multiple PCR assays, we also designed a 
pair of 3-target multiplex PCR assays which excluded CPS. There are a few explanations. 
Firstly, in our previous study, CPS tended to give a low estimate of potentially clinical important 
V. vulnificus strains compared to vcg, 16S rRNA, or viuB, and the agreement between CPS and 
other biomarkers was poor (Han et al., 2009). Secondly, there was an ambiguity associated with 
CPS as mentioned above, i.e., non-virulent-type V. vulnificus strains possessed either CPS allele 
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2 or none. Thirdly, CPS has not been used widely as a potential virulence biomarker for V. 
vulnificus as vcg or 16S rRNA. Therefore, in parallel to the 4-target multiplex PCR pair, we also 
designed the 3-target multiplex PCR pair, which could be used when the determination of CPS 
allele types is not desirable. 
Practically, when applying these multiplex PCR assays in microbial ecology or 
epidemiology studies, it is acceptable to run one multiplex PCR assay, either the virulent-type or 
non-virulent type. For the 3-target or 4-target virulent-type multiplex PCR, a typical virulent-
type V. vulnificus strain would generate 3 or 4 bands, respectively, whereas a typical non-virulent 
strain would generate only one vvhA band (Figure 4-2), and the opposite holds true for non-
virulent-type multiplex PCR assays. However, given the ambiguity associated with 16S rRNA 
and CPS mentioned above and the presence of atypical strains, it is preferable that the multiplex 
PCR assay pair be performed so that the definite strain characteristics for these biomarkers could 
be obtained. On the other hand, for oyster and water monitoring programs, the virulent-type 
multiplex PCR would be a preferred assay and the generation of more than one vvhA band would 
suggest virulent-type strains and warrant further characterization of strain genotypes. 
For the 4-target virulent-type multiplex PCR, the optimized annealing temperature was 
56oC since the CPS allele 1 target could not be amplified at annealing temperatures greater than 
56oC. In the corresponding 3-target virulent-type multiplex PCR, which excluded CPS, the 
optimized annealing temperature was increased to 60oC. For the non-virulent-type multiplex 
PCR assays, regardless of the number of targets included, vcgE could not be amplified at 
annealing temperatures greater than 50oC, therefore the optimized annealing temperature for was 
50oC for both 3-target and 4-target non-virulent-type multiplex PCRs. In a single PCR format, 
CPS allele 1 and vcgE could be amplified at >60oC and 56oC, respectively. While in a multiplex 
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PCR setting, due to the competition of primers and PCR reagents, several primers such as vcgE 
or CPS 1 may not amplify in certain stringent condition (i.e. higher annealing temperature).  
Besides the three potential virulence biomarkers used in this study, markers such as viuB 
(Han et al., 2009; Panicker et al., 2004a; Panicker et al., 2004b) and vvhA (Sanjuan et al., 2009; 
Senoh et al., 2005) have been used to differentiate V. vulnificus strain types. Recently, a 
phenotypic trait mannitol fermentation has been reported to correlate with these virulence-
associated genotypic characteristics (Drake et al., 2010). However, none of these biomarkers are 
confirmed unique virulent markers for V. vulnificus, and the assignment of strains to virulent-
type based on these biomarkers only suggests their potential to cause clinical infections. 
Conclusion 
The multiplex PCR assays developed in the present study were capable of detecting and 
characterizing multiple V. vulnificus potential virulence biomarkers simultaneously. Because of 
the multiplex format, these assays obviate the need to run multiple single PCR reactions and the 
need for high-fidelity enzyme. The assays would be valuable tools in microbial ecology and 
epidemiology studies as well as facilitating regulatory agencies and the oyster industry in 
controlling V. vulnificus risks in oysters by specifically detecting virulent-type strains, which has 
the potential to cause clinical infections. 
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Introduction 
First reported in 1979 as a foodborne pathogen associated with raw oysters (Blake et al., 
1979), the Gram-negative, halophilic bacterium Vibrio vulnificus is now recognized as the 
leading cause of seafood-related deaths in the United States, responsible for over 95% of such 
fatal incidences (Oliver, 2006). V. vulnificus causes three quite different human disease 
symptoms, gastroenteritis, primary septicemia, and wound infection. And the mortality rates run 
over 50% in primary septicemia and 25% in wound infections, the highest among those caused 
by foodborne pathogens (Oliver, 2006). In 2004 and 2005, approximately 200 V. vulnificus 
illnesses were reported to the Centers for Disease Control and Prevention (CDC), resulting in 
around 60 deaths. The majority of patients with known food histories reported oyster 
consumption prior to V. vulnificus infection (Centers for Disease Control and Prevention, 2005). 
Moreover, according to a recent CDC’s FoodNet report, the incidence of Vibrio 
parahaemolyticus and V. vulnificus infections in the U.S. due to eating raw or undercooked 
oysters has shown a sustained increase since 2001, indicating further measures are needed to 
prevent human illness caused by these pathogens in oysters (Centers for Disease Control and 
Prevention, 2007). In particular, there is a need for rapid, sensitive, specific, and cost-effective 
detection assays that can be readily employed in the field to better ensure the safety of oysters 
from harvest, post-harvest processing (PHP), to retail.    
Currently, the Interstate Shellfish Sanitation Conference (ISSC) recommends that all PHP 
oysters contain no more than 30 V. vulnificus colony forming units per gram of oyster (CFU/g) 
by the most probable number (MPN) analysis (Food and Drug Administration/National Shellfish 
Sanitation Program, 2005). Such traditional microbiological culturing methods followed by 
biochemical tests for species identification, however, are labor-intensive and time-consuming 
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(Kaysner & DePaola, 2001). Besides, reliable biochemical tests/media for Vibrio species 
confirmation are lacking (Warner & Oliver, 2007). DNA probe hybridization has been used in 
conjunction with direct plating, offering a more rapid (< 24 h) and specific alternative, but is still 
cumbersome (Kaysner & DePaola, 2001; Morris et al., 1987; Wright et al., 1993). The reported 
detection limits using DNA probe hybridization fell between 102 and 104 CFU/g (Kaysner & 
DePaola, 2001; Morris et al., 1987; Wright et al., 1993). Additionally, specific immunological 
tests for V. vulnificus have been developed with a reported detection limit of 2 × 103 cells and a 
total detection time of about 2-3 days (Simonson & Siebeling, 1986; Tamplin et al., 1991). 
However, the required V. vulnificus-specific antibodies are no longer commercially available. 
Molecular-based DNA amplification techniques, e.g., polymerase chain reaction (PCR) 
(Arias et al., 1995; Brauns et al., 1991; Coleman et al., 1996; Hill et al., 1991; Lee et al., 2003), 
reverse-transcription PCR (Fischer-Le Saux et al., 2002), and real-time PCR in recent years 
(Campbell & Wright, 2003; Panicker et al., 2004; Panicker & Bej, 2005; Takahashi et al., 2005; 
Wright et al., 2007), have been described for the rapid and sensitive detection of V. vulnificus in 
oysters. Primarily targeting the vvhA gene that codes for V. vulnificus cytolysin/hemolysin 
(Wright et al., 1985), these assays reached a detection limit of 102 CFU/g oyster without 
enrichment by real-time PCR or nested PCR (Arias et al., 1995; Campbell & Wright, 2003; 
Panicker et al., 2004), whereas a 24 h enrichment was required to achieve the same level of 
sensitivity by PCR (Hill et al., 1991). After 5 h enrichment, a sensitivity of 1 CFU/g was 
reported again by real-time PCR (Panicker et al., 2004; Panicker & Bej, 2005). The concerns 
associated with these assays include expensive thermal cycling instrument, particularly the high 
cost associated with a real-time PCR machine, and the inability to differentiate dead from live 
cells.  
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Recently, a novel loop-mediated isothermal amplification (LAMP) technique was 
described (Notomi et al., 2000) and has shown promise in both bacterial and viral detections 
(Hara-Kudo et al., 2005; Song et al., 2005; Yeh et al., 2006; Yoda et al., 2007). The assay 
employs a set of four or six primers that create a target-specific stem-loop DNA structure during 
initial amplification steps, and subsequent LAMP auto-cycling is achieve by the strand-
displacing Bst DNA polymerase large fragment (Notomi et al., 2000). Advantages of LAMP 
relevant to V. vulnificus detection include: 1) isothermal (60-65oC), no special thermal cycling 
instrument is required; 2) rapid, the assay can be completed in 15-60 min (Nagamine et al., 
2002); 3) specific, the assay targets 6-8 regions of the target gene sequence; 4) sensitive, 
extremely large amount of DNA can be amplified from a few target cells; 5) detection by the 
naked eye due to the formation of large quantities of a by-product, magnesium pyrophosphate, 
which turns positive reaction tubes turbid (Mori et al., 2001); 6) direct amplification, there is no 
need to denature DNA templates before amplification (Nagamine et al., 2001); and 7) robust, 
LAMP is less subjective to inhibition by biological substances (Kaneko et al., 2007).   
Given these advantages, we hypothesized that LAMP could potentially be a useful tool 
for the field detection of V. vulnificus in oysters and growing waters. The objective of the present 
study is to develop a LAMP assay suitable for the rapid and sensitive detection of V. vulnificus in 
raw oysters by targeting the vvhA gene.   
Materials and Methods 
Target and LAMP Primer Design. The V. vulnificus cytolysin/hemolysin gene (vvhA) 
(GenBank accession number M34670) was selected as the target for LAMP primer design. A set 
of four primers, two outer and two inner, that recognize six distinct regions of the target 
sequence (Figure 5-1) was designed using the PrimerExplorer software (V4, Fujitsu Limited, 
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Japan; http://primerexplorer.jp/e). Forward inner primer (FIP) consisted of a complementary 
sequence of F1 and a sense sequence of F2, without any linker sequence in between. Similarly, 
backward inner primer (BIP) was a direct combination of a complementary sequence of B1 and a 
sense sequence of B2. The two outer primers, forward outer primer and backward outer primer, 
were F3 and B3, respectively (Figure 5-1). These primers were selected based on criteria 
described previously by Notomi et al. (Notomi et al., 2000). 
Bacterial Strains, Culture Conditions, and DNA Preparation. Bacterial strains used in 
this study (Table 5-1) were selected from our culture collection at the Department of Food 
Science, Louisiana State University. V. vulnificus 1007, a clinical strain originally isolated by the 
Louisiana Department of Health and Hospitals, was used for assay optimization and sensitivity 
testing with pure culture and seeded raw oysters. Additional 19 V. vulnificus and 30 non-V. 
vulnificus strains were used to evaluate the assay specificity. All Vibrio strains were cultured 
using tryptic soy agar (TSA; BD Diagnostic Systems, Sparks, MD) or broth containing 2% NaCl 
at 35oC overnight. Non-Vibrio strains were grown on Luria-Bertani agar or blood agar (BD 
Diagnostic Systems). In addition, modified cellobiose-polymyxin B-colistin (mCPC) agar as 
recommended in Food and Drug Administration’s Bacteriological Analytical Manual  (Kaysner 
& DePaola, 2001) was used to quantify V. vulnificus levels in seeded oyster samples. 
To prepare DNA templates, a single bacterial colony grown on appropriate agar plates 
was selected and suspended in 500 µl of TE (10 mM Tris, pH 8.0; 1 mM EDTA). The bacterial 
suspension was heated for 10 min at 95oC in a dry heating block and stored at -30oC until use. 
PCR. As a comparison, two sets of PCR reactions were performed, using LAMP outer 
primers F3/B3, and the widely used Vvh-785F/Vvh-1303R primers specific for the V. vulnificus 
vvhA gene (Kaysner & DePaola, 2001). 
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Table 5 - 1 Bacterial strains used in this study, their source, and specificity of the Vibrio 
vulnificus cytolysin/hemolysin (vvhA) gene amplification by LAMP and PCR 
Strain ID, species and groupa Source and originb vvhA amplification 
LAMP PCR 
V. vulnificus clinical strain (n = 5)    
    ATCC 27562  Blood, Florida  + + 
    ATCC 29306 Corneal ulcer + + 
    ATCC 33815 Leg ulcer, Wisconsin + + 
    ATCC 33816 Blood, Alaska + + 
    1007 Clinical, Louisiana + + 
V. vulnificus environmental strain (n = 15)   
WR1 Sea Water, Washington + + 
515-4C2 Oyster, California + + 
541-0-84c Oyster, Gulf, Louisiana + + 
0106-0-14 Oyster, Gulf, Louisiana + + 
V97 Oyster, Gulf, Louisiana + + 
V156 Oyster, Gulf, Louisiana + + 
V195 Oyster, Gulf, Louisiana + + 
V196 Oyster, Retail, Louisiana + + 
V206 Oyster, Retail, Louisiana + + 
V240 Oyster, Retail, Louisiana + + 
V261 Oyster, Retail, Louisiana + + 
V276 Oyster, Retail, Louisiana + + 
V314 Oyster, Retail, Louisiana + + 
V325 Oyster, Retail, Louisiana + + 
V350 Oyster, Retail, Louisiana + + 
V. parahaemolyticus O3:K6 group (n = 2)  
    CT-6636, O3:K6 Clinical, Connecticut - - 
    TX-2103, O3:K6 Clinical, Texas - - 
V. parahaemolyticus non-O3:K6 group (some with unknown serotypes, n = 11)   
    8332924, O1:K56 Oyster, Gulf of Mexico - - 
    NY477, O4:K8 Oyster, New York - - 
    ATCC 49529, O4:K12 Feces, California - - 
    M350A, O5 Oyster, Washington - - 
    ATCC 17802 Shirasu food poisoning, Japan - - 
    ATCC 27969 Blue crab, Maryland - - 
    ATCC 33847 Gastroenteritis, Maryland - - 
    916i Oyster, Gulf, Louisiana - - 
    541-0-44c Oyster, Gulf, Louisiana - - 
    V50 Oyster, Retail, Louisiana - - 
    V150 Oyster, Retail, Louisiana - - 
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Table continued 
Other Vibrio spp. (n = 5)    
    V. alginolyticus ATCC 17749 Spoiled horse mackerel, Japan - - 
    V. cholera ATCC 14035; O:1 NCTC, United Kingdom - - 
    V. cincinnatiensis ATCC 35912 Blood/cerebrospinal fluid, Ohio - - 
    V. harveyi ATCC 35084 Brown shark, Maryland - - 
    V. mimicus ATCC 33655 Feces, Tennessee - - 
Non-Vibrio spp. (n = 12)    
    Campylobacter jejuni 81-176 Human - - 
    Enterobacter aerogenes ATCC 13048 Sputum, South Carolina - - 
    Enterococcus faecalis ATCC 29212 Urine - - 
    Escherichia coli ATCC 25922 Human - - 
    Listeria monocytogenes ATCC 13932, 4b Spinal fluid, Germany - - 
    Listonella anguillarum ATCC 19264 Ulcerous lesion in cod, UK - - 
    Pseudomonas aeruginosa ATCC 27853 Human blood - - 
    Salmonella enteria Typhimurium LT2 Unknown - - 
    Shigella flexneri ATCC 12022 Unknown - - 
    Shigella sonnei ATCC 25931 Human feces, Panama - - 
    Staphylococcus aureus ATCC 29213 Wound - - 
    Streptococcus pneumoniae ATCC 49619 Sputum, Arizona - - 
a ATCC, American Type Culture Collection, Manassas, VA. 
b NCTC, the National Collection of Type Cultures, London, United Kingdom. 
“+” stands for amplificaition of the gene, “-” stands for no amplification of the gene. 
 
The PCR mixture contained 1 × PCR buffer, 0.2 mM of each deoxynucleotide 
triphosphate (dNTP), 1.5 mM of MgCl2, 0.5 µM of each primer (synthesized by Invitrogen, 
Carlsbad, CA), 0.5 U of Taq DNA polymerase (Applied Biosystems, Foster City, CA), and 2 µl 
of DNA template in a total volume of 25 µl. The PCR reaction was conducted using 30 cycles of 
denaturation at 94°C for 1 min, primer annealing at 58°C for 1 min, extension at 72°C for 1 min, 
and a final extension at 72°C for 7 min in a GeneAmp PCR System 2400 (Applied Biosystems). 
Aliquots (10 µl) of PCR products were analyzed by electrophoresis on 2% agarose gel, stained 
with ethidium bromide, and visualized under UV light. Gel images were documented by a Bio-
Rad Gel Doc XR system (Hercules, CA). 
LAMP. The LAMP mixture in 25 μl total volume consisted of the following: 1 × Thermo 
buffer (containing 2 mM MgSO4), 6 mM of MgSO4, 0.8 M of betaine (Sigma-Aldrich, St. Louis, 
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MO), 1.4 mM of dNTP, 0.2 μM of each outer primer, 1.6 μM of each inner primer, 8 U of Bst 
DNA polymerase (New England Biolabs, Ipswich, MA), and 2 µl of DNA template. The LAMP 
reaction was carried out at 63oC for 1 h and terminated at 80oC for 2 min in a water bath. 
Aliquots (2 µl) of LAMP amplicons were analyzed similarly by gel electrophoresis.  
 LAMP Specificity and Sensitivity. The 50 bacterial strains in Table 5-1 were used to 
determine the LAMP specificity in a blinded manner. DNA templates were made from fresh 
overnight bacterial cultures and subjected to both LAMP and PCR amplification. False positive 
and false negative rates, if any, were calculated. Specificity tests were repeated twice. 
 To determine the sensitivity of the optimized LAMP assay, tenfold serial dilutions of an 
overnight V. vulnificus 1007 culture were prepared in sterile saline solution, quantified using 
standard plate counts on TSA with 2% NaCl, and aliquots (2 µl) were subjected to both LAMP 
and PCR amplification. Sensitivity tests were repeated five times and the data were presented as 
the lower limits of detection (CFU/reaction). 
Detection of V. vulnificus in Seeded Oyster Tissue Homogenate. V. vulnificus strain 
1007 was used to evaluate the capability of LAMP to detect the bacterium in oyster tissue 
homogenates. All oyster samples (12 oysters per sample) were collected from local seafood 
restaurants between February and August 2006, shucked, and homogenized with equal volume of 
alkaline peptone water (APW; BD Diagnostic Systems) in a food stomacher (Model 400; 
Tekmar Company, Cincinnati, OH). Aliquots of the 1:1 oyster homogenate were tested for the 
presence of V. vulnificus by direct plating and enrichment following procedures described in our 
previous study (Han et al., 2007), and the remainders were stored at -80oC until use. Only oyster 
homogenates that were tested negative for V. vulnificus were used in the following seeded oyster 
experiments, which were repeated five times. 
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Tenfold serial dilutions of a fresh overnight V. vulnificus 1007 culture were made in 
sterile saline, and 1 ml of each dilution was added into 1 ml (i.e., 0.5 g) of thawed oyster tissue 
homogenate, resulting in bacterial concentrations ranging from approximately 108 CFU/g to 1 
CFU/g of oyster tissue. Negative oyster control sample without inoculation was also included. 
For direct detection, the seeded oyster samples were mixed well and aliquots (1 ml) were 
centrifuged at 200 g for 5 min to remove oyster tissues. Supernatants were transferred to a fresh 
tube, centrifuged at 12,000 g for 10 min and the pellets were resuspended in 200 µl TE. After 
heating at 95oC for 10 min to release the DNA, the solution was centrifuged again at 12,000 g for 
10 min, and an aliquot (2 µl) of the supernatant was used for both LAMP and PCR amplification. 
Alternatively, a dilution step was added right after inoculation by adding 1 ml of the seeded 
oyster sample into 50 ml of APW, and processed similarly as above.  
For enrichment, 1 ml of each dilution of the overnight V. vulnificus 1007 culture was 
added into a flask containing 48 ml of sterile APW and 1 ml (i.e., 0.5 g) of thawed oyster tissue 
homogenate, and enriched at 35oC for 5 h. After enrichment, aliquots (1 ml) were taken and 
processed similarly as above. The V. vulnificus levels after enrichment were quantified by 
standard plate counts on both TSA with 2% NaCl and mCPC agar. 
Visualization of LAMP Amplicons by the Naked Eye. To facilitate future field 
applications of the LAMP assay, detection of LAMP amplicons was also carried out by 
inspection with naked eyes as described by Parida et al. (Parida et al., 2007). Briefly, after 
LAMP amplification, each reaction tube was inspected first for white turbidity, then observed 
immediately for color change (from orange to green or greenish yellow) after adding 0.5 μl of 
SYBR Green I dye (Invitrogen). The SYBR Green I color change was observed under both 
natural light and UV. 
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Results 
Figure 5-1 indicates that six specific locations on the V. vulnificus cytolysin/hemolysin 
gene (vvhA) were recognized by the LAMP primers, along with detailed information on each 
LAMP primer. The detection of LAMP amplicons was done by conventional gel electrophoresis, 
turbidity inspection, and color observation with the aid of SYBR Green I fluorescent dye. 
 
Figure 5 - 1 Partial nucleotide sequence of the cytolysin/hemolysin (vvhA) gene of Vibrio 
vulnificus EDL174 (accession number M34670), six target regions, and four primers used in the 
LAMP assay.  
Underlined sequences are the six target regions. Oligonucleotide sequences in bold and also 
listed at the bottom were used as LAMP primers. F3 and B3 are the forward outer primer and 
backward outer primer, respectively. FIP and BIP are the forward inner primer and the backward 
inner primer, respectively. 
 
Specificity and Sensitivity of the LAMP Assay. Among 50 bacterial strains used to 
determine the LAMP specificity, all of the 20 V. vulnificus clinical and environmental strains 
generated the typical ladder-like LAMP banding pattern, and none of the 30 non-V. vulnificus 
strains were positive for LAMP (Table 5-1, second to the last column). There was no false 
positive or false negative reactions detected, indicating the LAMP assay was highly specific. 
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Similarly, two sets of PCR assays using both F3/B3 and Vvh-785F/Vvh-1303R did not produce 
any false positive or false negative results when testing the 50 bacterial strains (Table 5-1, the 
last column).  
The sensitivity of the LAMP assay was determined by testing tenfold serial dilutions of V. 
vulnificus 1007 and comparing it with that of the two conventional PCRs. LAMP was found to 
be 10-fold more sensitive than PCR, with a detection limit of approximately 20 CFU versus 202 
CFU for PCR (Figure 5-2, Table 5-2), whereas the two PCR assays using either F3/B3 or Vvh-
785F/Vvh-1303R primers possessed the same level of sensitivity (data not shown). 
 
Figure 5 - 2 Sensitivity of vvhA LAMP (A) and PCR (B) for detecting Vibrio vulnificus 1007 in 
pure cultures.  
For PCR products shown here, primers used were F3 and B3, and the expected size was 217 bp. 
In both gel, lanes 1-7 are amplicons from serial tenfold dilutions of a bacterial culture (1.01 × 108 
CFU/ml). Two μl of boiled bacterial dilutions were added into the reaction tube, resulting in the 
total CFU numbers in individual tube for lanes 1-7 were 2.02 × 105, 2.02 × 104, 2.02 × 103, 2.02 
× 102, 20.2, 2.02, and 2.02 × 10-1, respectively. Lane 8 is 100 bp molecular weight marker (New 
England Biolabs). Negative controls used were water (not shown). In gel A, 2 μl of LAMP 
amplicons were loaded per lane, whereas in gel B, 10 μl of PCR amplicons were loaded per lane. 
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Table 5 - 2 Comparison of sensitivities of LAMP and PCR in detecting Vibrio vulnificus 1007 in 
pure cultures and seeded oyster samples 
Samples and preparations Methods Detection limit (CFU or CFU/g)a 
Cells in the reaction 
tube (CFU)b 
Pure culture LAMP 20 20 
PCR 202 202 
Seeded oyster  
(no enrichment, no dilution) 
LAMP 4×108 4×106 
PCR ND N/A 
Seeded oyster  
(no enrichment, with dilution) 
LAMP 4×107 8×103 
PCR ND N/A 
Seeded oyster  
(5 h enrichment) 
LAMP 7 80 
PCR 7×103 4×105 
a For pure culture, the unit for detection limit was colony forming unit (CFU), whereas the units 
for those in seeded oysters were CFU/g of oyster tissue.  
b The formula used to calculate the number of cells in the reaction tubes were: cell concentration 
(CFU/ml)×2×10-3 for pure culture, CFU/ml×10-2 for seeded oyster with no enrichment or 
dilution, CFU/ml×2×10-4 for seeded oyster with no enrichment but with 1:50 dilution before 
detection, CFU/ml after enrichment×10-2 for seeded oysters with 5 h enrichment.   
ND means not detected. N/A means not applicable. 
 
LAMP Detection of V. vulnificus in Experimentally Seeded Oysters. When applying 
LAMP and PCR for the direct detection of V. vulnificus in experimentally seeded raw oysters 
without enrichment, LAMP was able to detect V. vulnificus only at the highest inoculum level 
tested, i.e. 4×108 CFU/g. When the seeded oyster samples were diluted 1:50 in APW before 
detection, the LAMP detection limit without enrichment increased tenfold to 4×107 CFU/g 
(Table 5-2). PCR, however, failed to detect any of the seeded oyster samples without enrichment.  
After 5 h enrichment in APW, the LAMP assay was able to detect an initial V. vulnificus 
inoculum of 7 CFU/g of oyster tissue, when the actual V. vulnificus level in the enrichment broth 
reached approximately 8×103 CFU/ml based on cellobiose-positive colony counts on mCPC agar. 
The detection limit of PCR for seeded oyster samples after enrichment was 1,000-fold higher 
than that of LAMP, i.e., 7×103 CFU/g in the case of PCR, which had an actual cell concentration 
of 4×107 CFU/ml after 5 h enrichment.  
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Direct Visualization of LAMP Amplicons by the Naked Eye. Following LAMP 
amplification at 63oC for 1 h in a water bath, white turbidity could be observed in LAMP-
positive samples with the naked eye (Figure 5-3). After adding 0.5 µl of SYBR Green I 
fluorescent dye, the LAMP-positive samples clearly showed color change from original orange 
color to green or greenish yellow under normal light, whereas for LAMP-negative samples, the 
tubes remained the original orange color of the dye (Figure 5-3A). The color difference was 
more obvious when both positive and negative tubes were exposed to UV light, as positive tubes 
fluoresced bright green (Figure 5-3B). No turbidity change or color change after adding SYBR 
Green I was observed in PCR-positive samples. 
 
 
 
Figure 5 - 3 SYBR Green I fluorescent dye-mediated visualization of LAMP amplification 
products by the naked eye under normal light (A) and UV (B).  
After 0.5 μl of SYBR Green I was added, positive wells immediately turned green or greenish-
yellow, whereas negative wells remained the orange color of the dye. This color difference was 
more obvious under UV as positive wells fluoresced bright green. Both photos were taken by 
John Wozniak of the LSU Agricultural Center. 
 
Discussion 
As the cause of over 95% of seafood-related deaths (Oliver, 2006), V. vulnificus presents 
an imminent threat to public health as well as the Gulf oyster industry. To meet the regulatory 
guideline of less than 30 CFU/g of V. vulnificus in PHP oysters, a rapid, sensitive, specific, and 
B 
 A 
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cost-effective detection assay is desirable, particularly if the assay has the potential to be applied 
in the field. In this study, we applied a novel molecular detection assay, LAMP, for the rapid and 
sensitive detection of this pathogen in oyster tissue homogenate by targeting the vvhA gene. In 
this initial effort, the LAMP assay was developed and optimized, assay characteristics were 
evaluated, and its applicability in oyster samples were tested.  
The specificity of the LAMP assay was ensured by designing primers targeting unique 
regions of the vvhA gene, and was confirmed by testing 50 V. vulnificus and non-V. vulnificus 
strains. This is not surprising since LAMP assays inherently carry a high level of specificity due 
to the fact that at least six regions on the target DNA sequence were targeted (Notomi et al., 
2000). Similarly, PCR using two LAMP outer primers also demonstrated high levels of 
specificity, further confirming that the region of vvhA used for primer design is unique to V. 
vulnificus. 
When testing V. vulnificus in pure cultures, the LAMP assay was found to be 10-fold 
more sensitive than the two conventional PCRs included for comparison, capable of detecting 20 
CFU of V. vulnificus per reaction tube. This greater sensitivity of LAMP compared to PCR has 
been reported previously (Hara-Kudo et al., 2005; Hara-Kudo et al., 2007; Yano et al., 2007), 
however, PCR was found to be one order more sensitive than LAMP in detecting 
Flavobacterium columnare when 40 cycles of PCR reaction was used rather than 30 (Yeh et al., 
2006). In addition, the LAMP sensitivity observed in this study was comparable to previously 
reported real-time PCR assays for detecting V. vulnificus, ranging from 6 CFU to 100 CFU 
(Campbell & Wright, 2003; Panicker et al., 2004).  
In addition to its specificity and sensitivity, LAMP was demonstrated to be a faster assay 
than PCR, taking 1 h rather than > 2 h for PCR. Moreover, during LAMP amplification, very 
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large amount of amplicons were generated rapidly, which could result in white turbidity as well 
as SYBR Green I fluorescent dye color change. PCR, on the other hand, did not generate 
sufficient amount of amplicons to be detected by these simple visual observations. According to 
Mori et al., LAMP synthesized DNA in the range of 10-20 µg/25 µl reaction mix, whereas DNA 
yield by PCR was about 0.2 µg/25 µl (Mori et al., 2001). This discrepancy accounted for the 
different reactions observed when adding SYBR Green I dye. This unique yet simple detection 
method for LAMP could facilitate future field applications of the assay.  
When the optimized LAMP assay was used to detect V. vulnificus in experimentally 
seeded Louisiana raw oysters, LAMP was demonstrated to be much less susceptible to certain 
inhibitors present in oyster samples, resulting in 1,000 fold greater sensitivity than PCR for 
detection following enrichment (Table 5-2). Nonetheless, although an internal amplification 
control was not included in our assay development, the inhibitory effects of certain biological 
substances in the oyster samples were obvious, as evidenced by much hampered sensitivity 
compared to that in pure cultures (Table 5-2). This observation was in contrast to a previous 
report that conducted inhibition control study in Alabama oysters and concluded that the oyster 
tissue matrix did not affect the sensitivity of a real-time PCR (Panicker & Bej, 2005). This 
discrepancy could be due to that oyster samples from different regions were assessed. Diluting 
the seeded oyster samples in APW (1:50) before detection was tested, and it lowered the 
detection limit by 10-fold. However, as indicated in Table 5-2, the actual number of cells in the 
reaction tube after this dilution step was 8×103 compared to 4×106 without dilution, suggesting 
that the dilution procedure did greatly reduce the oyster matrix effect. 
Our data clearly indicated that when DNA amplification assays such as LAMP were 
applied to the detection of Vibrio in oysters, direct detection without enrichment lacked the 
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needed sensitivity (30 CFU/g). Based on theoretical calculations, given a LAMP detection limit 
of 20 cells/reaction (2 µl) in pure cultures, it needs at least 1×104 CFU/ml bacteria in oyster 
homogenate not counting oyster matrix effects. There was also a dilution factor (1:50) to reduce 
inhibitor concentrations (1 ml of bacterial suspension into 50 ml APW) and a concentrating 
factor (5:1) during sample preparation (1 ml into 200 µl TE). Taken together, a cell concentration 
of at least 1×105 CFU/ml (i.e., 1×105 CFU/g) is needed. Therefore, enrichment seems an 
inevitable step in terms of V. vulnificus detection in oysters, concurring with findings in the 
literature (Panicker et al., 2004; Panicker & Bej, 2005). Very recently, two studies using real-
time PCR to detect pathogenic V. parahaemolyticus (Nordstrom et al., 2007) or V. vulnificus 
(Wright et al., 2007) also sought to use a combination of MPN enrichment and real-time PCR 
approach to achieve the needed sensitivity. In this regard, the LAMP assay could readily pair 
with MPN but further evaluation is needed. 
During the assay development and application in oyster samples, several simple 
centrifugation steps were used to remove oyster liquid and tissue, which were quite efficient and 
achieved a detection limit of 7 CFU/g after enrichment. This level of detection was comparable 
to that of previously reported assays by real-time PCR (Panicker et al., 2004; Panicker & Bej, 
2005), and well met the current ISSC recommended 30 CFU/g guidelines (Food and Drug 
Administration/National Shellfish Sanitation Program, 2005). This simple oyster sample 
processing method obviated the need for lengthy nucleic acid purification steps, therefore 
reducing the cost and turnaround time for detection. 
Conclusion 
A rapid, specific, and inexpensive LAMP assay for detecting V. vulnificus in raw oysters 
was developed and evaluated in this study. The lower limit of detection was 20 CFU of V. 
 106
vulnificus in pure cultures. After 5 h enrichment, the assay was capable of detecting 7 CFU/g V. 
vulnificus in experimentally inoculated Louisiana oyster samples. Because of its isothermal 
format and unique amplicon detection technique, this rapid and sensitive LAMP assay holds 
potential for future field application. Further optimization of the oyster sample processing 
procedure and large-scale testing on oyster samples obtained from various regions of the U.S. are 
needed to bring this assay a step closer to the field.  
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Introduction 
Vibrio vulnificus is a Gram-negative, halophilic bacterium that inhabits warm coastal and 
estuarine waters throughout the world (Oliver, 2006). Most human infections result from the 
consumption of raw or undercooked seafood, particularly oysters (Cholera and Other Vibrio 
Illness Surveillance, 2009). V. vulnificus is capable of causing fatal diseases such as primary 
septicemia and wound infections, with reported mortality rates over 50% and 25%, respectively 
(Oliver, 2006). At-risk groups for fatal V. vulnificus infections include people with 
immunocompromising conditions, diabetes, and elevated serum iron concentrations due to 
chronic liver disease or alcohol abuse (Strom & Paranjpye, 2000). Annually, there are 
approximately 30 V. vulnificus-associated deaths in the United States (Centers for Disease 
Control and Prevention, 2010). Therefore, rapid and sensitive detection assays are needed to 
facilitate better control of potential V. vulnificus infections from seafood consumption. 
Conventional culture-based methods for the detection and quantification of V. vulnificus 
include the most probable number (MPN) method and DNA hybridization, which are time-
consuming and labor-intensive (Kaysner & DePaola, 2001; Wright et al., 1993). Molecular-
based assays such as PCR and real-time PCR have been widely employed for the rapid, specific, 
and sensitive detection and quantification (in the case of real-time PCR) of V. vulnificus 
(Campbell & Wright, 2003; Coleman et al., 1996; Hill et al., 1991; Panicker et al., 2004; 
Panicker & Bej, 2005; Takahashi et al., 2005; Wright et al., 2007). A previous study reported 
that a real-time Taqman PCR assay was able to detect 1 CFU of V. vulnificus per gram of oyster 
tissue homogenate after 5 h enrichment (Panicker & Bej, 2005). However, for both PCR and 
real-time PCR, a dedicated thermal cycler is needed, which is rather expensive especially for 
real-time PCR, and hinders the wide application of such assays. 
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A newer DNA amplification technique, loop-mediated isothermal amplification (LAMP) 
was developed in 2000 (Notomi et al., 2000). LAMP utilizes four to six primers that specifically 
recognize six to eight regions of the target DNA sequence and amplifies millions of DNA copies 
under isothermal conditions (60-65oC) within an hour (Notomi et al., 2000). Since its invention, 
LAMP has been applied to detect multiple bacterial and viral agents, including those of major 
food safety concerns, such as Campylobacter, pathogenic, Escherichia coli, Salmonella, 
Staphylococcus aureus, and noroviruses (Goto et al., 2007; Hara-Kudo et al., 2005; Hara-Kudo 
et al., 2007; Yamazaki et al., 2008c; Yoda et al., 2007). Very recently, our research group and 
two others independently developed LAMP assays for V. vulnificus detection, of which two 
targeted the V. vulnificus hemolysin (vvhA) (Han & Ge, 2008; Ren et al., 2009) and one targeted 
the V. vulnificus toxR gene (Nemoto et al., 2008). These assays were reported to be specific and 
sensitive; however, none of them applied real-time LAMP for V. vulnificus quantification. One 
way to quantify LAMP products is by using a fluorescent DNA-intercalating dye as in a real-
time PCR format (Aoi et al., 2006; Hara-Kudo et al., 2005; Monis et al., 2005; Njiru et al., 
2008). Additionally, the formation of a by-product (magnesium pyrophosphate) during LAMP 
amplification causes turbidity change, which correlates with the amount of amplified DNA and 
could be monitored by a real-time turbidimeter (Mori et al., 2001; Mori et al., 2004). 
Built upon our previous report (Han & Ge, 2008), the present study aimed to develop 
real-time LAMP assays suitable for the quantitative detection of V. vulnificus in raw oysters by 
utilizing two real-time platforms, one was fluorescence-based and the other one turbidity-based. 
Materials and Methods 
 Bacterial Strains and DNA Templates Preparation. Vibrio vulnificus clinical strain 
ATCC 27562 was used for sensitivity testing. An additional 37 V. vulnificus clinical and 
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environmental strains and 42 non- V. vulnificus strains were used to evaluate assay specificity 
(Table 5-3). All Vibrio strains were grown overnight at 35oC on trypticase soy agar or in broth 
(TSA or TSB; BD Diagnostic Systems, Sparks, MD) supplemented with 2% NaCl. Non- Vibrio 
strains were grown on Luria-Bertani agar or blood agar (BD Diagnostic Systems). 
Table 5 - 3 Bacterial strains used in real-time LAMP study to detect total Vibrio vulnficicus 
Strain group Strain ID and serotype a Source and reference 
V. vulnificus, clinical ATCC 27562  Blood, Florida  
(n = 9) ATCC 29306 Corneal ulcer, Virginia 
 ATCC 33815 Leg ulcer, Wisconsin 
 ATCC 33816 Blood, Alaska 
 C7184 Thumb drainage, Texas (Oliver 
et al., 1982) 
 1003 Wound, Louisiana (Martin & 
Siebeling, 1991) 
 1004 Stool, Louisiana (Martin & 
Siebeling, 1991) 
 1006, 1007 Blood, Louisiana (Martin & 
Siebeling, 1991) 
V. vulnificus, environmental 
(n = 29) 
WR1 Sea water, Washington 
V195 Gulf oyster, Louisiana (Han et 
al., 2007) 
 V244, V262, V350, V353, V398, 
V420, V463, V531, V560, V606 
Retail oyster, Louisiana (Han et 
al., 2007) 
 132 (A1, B5, B8, T5, Z2), 212 
(B6, E12, F14, F15, F18, S7, S8, 
Y10), 342 (E3, E4, E6, E9)  
Gulf oyster, Louisianab 
V. parahaemolyticus ATCC 17802; O1:K1 Shirasu food poisoning, Japan 
(n = 20) ATCC 27969 Blue crab, Maryland 
 ATCC 33847 Gastroenteritis, Maryland 
 ATCC 49529; O4:K12 Feces, California 
 CT-6636; O3:K6 Clinical, Connecticut 
 M350A; O5 Oyster, Washington 
 NY477; O4:K8 Oyster, New York 
 TX-2103; O3:K6 Clinical, Texas 
 8332924; O1:K56 Oyster, Gulf of Mexico 
 83AO8757 Clinical, feces 
 83AO9148 Clinical, feces 
 83AO9756; O4:K12 Clinical, feces 
 84AO1516; O4:K12 Clinical, feces 
 84AO4226 Clinical, feces 
 916i, 541-0-44c, V68, V69, V155 Oyster, Gulf, Louisiana (Han et 
al., 2007) 
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Table continued   
 V86 Oyster, Retail, Louisiana (Han 
et al., 2007) 
Other Vibrio spp. (n = 10)    
Vibrio alginolyticus ATCC 17749 Spoiled horse mackerel, Japan 
 ATCC 33787 Seawater, Hawaii 
Vibrio cholerae ATCC 14035; O:1 NCTC, United Kingdom 
Vibrio cincinnatiensis ATCC 35912 Blood/cerebrospinal fluid, Ohio 
Vibrio fluvialis ATCC 33809 Human feces, Bangladesh 
Vibrio harveyi ATCC 14126 Dead amphipod, Massachusetts 
 ATCC 35084 Brown shark, Maryland 
Vibrio mimicus ATCC 33653 Human ear, North Carolina 
 ATCC 33655 Feces, Tennessee 
Vibrio natriegens ATCC 14048 Salt marsh mud, Georgia 
Non-Vibrio spp. (n = 12)   
Campylobacter jejuni  81-176 Human 
Enterobacter aerogenes  ATCC 13048 Sputum, South Carolina 
Enterococcus faecalis  ATCC 29212 Urine 
 Escherichia coli  ATCC 25922 Human 
 Listeria monocytogenes  ATCC 13932; 4b Spinal fluid, Germany 
 Litonella anguillarum  ATCC 19264 Ulcerous lesion in cod, UK 
Pseudomonas aeruginosa  ATCC 27853 Human blood 
Salmonella enterica  LT2; Typhimurium Unknown 
Shigella flexneri  ATCC 12022; 2b Unknown 
 Shigella sonnei  ATCC 25931 Human feces, Panama 
 Staphylococcus aureus  ATCC 29213 Wound 
 Streptococcus pneumoniae  ATCC 49619; type 59 Sputum, Arizona 
a ATCC, American Type Culture Collection, Manassas, VA; NCTC, the National Collection of 
Type Cultures, London, United Kingdom. 
b Isolated from three Louisiana coastal locations (designated as 132, 212, and 342) between 
2006-2007. 
 
DNA templates were prepared by suspending a single bacterial colony grown on 
appropriate agar plates in 500 µl of TE (10 mM Tris, pH 8.0; 1 mM EDTA; Sigma-Aldrich, St. 
Louis, MO), followed by heated at 95oC for 10 min in a dry heating block. After centrifuge at 
12,000 g for 2 min, the supernatants were stored at -30oC until use. To prepare templates for 
sensitivity testing, an overnight V. vulnificus ATCC 27562 culture was diluted 50 fold in TSB 
and incubated at 35°C for 5 h with shaking at 100 rpm. Serial 10-fold dilutions of the mid-log 
phase culture were made in phosphate-buffered saline (PBS; Sigma-Aldrich) and aliquots of each 
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dilution were used to prepare DNA templates similarly by the boiling method. The exact cell 
counts in the templates were obtained by standard plate counting on TSA with 2% NaCl.  
Fluorescence-based Real-time LAMP. Four LAMP primers (F3, B3, FIP, and BIP) 
targeting the V. vulnificus cytolysin/hemolysin gene (vvhA) as described in our previous report 
(Han & Ge, 2008) were adopted. Additionally, a loop primer (5-
TCCATTCGCCAGCAGTTACG-3) was designed using the PrimerExplorer software version 4 
(Fujitsu Limited, Japan; http://primerexplorer.jp/e). All primers were synthesized by Invitrogen 
(Carlsbad, CA). The LAMP reaction mix (25 μl) consisted of the following: 1 × Thermo buffer 
(New England Biolabs, Ipswich, MA), 6 mM of MgSO4, 0.8 M of betaine (Sigma-Aldrich), 1.4 
mM of deoxynucleotide triphosphate (dNTP), 0.2 μM of each outer primer (F3 and B3), 1.6 μM 
of each inner primer (FIP and BIP), 0.8 μM of the loop primer, 0.4 μM of SYTO-9 green 
fluorescent dye (Invitrogen), 8 U of Bst DNA polymerase (New England Biolabs), and 2 µl of 
DNA template. A positive control and a negative control were included in each LAMP run. 
For the fluorescence-based platform, the LAMP reaction was conducted in a SmartCycler 
II System (Cepheid, Sunnyvale, CA) at 63oC for 1 h. Fluorescence readings were obtained every 
60 s using the FAM channel (excitation at 450-495 nm and detection at 510-527 nm), followed 
by melting curve analysis from 63oC to 96oC with an increment of 0.2oC per second. The 
fluorescence threshold unit was set at 30 for background noise deduction.  
 Turbidity-based Real-time LAMP. The reaction mix was essentially the same as 
described above for the fluorescence-based platform except that SYTO-9 was omitted. The 
reaction was carried out at 63oC for 1 h and terminated at 80oC for 5 min in a real-time 
turbidimeter (LA-320C; Teramecs, Kyoto, Japan), which acquired turbidity readings of the 
LAMP reaction mix at 650 nm every 6 second. A turbidity threshold value of 0.1 was used. 
 116
 PCR. As a comparison, two sets of PCR assays targeting the vvhA gene were performed, 
one using the LAMP outer primers (F3/B3) (Han & Ge, 2008) and the other one using the Vvh-
785F/Vvh-1303R primers described in the U.S. Food and Drug Administration Bacteriological 
Analytical Manual (BAM) (Kaysner & DePaola, 2001). PCR conditions followed those 
described previously (Han & Ge, 2008; Kaysner & DePaola, 2001). 
 Assay Specificity and Sensitivity. Methods published previously were followed (Chen 
& Ge, 2010). Briefly, eighty bacterial strains (Table 5-3) were used to determine the real-time 
LAMP specificity. Aliquots (2 µl) of each DNA template were subjected to both real-time 
LAMP and PCR amplifications. Specificity tests were repeated twice. 
To determine LAMP sensitivity, aliquots (2 µl) of the 10-fold serial dilutions of 
sensitivity templates prepared above were subjected to both real-time LAMP and PCR 
amplifications. Sensitivity tests were repeated five times. 
 Quantification of V. vulnificus Cells in Spiked Oysters. Oyster samples were obtained 
from local seafood restaurants and determined to be V. vulnificus-free as described previously 
(Han et al., 2007). Oyster samples were processed following a previous study (Yamazaki et al., 
2008a) with slight modifications. Briefly, 25 g of oyster sample was mixed with 225 ml of 
alkaline peptone water (APW; BD Diagnostic Systems) and homogenized in a food stomacher 
(Model 400; Tekmar Company, Cincinnati, OH) for 90 s to generate 1:10 oyster in APW 
homogenate. After homogenization, aliquots (100 µl) of serial 10-fold dilutions of a mid-log 
phase V. vulnificus ATCC 27562 culture were inoculated into 900 µl of the 1:10 oyster in APW 
homogenate. The spiked oyster samples were mixed well and centrifuged at 900 g for 1 min to 
remove oyster tissues. The supernatants were transferred to a fresh tube and centrifuged at 
10,000 g for 5 min to pellet bacterial cells. After removing the supernatants, pellets were 
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resuspended in 100 µl of TE and boiled for templates as described above. Aliquots (2 µl) of the 
supernatant were used for both real-time LAMP and PCR amplifications. Three sets of 
independent spiking experiments were performed, and the LAMP reactions were repeated two 
times for each set of inoculation. 
Data Analysis. For specificity data, means and standard deviations of Ct (cycle 
threshold; for the fluorescence-based platform) or Tt (time threshold; for the turbidity-based 
platform) values were calculated by using the Microsoft Excel software (Microsoft, Seattle, WA). 
For sensitivity data, means and standard deviations of Ct or Tt values for detecting 10-fold serial 
dilutions of V. vulnificus ATCC 27562 in pure culture and spiked oyster homogenates were 
calculated similarly using Microsoft Excel. The limits of detection (CFU/reaction in pure culture 
or CFU/g in spiked oysters) were determined. In spiked oyster samples, CFU/reaction was 
calculated by using CFU/g × 0.09 g/ml × 10 × 2 × 10-3, i.e., CFU/g × 1.8 × 10-3. 
Standard curves to quantify V. vulnificus in pure culture and spiked oysters were 
generated by plotting Ct or Tt values against log CFU/reaction or log CFU/g and linear 
regression was calculated using Microsoft Excel. Amplification efficiency (E; %) was obtained 
by using the formula [10(–1/slope) – 1] × 100. 
Results 
Specificity of Real-time LAMP Assays. Among 80 bacterial strains used to determine 
LAMP specificity on two real-time platforms, no false positive or false negative results were 
observed. On the fluorescence-based platform performed in a SmartCycler II system, mean Ct 
values for 38 V. vulnificus clinical and environmental strains ranged between 15.01 and 24.37 
min, with an average of 19.35 ± 2.89 min. The melting temperatures for the 38 V. vulnificus 
strains consistently fell between 83.97 and 85.21oC, with an average of 84.79 ± 0.33oC. For 42 
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non- V. vulnificus strains, no Ct value was obtained, with melting curve analysis showing either 
no peak or a melting temperature at around 63oC, suggesting possible primer-dimer formations. 
Using the turbidity-based platform in a real-time turbidimeter, Tt values for the 38 V. vulnificus 
clinical and environmental strains ranged from 27.4 to 37.05 min with an average of 32.55 ± 2.92 
min. For the 42 non -V. vulnificus strains, no Tt value was obtained, indicating negative results 
for LAMP. 
Similarly, no false positive or false negative results for the 80 bacterial strains were 
observed by PCR using the two primer sets, F3/B3 and BAM primers, indicating good 
specificity. 
Sensitivity and Quantitative Capability of Real-time LAMP Assays. Figure 5-4 
presents sensitivity of the fluorescence-based real-time LAMP assay when testing 10-fold serial 
dilutions of V. vulnificus ATCC 27562 DNA templates.  
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 Figure 5 - 4 Sensitivity of the fluorescence-based real-time LAMP when detecting Vibrio 
vulnificus ATCC 27562 in pure culture. 
(A) A representative optic graph; (B) Corresponding melting curve analysis for samples shown 
in (A); (C) A standard curve generated based on five independent repeats. Samples (1-9) 
correspond to 10-fold serial dilutions of V. vulnificus ATCC 27562 cells ranging from 1 × 108 to 
1 CFU/reaction; sample 10 is water. 
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A representative optic graph, corresponding melting curve analysis, and a standard curve 
are shown in Figure 5-4A-C, respectively. For templates ranging in concentration from 1 × 108 to 
10 CFU/reaction, the average Ct values of five repeats ranged from 19.26 to 39.79 min, with 
melting temperatures consistently falling at around 86oC. For the 1 CFU template, in three out of 
five repeats, amplification occurred. Therefore, the detection limit of the fluorescence-based real-
time LAMP assay was 1-10 CFU/reaction. From the standard curve (Figure 5-4C) generated by 
the fluorescence-based real-time LAMP assay, the correlation coefficient (r2) was calculated to 
be 0.98 and the amplification efficiency (E) was 130%. 
Figure 5-5 shows the sensitivity of real-time LAMP on the turbidity-based platform when 
testing the same set of DNA templates. A representative turbidity judgment graph and a standard 
curve are shown in Figure 5-5A and 5-5B, respectively.  
 
Figure 5 - 5 Sensitivity of the turbidity-based real-time LAMP when testing the same set of 
Vibrio vulnificus ATCC 27562 DNA templates. 
(A) A representative turbidity judgment graph; (B) A standard curve generated based on 
five independent repeats. Samples 1-8 are the same as those shown in Figure 5-4, 10-fold serial 
dilutions of V. vulnificus ATCC 27562 cells ranging from 1 × 108 to 10 CFU/reaction 
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For templates ranging from 1 × 108 to 10 CFU/reaction, based on five repeats, the 
average Tt values fell between 34.5 and 51.1 min. In two out of five repeats, amplification of the 
1 CFU template occurred. Therefore, the limit of detection for the turbidity-based real-time 
LAMP assay was 1-10 CFU/reaction. Based on the standard curve (Figure 5-5B), the turbidity-
based real-time LAMP assay had an r2 value of 0.99 and an E value of 111%. 
When testing the same set of V. vulnificus ATCC 27562 templates by PCR using F3/B3 
and BAM primers, both primer sets detected 100 CFU/reaction, which were up to 100-fold less 
sensitive than real-time LAMP assays. 
Detection of V. vulnificus Cells in Spiked Oysters. In three independent spiking 
experiments, the average Ct values ranged from 25.26 to 34.10 min, whereas the average Tt 
values ranged from 39.83 to 54.80 min. The limit of detection by real-time LAMP assays using 
the two platforms was 116 CFU/reaction (i.e., 6.4 × 104 CFU/g) of V. vulnificus ATCC 27562 in 
spiked oyster samples without enrichment. However, for PCR assays using either F3/B3 or BAM 
primers, the limit of detection in spiked oysters was 6.4 × 107 CFU/g (data not shown), 1,000-
fold less sensitive than that of real-time LAMP assays. Standard curves (Figure 5-6) generated 
for the quantitative detection of V. vulnificus cells in spiked oyster samples had an r2 value of 
0.99 for both real-time LAMP platforms. 
Discussion 
In this study, we used our previously designed LAMP inner and outer primers (Han & 
Ge, 2008) and added a loop primer to specifically target the V. vulnificus vvhA gene. We further 
developed the LAMP assay by running on two real-time platforms, one was fluorescence-based 
and the other one turbidity-based, to quantitatively detect V. vulnificus in pure culture and spiked 
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oyster samples. This is the first report examining the quantitative capability of real-time LAMP 
for detecting V. vulnificus in oysters by targeting the vvhA gene. 
 
 
Figure 5 - 6 Quantitative detection of Vibrio vulnificus ATCC 27562 in spiked oysters by using 
fluorescence-based and turbidity-based real-time LAMP. 
Three sets of independent spiking experiments were performed, and the LAMP reactions were 
repeated two times for each set of inoculation. (A) A representative optic graph; (B) 
Corresponding melting curve analysis for samples shown in (A); (C) A representative turbidity 
judgment graph; (D) A standard curve generated for the fluorescence-based real-time LAMP; (E) 
A standard curve generated for the turbidity-based real-time LAMP. Samples 1-5 correspond to 
10-fold spiked oyster sample ranging from 6.4 × 107 to 6.4 × 103 CFU/g, sample 6 is water. 
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Among a total of 38 V. vulnificus and 42 non- V. vulnificus strains tested, the real-time 
LAMP assay run on both platforms achieved 100% inclusivity and 100% exclusivity. This level 
of specificity was the same as that of two PCR assays tested simultaneously in this study and 
several LAMP assays for V. vulnificus reported recently (Han & Ge, 2008; Nemoto et al., 2008; 
Ren et al., 2009). 
In addition to high specificity, the real-time LAMP assays were able to detect 1-10 
CFU/reaction of V. vulnificus, in contrast to 100 CFU/reaction by the two PCR assays. We 
previously reported a LAMP sensitivity of 20 CFU/reaction and a PCR sensitivity of 202 
CFU/reaction (Han & Ge, 2008), which are comparable to findings of this study. A toxR-based 
LAMP assay for V. vulnificus reported a minimum detection level of 1 CFU per test (Nemoto et 
al., 2008), whereas another vvhA-based LAMP assay found it to be 10-fold more sensitive than 
conventional PCR, although the exact cell number was not reported (Ren et al., 2009). 
Additionally, increased sensitivity (at least 10-fold) of LAMP compared to PCR was reported in 
studies on the detection of other Vibrio spp. (Fall et al., 2008; Yamazaki et al., 2008a; Yamazaki 
et al., 2008b) or other foodborne pathogens (Hara-Kudo et al., 2005; Hara-Kudo et al., 2007; 
Yano et al., 2007).  
 The addition of loop primers generally accelerates LAMP assay by hybridizing to stem-
loops formed during LAMP reaction and facilitating DNA strand displacement and amplification 
(Nagamine et al., 2002). In our previous study, we found that at least 45 min was required to 
reach a positive signal without the loop primer (Han & Ge, 2008). In this study, the time to 
positive results was shortened after adding the loop primer on both fluorescence- and turbidity-
based platforms, confirming the assay accelerating effect of the loop primer. Noticeably, when 
testing 38 V. vulnificus strains, the average time to positive results for the fluorescence-based 
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platform as indicated by Ct (19.35 min) was markedly shorter than that of the turbidity-based 
platform as indicated by Tt (32.55 min). Using YO-PRO-1 as the intercalating dye, a previous 
study also found that fluorescence-based real-time LAMP was faster than a turbidimetry real-
time LAMP (Aoi et al., 2006). In addition, that study reported that the fluorescence-based LAMP 
assay generated anomalous and irreproducible results in low-concentration templates (less than 1 
× 103 copies), which could be due to the effect of the intercalating dye on DNA amplification 
efficiency (Aoi et al., 2006). Similarly, in our study, the standard curve generated for the 
fluorescence-based real-time LAMP (Figure 5-4C) showed less reproducible data when the 
templates concentrations were below 3 log CFU/reaction. 
Previously, SYBR Green I has been used as a way to visually observe LAMP results after 
amplification (Han & Ge, 2008; Parida et al., 2007). Since LAMP reactions generate a large 
amount of DNA, this open-tube procedure after amplification potentially acts as a significant 
source of cross-contamination, so close-tube endpoint detection has been suggested (Mori et al., 
2006). Real-time LAMP assays run on either platform are advantageous in this regard since the 
DNA-intercalating dye was added in the reagent mix before amplification on the fluorescence-
based platform or omitted on the turbidity-based platform.  
For the fluorescence-based real-time LAMP, SYTO-9 was used in this study as the 
intercalating dye instead of the commonly used SYBR Green I for real-time PCR. A previous 
study found that SYTO-9 had lower inhibitory effect on the amplification and higher melting 
curve reproducibility over a broader range of dye concentrations than SYBR Green I (Monis et 
al., 2005). Additionally, EvaGreen (Biotium, Hayward, CA) was tested but showed high 
inhibition for LAMP amplification (data not shown). After optimizing SYTO-9 concentration, 
0.4 µM SYTO-9 was used.  
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The strong linear correlation (r2 = 0.98-0.99) between the number of V. vulnificus cells in 
the LAMP reaction and the associated Ct or Tt values over a dynamic range of template 
concentrations (108 to 103 CFU/reaction in pure culture and 105 to 102 CFU/reaction in spiked 
oyster extract) illustrates the quantitative capability of the real-time LAMP assays when 
detecting this organism in both pure culture and spiked oysters. Very few reports have examined 
the quantitative ability of LAMP. One study monitoring ammonia-oxidizing bacteria using 
LAMP also reported it to possess good quantitative capability between 1 × 104 to 1 × 1010 DNA 
copies (Aoi et al., 2006). 
In spiked oyster samples, a detection limit of 116 V. vulnificus CFU/reaction was found 
for real-time LAMP assays run on both platforms, which translates to 6.4 × 104 CFU/g of oyster 
sample. In contrast, the detection limit of two PCR assays was 6.4 × 107 CFU/g, indicating 
LAMP was less prone to inhibitor effects in oyster samples compared to PCR. In a most recent 
survey of the U.S. market oysters, approximately 44% of live oyster samples harvested from 
Lousiana exceeded 10,000 MPN/g for V. vulnificus whereas other states had non-detectable 
levels of this organism (DePaola et al., 2010). Nonetheless, given the severe disease symptoms 
and low infectious dose (less than 100) of this organism in immunocompromised persons (U.S. 
Food and Drug Asministration, 2009), the Interstate Shellfish Sanitation Conference 
recommends that all postharvest-processed oysters contain lower than 30 MPN/g of V. vulnificus 
(U. S. Food and Drug Administration, 2007). Therefore, without enrichment, DNA amplification 
assays such as LAMP, although potentially quantitative, lack the needed sensitivity when applied 
in oyster samples (Han & Ge, 2008). Combining MPN overnight enrichment (Nordstrom et al., 
2007) or pre-enrichment for 6 h (Nemoto et al., 2009) with LAMP or other DNA amplification 
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assays is a desirable approach to achieve the needed sensitivity, although in that situation, the 
quantitative capability of real-time LAMP would not be possible.  
The detection limit for V. vulnificus was higher in oyster samples (116 CFU/reaction) vs. 
in pure culture (1-10 CFU/reaction). However, since no extensive sample preparation other than 
homogenization and two simple centrifugation steps was required, the total assay time was 
significantly reduced. Adding the 1 h required for the real-time LAMP run, the complete LAMP 
detection system from sample preparation to quantitative result was markedly faster than either 
PCR or conventional culture-based methods.  
Conclusion 
In conclusion, the real-time LAMP assays developed in this study was a highly specific, 
sensitive, rapid, and quantitative method for the detection of V. vulnificus in oysters. Comparable 
sensitivity was obtained using the two real-time platforms, with the assay limits of detection to 
be approximately 1-10 CFU/reaction of V. vulnificus for pure culture, up to 100-fold more 
sensitive than PCR. When applied to spiked oyster samples, the real-time LAMP assays were 
able to detect 6.4 × 104 CFU/g of oyster without enrichment, 1,000 fold more sensitive than 
PCR. Standard curves generated for detecting V. vulnificus in both pure culture and spiked oyster 
samples showed good linear regression between cell counts and the fluorescence Ct or turbidity 
Tt values. Future testing with natural or commercial oyster samples is desired to further evaluate 
the efficacy of the assay. 
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Part III: Quantitative Detection of Virulent-Type Vibrio vulnificus in Raw Oysters by Real-Time 
Loop-Mediated Isothermal Amplification 
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Introduction 
Vibrio vulnificus is a Gram-negative, halophilic bacterium that inhabits warm coastal and 
estuarine waters worldwide. The organism is capable of causing fatal diseases such as primary 
septicemia and wound infections, with reported mortality rates over 50% and 25%, respectively 
(Oliver, 2006). At-risk groups for fatal V. vulnificus infections include people with 
immunocompromising conditions, diabetes, and elevated serum iron concentrations due to 
chronic liver disease or alcohol abuse (Strom & Paranjpye, 2000). The primary source of V. 
vulnificus infection has been reported to be the consumption of raw or undercooked seafood, 
particularly oysters (Rippey, 1994). Therefore, rapid and sensitive detection assays are needed to 
facilitate better control of potential V. vulnificus infections from oyster consumption. 
Besides being an opportunistic human pathogen, epidemiological data suggested that 
only a small percentage of V. vulnificus strains in oysters are virulent (Cholera and Other Vibrio 
Illness Surveillance, 2008; Jackson et al., 1997). However, none of the virulence factors 
identified to date (Jones & Oliver, 2009),  have been shown to be unique for virulent V. 
vulnificus. Therefore, alternative strategies are sought. Recently, several biomarkers have been 
explored to differentiate virulent- (i.e. clinical-) from non-virulent- (i.e. environmental-) type V. 
vulnificus strains, although with varied degree of success. Using a randomly amplified 
polymorphic DNA method, a virulence-correlated gene (vcg) was identified in V. vulnificus 
(Warner & Oliver, 1999). Testing 55 randomly selected V. vulnificus strains using this biomarker 
showed that 90% of clinical isolates possessed the vcgC sequence variant and 93% of 
environmental isolates had the vcgE variant (Rosche et al., 2005). One study characterizing vcg 
genotypes among V. vulnificus oyster and seawater isolates recovered from the eastern coast of 
North Carolina found that 84.4% of the 880 oyster isolates had the vcgE type, while a similar 
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distribution of the two vcg genotypes (46.9% vcgE versus 53.1% vcgC) was found among 292 
seawater isolates (Warner & Oliver, 2008). Secondly, polymorphism in 17 bp of the V. vulnificus 
16S rRNA gene has been explored to differentiate between clinical and environmental strains. A 
study showed that that the majority (31 out of 33) of nonclinical V. vulnificus isolates had 16S 
rRNA type A, whereas a significant percentage (24 out of 34) of clinical isolates belonged to 16S 
rRNA type B (Nilsson et al., 2003). Real-time PCR assays based on 16S rRNA polymorphism 
have been developed to differentiate virulent from non-virulent ones (Gordon et al., 2008; 
Vickery et al., 2007). Lastly, the capsular polysaccharide operon (CPS) has been identified, 
which showed a significant association between clinical isolates and CPS allele 1 whereas 
environmental isolates were associated with CPS allele 2 (Chatzidaki-Livanis et al., 2006a; 
Chatzidaki-Livanis et al., 2006b). In a previous study, we characterized 349 V. vulnificus isolates 
from the Gulf Coast and retail oysters in Louisiana using these biomarkers (Han et al., 2009). 
CPS tended to give a low estimate of potentially clinical important V. vulnificus strains compared 
to other biomarkers and the agreement between CPS and other biomarkers was poor, whereas 
vcg and 16S rRNA demonstrated good correlations (Han et al., 2009).  
The application of biomarkers for the detection of virulent-type V. vulnificus has been 
mostly used in PCR or real-time PCR assays. However, for both PCR and real-time PCR, a 
dedicated thermal cycler is needed, which is rather expensive and hinders the wide application of 
such assays. Loop-mediated isothermal amplification (LAMP), is a novel nucleic acid 
amplification assay developed in 2000 that utilizes four to six primers to specifically recognize 
six to eight regions of the target DNA sequence and amplify millions of DNA copies under 
isothermal conditions (60-65oC) within an hour (Notomi et al., 2000). Additionally, LAMP can 
be quantitative  (i.e., real-time LAMP) by measuring the formation of a by-product (magnesium 
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pyrophosphate) during LAMP amplification, which correlates with the amount of amplified 
DNA and could be monitored by a real-time turbidimeter (Mori et al., 2001; Mori et al., 2004). 
Since its invention, LAMP has emerged as a powerful tool by various investigators for the rapid 
detection of multiple bacterial and viral agents (Goto et al., 2007; Hara-Kudo et al., 2005; Hara-
Kudo et al., 2007; Yamazaki et al., 2008c; Yoda et al., 2007). Very recently, our research group 
and two others independently developed LAMP assays for V. vulnificus detection, of which two 
targeted the V. vulnificus hemolysin (vvhA) gene (Han & Ge, 2008; Ren et al., 2009) and one 
targeted the V. vulnificus toxR gene (Nemoto et al., 2008). However, no LAMP assay has been 
developed for the detection of virulent-type V. vulnificus. 
The present study aimed to develop a real-time-LAMP assay suitable for the quantitative 
detection of virulent-type V. vulnificus in raw oysters by targeting vcgC and 16S rRNA type B. 
Materials and Methods 
Target and LAMP Primer Design. The V. vulnificus vcgC (GenBank accession number 
AY626575) and 16S rRNA B type (GenBank accession number X76334) were selected as the 
target for LAMP primer design. A set of six primers, two outer and two inner, as well as two 
loop primers, that recognize eight distinct regions of the target sequence (Figure 5-7) was 
designed using the PrimerExplorer software (V4, Fujitsu Limited, Japan; 
http://primerexplorer.jp/e). Forward inner primer (FIP) consisted of a complementary sequence 
of F1 and a sense sequence of F2. Similarly, backward inner primer (BIP) was a combination of 
a complementary sequence of B1 and a sense sequence of B2. The two outer primers, forward 
outer primer and backward outer primer, were F3 and B3, respectively. LF and LB were two 
Loop primers designed to accelerate the amplification reaction. For 16S rRNA, specific primers 
with the potential to differentiate between A and B type sequences were designed using a special 
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feature of the software. All primers were synthesized by the Integrated DNA Technologies 
(Coralville, IA). 
Bacterial Strains and DNA Templates Preparation. V. vulnificus clinical strain ATCC 
33815 (vcgC +, 16S rRNA B +) was used for the sensitivity testing in pure culture and spiked 
oysters. Another 33 vcgC + and 50 vcgC - (i.e., vcgE type) V. vulnificus, as well as 30 other 
Vibrio and 12 non-Vibrio strains were used to evaluate vcgC LAMP assay specificity (Table 5-
4). Similarly, 33 16S rRNA B + and 50 16S rRNA B – (i.e., A type) V. vulnificus, as well as 30 
other Vibrio and 12 non-Vibrio strains were used to evaluate 16S rRNA LAMP assay specificity. 
All Vibrio strains were grown overnight at 35oC on trypticase soy agar or in broth (TSA or TSB; 
BD Diagnostic Systems, Sparks, MD) supplemented with 2% NaCl. Non-Vibrio strains were 
grown on Luria-Bertani agar or blood agar (BD Diagnostic Systems). 
Table 5 - 4 Bacterial strains used in LAMP to detect virulent-type Vibrio vulnificus 
Strain group Strain ID and serotype a Source and reference 
V. vulnificus, vcgC-type V199, V214, V241, V246, V332, V358,  
V360, V363, V371, V377, V385, V388, 
V389, V414, V419, V443, V444, V447, 
V457, V465, V469, V499, V501, V504,  
V513, V534, V544, V545, V552, V560,  
V576, V601, V616 
Gulf and Retail oyster, 
Louisiana (Han et al., 2007) (n = 33) 
  
  
  
  
V. vulnificus, vcgE-type V209, V213, V217, V223, V225, V238, 
V239, V240, V242, V248, V252, V260, 
V261, V274, V280, V292, V297, V299, 
V302, V304, V308, V324, V327, V328, 
V333, V337, V350, V354, V364, V372, 
V381, V383, V387, V392, V416, V432, 
V433, V438, V470, V471, V474, V477, 
V484, V490, V546, V574, V584, V598, 
V606, V631 
Gulf and Retail oyster, 
Louisiana (Han et al., 2007) (n = 50) 
  
  
  
  
  
  
  
Other Vibrio spp. (n = 30)  
Vibrio parahaemolyticus ATCC 17802; O1:K1 Shirasu food poisoning, 
Japan 
 ATCC 27969 Blue crab, Maryland 
 ATCC 33847 Gastroenteritis, Maryland 
 ATCC 49529; O4:K12 Feces, California 
 CT-6636; O3:K6 Clinical, Connecticut 
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Table continued   
 M350A; O5 Oyster, Washington 
 NY477; O4:K8 Oyster, New York 
 TX-2103; O3:K6 Clinical, Texas 
 8332924; O1:K56 Oyster, Gulf of Mexico 
 83AO8757 Clinical, feces 
 83AO9148 Clinical, feces 
 83AO9756; O4:K12 Clinical, feces 
 84AO1516; O4:K12 Clinical, feces 
 84AO4226 Clinical, feces 
 916i, 541-0-44c, V68, V69, V 86, V155 Gulf and Retail oyster, 
Louisiana (Han et al., 2007) 
Vibrio alginolyticus ATCC 17749 Spoiled horse mackerel, 
Japan 
 ATCC 33787 Seawater, Hawaii 
Vibrio cholerae ATCC 14035; O:1 NCTC, United Kingdom 
Vibrio cincinnatiensis ATCC 35912 Blood/cerebrospinal fluid, 
Ohio 
Vibrio fluvialis ATCC 33809 Human feces, Bangladesh 
Vibrio harveyi ATCC 14126 Dead amphipod, 
Massachusetts 
 ATCC 35084 Brown shark, Maryland 
Vibrio mimicus ATCC 33653 Human ear, North Carolina 
 ATCC 33655 Feces, Tennessee 
Vibrio natriegens ATCC 14048 Salt marsh mud, Georgia 
Non-Vibrio spp. (n = 12)   
Campylobacter jejuni  81-176 Human 
Enterobacter aerogenes  ATCC 13048 Sputum, South Carolina 
Enterococcus faecalis  ATCC 29212 Urine 
Escherichia coli  ATCC 25922 Human 
Listeria monocytogenes  ATCC 13932; 4b Spinal fluid, Germany 
Litonella anguillarum  ATCC 19264 Ulcerous lesion in cod, UK 
Pseudomonas aeruginosa  ATCC 27853 Human blood 
Salmonella enterica  LT2; Typhimurium Unknown 
Shigella flexneri  ATCC 12022; 2b Unknown 
Shigella sonnei  ATCC 25931 Human feces, Panama 
Staphylococcus aureus  ATCC 29213 Wound 
Streptococcus pneumoniae  ATCC 49619; type 59 Sputum, Arizona 
a ATCC, American Type Culture Collection, Manassas, VA; NCTC, the National Collection of 
Type Cultures, London, United Kingdom. 
 
 
DNA templates were prepared by suspending a single bacterial colony grown on 
appropriate agar plates in 500 µl of TE (10 mM Tris, pH 8.0; 1 mM EDTA; Sigma-Aldrich, St. 
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Louis, MO) and heated at 95oC for 10 min in a dry heating block. After centrifuge at 12,000 g for 
2 min, the supernatants were stored at -30oC until use.  
To prepare templates for sensitivity testing, an overnight V. vulnificus ATCC 33815 
culture was diluted 50 fold in TSB and incubated at 35°C for 5 h with shaking at 100 rpm. Serial 
10-fold dilutions of the mid-log phase culture were made in phosphate-buffered saline (PBS; 
Sigma-Aldrich) and aliquots of each dilution were used to prepare DNA templates similarly by 
the boiling method. The exact cell counts in the templates were obtained by standard plate 
counting on TSA with 2% NaCl.  
Real-time LAMP Reaction. The real-time LAMP reaction mix (25 μl) consisted of the 
following: 1 × Thermo buffer (New England Biolabs, Ipswich, MA), 6 mM of MgSO4, 0.8 M of 
betaine (Sigma-Aldrich), 1.4 mM of deoxynucleotide triphosphate (dNTP), 0.2 μM of each outer 
primer (F3 and B3), 1.6 μM of each inner primer (FIP and BIP), 0.8 μM of each loop primer (LF 
and LB), 8 U of Bst DNA polymerase (New England Biolabs), and 2 µl of DNA template. A 
positive control and a negative control were included in each LAMP run. The reaction was 
carried out at 63oC for 1 h and terminated at 80oC for 5 min in a real-time turbidimeter (LA-
320C; Teramecs, Kyoto, Japan), which acquired turbidity readings of the LAMP reaction mix at 
650 nm every 6 seconds. The cutoff values for positive samples were determined when turbidity 
increased above the threshold value, which was fixed at 0.1.  
PCR. As a comparison, two sets of PCR targeting the vcgC gene were performed: one 
using the vcgC LAMP outer primers (F3/B3) and the other one using P1/P3 (Rosche et al., 2005). 
Similarly, two sets of PCR targeting the 16S rRNA B type were performed: one using the 16S 
rRNA B LAMP outer primers (F3/B3) and the other one using B F1/ B R1 (Warner & Oliver, 
2008). The 25 μl PCR mixture contained 1 × PCR buffer, 0.2 mM of each dNTP, 1.5 mM of 
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MgCl2, 0.5 unit of GoTaq Hot Start Polymerase (Promega, Madison, WI), 0.2 µM of forward 
and reverse primer, and 2 µl of DNA template. The PCR reaction was conducted using 95°C for 
5 min followed by 30 cycles of denaturation at 94°C for 1 min, primer annealing at 55°C for 1 
min, extension at 72°C for 1 min, and a final extension at 72°C for 7 min in a Bio-Rad C1000 
Thermal Cycler (Hercules, CA). PCR products were analyzed by electrophoresis on 2.0% 
agarose gel containing ethidium bromide, and visualized under UV light, and documented by a 
Gel Doc XR system (Bio-Rad).  
Real-time LAMP Optimization. The assay optimization was performed using V. 
vulnificus ATCC 33815 by varying assay parameters including the concentrations of MgCl2 (2 to 
10 mM in 2 mM increments), betaine (0 to 1 M in 0.2 M increments), dNTP (0.4 to 2 mM in 0.4 
mM increments), enzyme (2 to 10 U in 2 U increments), inner primer (1.2 to 2.0 M in 0.2 M 
increments), outer primer (0.05 to 0.4 M in 0.05 M increments) and loop primer (0.2 to 1.0 
M in 0.2 M increments), assay temperature (60 to 65oC in 2.5 oC increments) and duration (30 
to 60 min in 15 min increments). Each of the optimization experiments were repeated three 
times. 
Real-time LAMP Specificity and Sensitivity. A total of 125 bacterial strains (Table 5-
4) were used to determine the real-time LAMP specificity. Aliquots (2 µl) of each DNA template 
were subjected to both real-time LAMP and PCR amplifications. Specificity tests were repeated 
twice. 
To determine real-time LAMP sensitivity, aliquots (2 µl) of the 10-fold serial dilutions of 
sensitivity templates prepared above were subjected to both real-time LAMP and PCR 
amplifications. Sensitivity tests were repeated five times. 
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Quantification of Virulent-type V. vulnificus Cells in Spiked Oysters. Oyster samples 
were obtained from local seafood restaurants and determined to be V. vulnificus-free as described 
previously (Han et al., 2007). Oyster samples were processed following a previous study 
(Yamazaki et al., 2008a) with slight modifications. Briefly, 25 g of oyster sample was mixed 
with 225 ml of alkaline peptone water (APW; BD Diagnostic Systems) and homogenized in a 
food stomacher (Model 400; Tekmar Company, Cincinnati, OH) for 90 s to generate 1:10 oyster 
in APW homogenate. Aliquots (100 µl) of serial 10-fold dilutions of a mid-log phase V. 
vulnificus ATCC 33815 were inoculated into 900 µl of the 1:10 oyster in APW homogenate. The 
spiked oyster samples were mixed well and centrifuged at 900 g for 1 min to remove oyster 
tissues. The supernatants were transferred to a fresh tube and centrifuged at 10,000 g for 5 min to 
pellet bacterial cells. After removing the supernatants, pellets were resuspended in 100 µl of TE 
and boiled for templates as described above. Aliquots (2 µl) of the supernatant were used for 
both real-time LAMP and PCR amplifications. Three sets of independent spiking experiments 
were performed, and the real-time LAMP and PCR reactions were repeated three times for each 
set of inoculation. 
Data Analysis. For specificity data, means and standard deviations of Tt (time threshold) 
for turbidimeter were calculated by using the Microsoft Excel software (Microsoft, Seattle, WA). 
For sensitivity data, means and standard deviations of Tt values for detecting 10-fold serial 
dilutions of V. vulnificus ATCC 33815 in pure culture and spiked oyster homogenates were 
calculated similarly using Microsoft Excel. The limits of detection (CFU/reaction in pure culture 
or CFU/g in spiked oysters) were determined. In spiked oyster samples, CFU/reaction was 
calculated by using CFU/g × 0.09 g/ml × 10 × 2 × 10-3, i.e., CFU/g × 1.8 × 10-3. 
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Standard curves to quantify V. vulnificus in pure culture and spiked oysters were 
generated by plotting Tt values against log CFU/reaction for pure culture or log CFU/g for 
spiked oyster and linear regression was calculated using Microsoft Excel. Amplification 
efficiency (E; %) was obtained by using the formula [10(–1/slope) – 1] × 100. 
Results 
LAMP Primer Design. We designed a LAMP assay targeting vcgC, which indicates that 
six specific locations on the vcgC were recognized by the LAMP primers, along with detailed 
information on each LAMP primer (Figure 5-7).  
 
Figure 5 - 7 Partial nucleotide sequence of the vcgC type of Vibrio vulnificus (accession number 
AY626575). 
F3 and B3 are the forward outer primer and backward outer primer, respectively. FIP and BIP 
are the forward inner primer and the backward inner primer, respectively. LF and LB are the 
Loop F and Loop B primer, respectively.  
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For 16S rRNA, we designed a total of 13 pairs of primers and tested their specificity, 
which indicated none of those primers could differentiate virulent-type V. vulnificus from non-
virulent-type strains. The only difference is the virulent-type strains would amplify faster than 
non-virulent-type ones (~10 min earlier); however, within one hour, all V. vulnificus strains 
could be detected in the turbidimeter regardless of virulent-type and non-virulent-type strains 
Figure 5-8 showed the amplification graph by one set of primer in the turbidimeter using V. 
vulnificus ATCC 33815 (16S rRNA B +, black line, Tt =19.8 min) and V. vulnificus WR1 (16S 
rRNA B -, green line, Tt = 26.2 min), suggesting non-specific amplification. Therefore, after 
testing 13 pairs of primers, we withdrew 16S rRNA B type as a target for the remaining sections 
of this study. 
 
Figure 5 - 8 16S rRNA-LAMP using Vibrio vulnificus ATCC 33815 and WR1.  
Sample 1 is V. vulnificus ATCC 33815. Sample 2 is V. vulnificus WR1. Sample 3 is water. 
 
Real-time LAMP Optimization. The optimized LAMP assay reagent mix and reaction 
condition for vcgC were: 6 mM MgCl2, 0 M betaine, 1.2 mM dNTP, 10 U Bst DNA polymerase, 
2.0 M each inner primer, 0.05 M each outer primer, and 1.0 M each loop primer at 65oC for 
40 min. Figure 5-9 showed the amplification graph in the turbidimeter using V. vulnificus ATCC 
33815 under optimized condition (red line, Tt = 18.27 min) compared to the prototype condition 
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(black line, Tt = 26.33 min). Besides decreasing Tt values, the optimized LAMP conditions also 
achieved higher signal intensity. 
 
Figure 5 - 9 Comparison between optimized LAMP and prototype LAMP using Vibrio vulnificus 
ATCC 33815.  
Sample 1 is under optimized condition. Sample 2 is under prototype condition. Sample 3 is 
water. 
 
Specificity of the Real-time LAMP Assay. Among 125 bacterial strains (Table 5-4) 
used to determine LAMP specificity, no false positive or false negative results were observed. 
The Tt values for the 33 vcgC-type V. vulnificus ranged from 16.1 to 22.3 min with an average of 
18.17 ± 1.45 min. For the other 92 strains, no Tt value was obtained, indicating negative results 
for real-time LAMP. 
For PCR results, 33 vcgC-type V. vulnificus could amplify using both F3/B3 and P1/P3 
primers while no PCR amplification was observed for the other 92 bacterial strains, indicating 
good specificity (data not shown). 
Sensitivity and Quantitative Capability of Real-time LAMP Assay. Figure 5-10 
presents sensitivity of the vcgC real-time LAMP assay in turbidimeter and two sets of PCR 
amplification when testing 10-fold serial dilutions of V. vulnificus ATCC 33815 DNA templates. 
A representative turbidity graph and a standard curve are shown in Figure 5-10A and 5-10B, 
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respectively. For templates ranging from 5.4 × 104 to 5.4 CFU/reaction, based on five repeats, 
the average Tt values fell between 17.5 and 31.0 min. In two out of five repeats, amplification of 
the 0.5 CFU template occurred. Therefore, the limit of detection for the real-time LAMP assay 
was 0.5-5.4 CFU/reaction. Based on the standard curve (Figure 5-10B); the real-time LAMP 
assay had an r2 value of 0.97 and an E value of 105%. 
When testing the same set of V. vulnificus ATCC 33815 templates by PCR using F3/B3 
and P1/P3, F3/B3 PCR detected 5.4 × 102 CFU/reaction (Figure 5-10C) while P1/P3 PCR 
detected 5.4 × 103 CFU/reaction (Figure 5-10D), which were up to 1,000-fold less sensitive than 
real-time LAMP assay. 
 
Figure 5 - 10 Sensitivity of vcgC real-time LAMP and PCR when testing serial-diluted Vibrio 
vulnificus ATCC 33815 DNA templates. 
(A) A representative real-time LAMP turbidity graph; (B) A standard curve of real-time LAMP 
generated based on five independent repeats. (C) PCR using F3/B3 primer (226 bp). (D) PCR 
using P1/P3 primer (278 bp). Samples (1-7) correspond to 10-fold serial dilutions of V. vulnificus 
ATCC 33815 cells ranging from 5.4 × 104 to 0.05 CFU/reaction; sample 8 is water. M is 
molecular DNA marker. 
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Real-time LAMP in Spiked Oysters. A representative turbidity graph and a standard 
curve of vcgC LAMP in spiked oyster are shown in Figure 5-11A and 5-11B, in comparison with 
PCR using F3/B3 PCR (Figure 5-11C) and P1/P3 PCR (Figure 5-11D). In three independent 
spiking experiments, the average Tt values ranged from 17.47 to 25.7 min. The limit of detection 
by real-time LAMP assay was 4.52 CFU/reaction (i.e., 2.5 × 103 CFU/g) of V. vulnificus ATCC 
33815 in spiked oyster samples without enrichment. However, for PCR assays using F3/B3 
primer, the limit of detection in spiked oysters was 2.5 × 106 CFU/g; and PCR using P1/P3 could 
detect 2.5 × 107 CFU/g, 1,000-fold less sensitive than that of real-time LAMP assay. Standard 
curves generated for the quantitative detection of V. vulnificus cells in spiked oyster samples had 
an r2 value of 0.99. 
 
Figure 5 - 11 Quantitative detection of vcgC real-time LAMP and PCR using Vibrio vulnificus 
ATCC 33815 in spiked oysters. 
(A) A representative real-time LAMP turbidity graph; (B) A standard curve of real-time LAMP 
generated based on three independent repeats. (C) PCR using F3/B3 primer (226 bp). (D) PCR 
using P1/P3 primer (278 bp). Samples (1-7) correspond to 10-fold spiked oyster sample ranging 
from 2.5 × 108 to 250 CFU/g, sample 8 is water. M is molecular DNA marker.
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Discussion 
We previously designed a LAMP assay targeting the V. vulnificus vvhA gene, which is a 
species-specific gene (Han & Ge, 2008), followed by developing a real-time LAMP assay to 
quantify total V. vulnificus (Chapter 4, Part II). Besides our studies, two other LAMP assays for 
V. vulnificus detection were reported, one targeting the vvhA gene (Ren et al., 2009) and the 
other the toxR gene (Nemoto et al., 2008), both species-specific genes. To our knowledge, this is 
the first report examining the quantitative capability of real-time LAMP for the detection of 
virulent-type V. vulnificus in oysters by targeting virulence-type biomarkers. 
We chose vcgC and 16S rRNA B type as target genes based on our previous study (Han 
et al., 2009). The mutual exclusivity of vcgC and vcgE sequences variants in V. vulnificus made 
vcgC a good candidate for virulent-type V. vulnificus characterization/detection, which was 
confirmed by several studies (Han et al., 2009; Rosche et al., 2005; Warner & Oliver, 2008). 
Practically, if a strain shows positive for vcgC by using vcgC LAMP, it would show negative for 
vcgE. When applying the vcgC LAMP in microbial ecology or epidemiological studies, it is 
acceptable to run the vcgC LAMP only, no need to test vcgE.  
For the other target, 16S rRNA B, we failed to generate satisfactory results with LAMP 
design. Among a total of 13 pairs of primers designed, none could effectively differentiate 
virulent-type V. vulnificus from non-virulent strains. Alignment between 16S rRNA A (non-
virulent-type, GenBank X76333) and B type (virulent-type, GenBank X76334) showed a 
difference of 17 bases out of 1,535 bases, with most of the polymorphism centered near helix 10 
of the secondary structure for bacterial 16S rRNA (Van de Peer et al., 1996). The alignment 
between 16S rRNA A and B type identified three variable regions, positions 177 to 186 (contain 
5 bases), 437 to 483 (contain 8 bases), 999 to 1016 (contain 4 bases), which could be used as 
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targets to design primers for differentiation of B type from A type. Our LAMP primer design, 
although tried on different positions of the three variable regions in our 13 pairs of primer sets, 
could not succeed in sufficient differentiation of 16S rRNA B type from A type. In the 
previously studies, the 16S rRNA was used in a real-time format which applied primer and probe 
to obtain specific amplification (Vickery et al., 2007). 
Using the optimized conditions of vcgC LAMP, the amplification time to a positive result 
was greatly accelerated compared to the prototype, as shown in Figure 5-9, which requires less 
than 20 min to be positive in a turbidimeter. Surprisingly, 0 M betaine was found to be most 
effective during assay optimization, which suggested that in a LAMP assay, betaine should be 
deleted to make the assay more efficient and cost-effective. Also, using the optimized conditions, 
the Tt values for the 33 vcgC-type V. vulnificus in the specificity test had an average of 18.17 
min, while the prototype condition has an average amplification time 27.17 min (data not 
shown). Currently, most reported LAMP studies did not conduct the optimization; instead using 
the amplification kit originally developed by the Eiken company (Tokyo, Japan). Our study, 
however, emphasized the importance of optimization studies for each specific primer set 
designed.  
Among a total of 33 vcgC-type and 50 vcgE-type V. vulnificus, as well as 30 other Vibrio 
and 12 non-Vibrio strains tested, the real-time LAMP assay achieved 100% inclusivity and 100% 
exclusivity, indicating high specificity. Similarly, the two sets of PCR, F3/B3 and P1/P3, were 
highly specific for virulent-type, non-virulent-type V. vulnificus and other strains. 
In addition to high specificity, the vcgC real-time LAMP assay was able to detect 0.5-5 
CFU/reaction of V. vulnificus, in contrast to 500-5 × 103 CFU/reaction by the two PCR assays. 
We previously reported a vvhA-based LAMP sensitivity of 20 CFU/reaction and a PCR 
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sensitivity of 202 CFU/reaction (Han & Ge, 2008) and further a real-time LMAP that could 
detect 1-10 CFU/reaction and a PCR comparison of 100 CFU/reaction (chapter 5, part II), which 
are comparable to findings of this study. A toxR-based LAMP assay for V. vulnificus reported a 
minimum detection level of 1 CFU per test (Nemoto et al., 2008), whereas another vvhA-based 
LAMP assay found it to be 10-fold more sensitive than conventional PCR, although the exact 
cell number was not reported (Ren et al., 2009). Additionally, increased sensitivity (at least 10-
fold) of LAMP compared to PCR was reported in studies on the detection of other Vibrio spp. 
(Fall et al., 2008; Yamazaki et al., 2008a; Yamazaki et al., 2008b; Yamazaki et al., 2010) or 
other foodborne pathogens (Hara-Kudo et al., 2005; Hara-Kudo et al., 2007; Yano et al., 2007).  
The strong linear correlation (r2 = 0.97-0.99) between the number of V. vulnificus cells in 
the LAMP reaction and the associated Tt values over a dynamic range of template concentrations 
(104 to 100 CFU/reaction in pure culture and 105 to 100 CFU/reaction in spiked oyster sample) 
illustrates the quantitative capability of the real-time LAMP assays when detecting virulent-type 
V. vulnificus in both pure culture and spiked oysters. Very few reports have examined the 
quantitative ability of LAMP, most on viruses (Mekata et al., 2009; Parida et al., 2006). 
Recently, a real-time LAMP assay was developed to target toxR in V. parahaemolyticus, and the 
linear correlation (r2) between the number of V. parahaemolyticus cells in the LAMP reaction 
and the associated Tt values was 0.94 (Chen & Ge, 2010) . 
In spiked oyster samples, a detection limit of 4.5 V. vulnificus CFU/reaction was found 
for real-time LAMP assay, which translates to 2.5 × 103 CFU/g of oyster sample. In contrast, the 
detection limit of two PCR assays was 2.5 × 106 / 2.5 × 107 CFU/g, indicating real-time LAMP 
was much less prone to inhibitor effects in oyster samples compared to PCR. Nonetheless, no 
extensive sample preparation other than homogenization and two simple centrifugation steps 
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were required. This significantly reduced the total assay time. Combined with less than 1 h for 
the real-time LAMP assay, the complete LAMP detection system was markedly faster than either 
PCR or conventional methods. On the other side, LAMP can be combined with overnight 
enrichment or pre-enrichment for 6 h to achieve higher sensitivity, although in that situation, the 
quantitative capability of real-time LAMP would not be possible.  
Conclusion 
The real-time LAMP assays targeting vcgC developed in this study was a highly specific, 
sensitive, rapid, and quantitative method for the detection of virulent-type V. vulnificus in 
oysters. The detection limit of the real-time LAMP assay was 0.5-5 CFU in pure cultures, 1,000-
fold more sensitive than conventional PCR. In spiked oyster samples, the real-time LAMP assay 
was able to detect 2.5 × 103 CFU/g of V. vulnificus without enrichment. Standard curves 
generated in both pure culture and spiked oyster samples showed good linear relationship 
between virulent-type V. vulnificus cell counts and the turbidity signals. This assay may facilitate 
regulatory and oyster industry personnel to better control potential V. vulnificus risks associated 
with oyster consumption. Future testing with natural oyster samples is desired to further evaluate 
the LAMP efficacy in a setting more close to application. 
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CHAPTER 6: CONCLUSIONS 
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The incidence of infections of Vibrio parahaemolyticus and V. vulnificus due to the 
consumption of oysters has shown a sustained increase since 2001, indicating further measures 
are needed to prevent human Vibrio illness. Given the lack of information on the prevalence, 
antimicrobial susceptibility profiles, and genotypic pattern of those two vibrios in Louisiana 
oysters, as well as the lack of sensitive and cost-effective methods that could be applied in the 
field sites, we conducted this research project.  
We isolated a total of 622 Vibrio isolates, consisting of 252 V. parahaemolyticus and 370 
V. vulnificus, from a total of 94 Louisiana oyster samples collected quarterly over a 15-month 
period from the Gulf Coast and obtained weekly from four retail outlets for 7 months. Overall, 
the prevalence of one or both species fell between 58.3% and 100%. The antimicrobial 
susceptibility testing of a randomly selected subset of 319 isolates indicated that the only 
resistance detected was for ampicillin, with 136 (42.6%) of the isolates showing either 
intermediate or resistant phenotype, all being V. parahaemolyticus. This study represents the first 
report on both prevalence and antimicrobial susceptibility of V. parahaemolyticus and V. 
vulnificus from Louisiana Gulf and retail oysters since 1998. 
Following the isolation, we characterized 349 V. vulnificus oyster isolates by the 
presence/absence of a viuB-associated fragment and genotypes of three biomarkers: vcg, 16S 
rRNA, and CPS. Genotyping data indicated that environmental-type V. vulnificus strains 
accounted for the majority of oyster isolates. Additionally, the presence of the viuB fragment 
(41%) was significantly associated with clinical genotypes of V. vulnificus. An interesting 
seasonal pattern was observed, with clinical-type V. vulnificus isolates more frequently 
associated with warmer months. This is the first study that a combination of these four 
biomarkers was used to independently evaluate their usefulness in predicting clinically important 
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V. vulnificus isolates from oysters. This study was followed up with the development of 
multiplex PCR assays and demonstrated the detection and characterization of general and 
virulent-type V. vulnificus in a single reaction. 
Finally, we adopted a novel DNA amplification technique, LAMP to detect assays for 
total or virulent-type V. vulnificus. No false positive or false negative results were observed. The 
real-time LAMP assay, in both fluorescence- and turbidity-based real-time platforms could 
detect approximately 1-10 CFU per reaction of total V. vulnificus for pure culture, and 6.4 × 104 
CFU/g for spiked oyster without enrichment. When real-time LAMP was applied for the 
quantitative detection of virulent-type V. vulnificus by targeting the vcgC gene, the detection 
limit of the real-time LAMP assay was 0.5-5 CFU in pure culture, and 2.5 × 103 CFU/g of V. 
vulnificus in spiked oyster without enrichment, up to 1,000-fold more sensitive than conventional 
PCR. Standard curves generated in both pure culture and spiked oyster sample testing showed 
good linear relationship between total or virulent-type V. vulnificus cell counts and the turbidity 
signals. 
This dissertation research provided comprehensive information on the genotypes, 
population dynamics, and antimicrobial resistance profiles of the two important vibrios. The 
development of LAMP assays provided invaluable tools for the regulatory agencies and seafood 
industry to facilitate better control of Vibrio in seafood, thereby reducing the incidence of 
foodborne illnesses and deaths resulting from the consumption of raw oysters due to the presence 
of these important Vibrio spp.  
The future study would include the continued surveillance of Vibrio in oysters to ensure 
seafood safety. Further evaluation of these assays using natural oysters will move these assays a 
step closer to field applications. 
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